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ABSTRACT
RecQ-like proteins are a family of DNA helicases that are evolutionary conserved from
prokaryotes to eukaryotes. A large amount of experimental evidence suggests these
proteins have a major role in the maintenance of genome stability. In humans five
RecQ-like helicase have been identified (RecQL1, BLM, WRN, RecQL4, and RecQL5),
three of which are associated with rare genetic disorders with sever chromosomal and
developmental abnormalities, and an elevated predisposition to cancer. Among the
disease associated RecQ-like helicases, BLM and WRN have been subject to extensive
research, while our collective knowledge about the function of RecQL4 is still very
limited. Similarly, little is known about the role of RecQL1 and RecQL5 in maintenance of
genome integrity. In the past studies of Sgs1, the Saccharomyces cerevisiae homolog of
RecQ, have been very informative regarding BLM function. Thus, here we sought to
further investigate BLM, RecQL1, and RecQL4 by using yeast as a model. By
constructing humanized yeast strains we evaluated the ability of these genes to
complement defects observed in sgs1∆. In Chapter 2, our investigation led to the
development of a novel chimeric system, which was able to complement some defects
of the sgs1∆ strain. In Chapter 3, by taking advantage of this chimeric system, we
evaluated 41 known BLM variants identified in the general human population. This study
resulted in identification of six novel variants that completely impaired BLM function and
three novel variants that partially impaired BLM function. In Chapter 4 we conducted
multiple yeast 2-hybrid screens in search for novel protein-protein interaction for RecQL1
and RecQL4. We have identified two new putatively interacting partners for RecQL1 and
xiv

three putatively interacting partners for RecQL4. In Chapter 5, functional characterization
of RecQL1, BLM, RecQL4 and RecQL5 in yeast suggested genetic interaction between
BLM and RecQL4 and RecQL5. Finally, in Chapter 6 a random mutagenesis screen of
BLM has led to identification a mutation that impairs BLM function by disrupting the
HRDC domain. This mutant suggests that the HRDC domain of BLM has an important
role in proper functionality of this helicase.

xv

CHAPTER 1:
HISTORY OF THE RECQ-LIKE FAMILY OF DNA HELICASES
The human genome encodes for 95 non-redundant helicase proteins, of which
64 are RNA helicases and 31 are DNA helicases. The RecQ-like, MCM, and RuvB-like
helicases are among the 31 DNA helicases. The identification of a group of helicases in
humans and their homologs in other model organisms suggests that the primary
members of helicase families are highly conserved throughout evolution (Umate, Tuteja
et al. 2011).

Discovery
In 1984, the Nakayama group conducted a screen for mutations that conferred
resistance to thymine starvation in Escherichia coli. They identified a mutant that
exhibited an increased sensitivity to ultraviolet radiation and named the gene responsible
“recQ” (Nakayama, Nakayama et al. 1984). Since its discovery, proteins identified in
various organisms with high homology to this DNA helicase have been collectively
referred to as the RecQ-like family. The RecQ-like DNA helicases are evolutionarily
conserved in both prokaryotes and eukaryotes. To date, more than 60 members of this
family have been identified in different organisms, including bacteria (E. coli), fungi
(Saccharomyces cerevisiae, Schizosaccharomyces pombe, Neurospora crassa), plants
(Arabidopsis thaliana) and animals (Caenorhabditis elegans, Drosophila melanogaster,
Xenopus laevis, Mus musculus, Homo sapians).

1

Similar to E.coli, the yeast S. cerevisiae has one known member of this helicase
family, Sgs1. In contrast, five homologs of the RecQ helicases have been identified in
humans. Moreover, some plant species (Arabidopsis thaliana) have as many as seven
RecQ homologs (Hartung, Plchova et al. 2000). Figure 1.1 provides a visual
representation of members of the RecQ-like family found in E.coli, S. cerevisiae, and
humans while identifying key conserved regions and domains.

Escherichia$coli!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!Amino!acids!
RecQ$
610$
Saccharomyces$cerevisiae!!
Sgs1$

1447$

Homo$sapiens!
RecQ1$

649$

BLM$

1417$

WRN$

1432$

RecQL4$

1208$

RecQL5$

991$

Helicase$domain$

Exonuclease$domain$

RQC$domain$

Acidic$residues$

HRDC$domain$

Nuclear$localizaHon$signal$

Figure 1.1. Select members of the RecQ-like family of helicases
RecQ-like family members identified in bacteria (RecQ), fungi (Sgs1), and humans
(RecQL1, BLM, WRN, RECQL4, and RECQL5). The conserved helicase domain is used
for alignment of the proteins, shown in red. The two other conserved RecQ-helicaseconserved (RQC) and Helicase/RNase D C-terminal (HRDC) domains are shown in
green and violet, respectively. The exonuclease domain in the N-terminal region of WRN
is shown in navy blue. Regions of acidic residues are shown in black. The nuclear
localization signal sequences found in C-terminus of BLM and WRN are shown in
orange.

2

Conserved domains of RecQ-Like members
Although the details of the molecular function of the RecQ-like family are not yet
clear, it is widely accepted that these proteins have a role in the maintenance of genome
stability and function at the interface between DNA replication and repair. This
hypothesis is derived from the knowledge acquired over the past 30 years about this
family of helicases.
RecQ-like proteins are part of a larger helicase family called Superfamily 2 (SF2).
The SF2 proteins are the largest superfamily and function in a variety of cellular
processes (Singleton, Dillingham et al. 2007). The members of the RecQ-like family all
share the seven-motif helicase domain (motifs I, Ia, II, III, IV, V, and VI) (Figure 1.1)
found in both helicase Superfamilies 1 and 2.

In addition, the RecQ-like proteins

possess a conserved motif upstream of motif I, referred to as motif 0 that is only found in
the SF2 family (Bernstein and Keck 2003).
The function of most of the motifs in the helicase domain have been identified,
either directly or by extrapolation, based on similarities to other proteins. For instance,
due to the high degree of similarity between motif 0 and the Q motif of the DEAD-box
RNA helicase (another member of the SF2 superfamily), characterization of the Q motif
has helped elucidate function of motif 0. As demonstrated by Tanner et.al (2003), this
motif assists in NTP binding and hydrolysis (Tanner, Cordin et al. 2003). Examination of
the crystal structure of the catalytic core of E.coli RecQ reveals that motif 0 creates a
pocket by which it accommodates ATP binding more efficiently than other NTP
molecules (Bernstein, Zittel et al. 2003). This finding correlates well with the fact that
RecQ of E.coli prefers ATP as a cofactor (Umezu, Nakayama et al. 1990).

3

Lobe 1

Lobe 2

ADP
Zn2+

Linker'between'
the'two'lobes'
Mg2+

Winged Helix
subdomain
Zinc binding
subdomain

Figure 1.2. Three-dimensional structure of the RecQL1 helicase core
The helicase core is comprised of the helicase domain and the RQC domain. The
helicase domain forms two lobes, denoted as lobe 1 and lobe 2 shown here in purple
and green respectively. A linker region indicated by a solid oval connects lobes 1 and 2.
The RQC domain is comprised of the zinc-binding subdomain (shown in yellow) and the
winged-helix subdomain (shown in orange). Included in this illustration are, the ADP
molecule in pink, Mg2+ as a yellow sphere, and Zn2+ as a red sphere. Similar domain
structure is present in RecQ, Sgs1, RecQL1, and BLM. Illustration modified from
(Bernstein, Zittel et al. 2003; Bernstein and Keck 2005).
Motifs I and II, most commonly known as Walker A and Walker B motifs,
respectively, are conserved among many proteins with ATP hydrolysis function (Walker,
Saraste et al. 1982; Ye, Osborne et al. 2004). Motifs I and II play a crucial role in
coordinating a Mg2+ ion adjacent to the ATP molecule (Ye, Osborne et al. 2004). The
combination of the phosphate binding loop formed by motif I, the interaction of the DExH
domain of motif II with ATP, and coordination of the Mg2+ ion by both motifs is required
for ATP hydrolysis. Distal to the Walker B motif (motif II) is an aromatic rich loop region
(AR loop). The AR loop, originally described in the helicase PcrA, has been
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demonstrated to have an important role in the coupling of ATP hydrolysis to DNA binding
and unwinding. (Dillingham, Soultanas et al. 1999; Velankar, Soultanas et al. 1999;
Dillingham, Soultanas et al. 2001). Motif VI has an arginine finger, which can be used to
communicate between the RecA-like domains of helicases. In the SF1 superfamily, this
arginine finger reaches into the ATP binding pocket and interacts with ATP. In RecQ-like
proteins, the arginine finger, in combination with the linker between the two lobes of the
helicase domain (Figure 1.2), could play a role in assisting with binding and hydrolysis of
ATP (Soultanas, Dillingham et al. 1999; Velankar, Soultanas et al. 1999; Killoran and
Keck 2006).
Motif Ia, which resides between the two Walker motifs, in collaboration with
motifs III and V, has been demonstrated to have role in single strand DNA (ssDNA)
annealing as determined by structural analysis (Korolev, Hsieh et al. 1997; Korolev, Yao
et al. 1998; Dillingham, Soultanas et al. 2001). Although very little is known about the
exact role of motif IV, it is hypothesized to have a role in stabilizing the helicase core and
assisting in DNA binding.
In addition to the helicase domain, most members of the RecQ-like family also
have a RecQ-helicase-conserved (RQC) domain and/or a Helicase/RNase D C-terminal
(HRDC) domain (Figure 1.1). The RQC domain and the helicase domain make up the
helicase core (Figure 1.2). The RQC domain is comprised of the zinc-binding and the
winged-helix (WH) subdomains. The zinc-binding subdomain consists of four conserved
cysteine residues, which together coordinate a zinc ion making a scaffold, which is
fundamental to the structural stability of the protein (Bernstein, Zittel et al. 2003;
Janscak, Garcia et al. 2003). In contrast, the WH subdomain appears to have varying
functions in different members of the RecQ-like family. Kitano et al., has demonstrated
that the WH subdomain plays a major role in binding and unwinding of DNA in the WRN
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helicase (Kitano, Kim et al. 2010). The authors illustrated that in the WRN helicase the
unwinding of the DNA double helix relies mostly on the RQC domain rather than the
helicase domain. However, in BLM, helicase activity is not impaired in the absence of
the WH subdomain (Gyimesi, Harami et al. 2012).
The exact function of the HRDC domain has not yet been established. Studies
from some groups have shown that this domain is not required for Sgs1 function, or
unwinding activity of BLM (Mullen, Kaliraman et al. 2000; Mirzaei, Syed et al. 2011;
Gyimesi, Harami et al. 2012). In contrast, others have demonstrated that the BLM HRDC
domain has an important role in the dissolution of the double Holliday junctions (Wu,
Chan et al. 2005; Kim and Choi 2010). The three-dimensional structure of the yeast
Sgs1 HRDC domain determined by NMR spectroscopy shows a structural scaffold
resembling auxiliary domains in proteins that are involved in DNA metabolism. Liu et al.
suggest that the HRDC domain of Sgs1 could function in regulation of the helicase
activity by providing additional contact with DNA (Liu, Macias et al. 1999).
In S. cerevisiae Sgs1 and E. coli RecQ, the HRDC domain preferentially binds
ssDNA. In contrast, the same domain in human WRN cannot bind ssDNA (Bernstein and
Keck 2005; Kitano, Yoshihara et al. 2007). Moreover, three-dimensional structure
analysis of the BLM HRDC domain by NMR reveals that, similar to Sgs1 and RecQ, the
BLM HRDC domain preferentially binds ssDNA. However, analysis of the affinity of each
of the HRDC domain in each of the three helicases (RecQ, Sgs1, and BLM) indicates
that E. coli RecQ has the highest affinity for ssDNA, while BLM has the lowest affinity
(Kim and Choi 2010).
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The Escherichia coli RecQ
The RECQ gene of E.coli is 1830 bp in length, which encodes a 609-residue
protein with a molecular weight of 68 kDa. This protein is an ATP-dependent DNA
helicase with 3’ to 5’ polarity (Umezu, Nakayama et al. 1990) and was discovered as a
component of the RecF recombinational pathway (Nakayama, Nakayama et al. 1984).
Aside from its helicase activity, this protein enhances the activity of topoisomerase III
while unwinding, resulting in enhanced supercoiling and catenation of covalently closed
DNA (Harmon, DiGate et al. 1999). As described by Hanada et al., this DNA helicase
also functions in blocking illegitimate recombination (Hanada, Ukita et al. 1997).
Furthermore, the activity of this protein is dependent on an Mg2+ ion and single strand
binding protein (SSB) (Harmon and Kowalczykowski 2001; Xu, Deprez et al. 2003).
RecQ has been shown to initiate SOS signaling when aiding in clearing of blocked
replication forks (Hishida, Han et al. 2004). The downstream affect of initiation of the
SOS signal leads to arrest of cell cycle progression followed by activation of various
other downstream pathways required for DNA repair (Radman 1975; Luchnik 1979). The
current model for the role of RecQ consists of two parts. First, by disruption of RecA
filament and D-loops, this helicase prevents illegitimate recombination (Figure 1.3). Next,
by assisting in removal of secondary DNA structures (or obstacles) in front of the
replication fork, this protein may help in restart of collapsed and stalled replication forks.
This task is further facilitated by the genetic interaction between RecQ and TopIII
(Figure 1.4).
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RecA, RPA, or Rad51
RecQ, Sgs1, or BLM

Figure 1.3. Disruption of homologous recombination (HR) intermediates by
RecQ-like helicases
In vitro analyses have demonstrated RecQ, BLM, and Sgs1 are able to disrupt HR at
crucial steps. (A) Disruption of the nucleoprotein filament. (B) Disruption of D-loop
formation. Illustration adopted from Bugreev, Mazina et al., (2009).
The Bernstein group has successfully crystalized the helicase core (comprising
the helicase domain and the RQC domain) as well as the HRDC domain (Bernstein,
Zittel et al. 2003; Bernstein and Keck 2005). The crystal structure revealed that the
catalytic core of this protein is composed of four subdomains (Figure 1.2). The first two
subdomains form the two lobes of the conserved helicase domain while the second two
subdomains together form the conserved RQC domain consisting of the zinc-binding
subdomain and the WH subdomain (Bernstein, Zittel et al. 2003).
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Figure 1.4. DNA structures processed by RecQ-like homologs
In vitro studies have demonstrated the ability of some members of the RecQ-like family
to unwind secondary DNA structures and to process stalled replication forks. Green
arrows indicate involvement of RecQ-like proteins while purple arrows indicate
processing in absence of RecQ-like proteins. (A) The resolution of DNA secondary
structures such as hairpins and G-quadruplexes. (B) The replication fork encountering a
blockage (shown in orange), which can be resolved by using the newly synthesized
strand as template to process through the blockage. (C) In the absence of RecQ-like
proteins, nicks and blocks could lead to replication fork collapse. The homologous
recombination pathway can repair the resulting double strand break.
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The Saccharomyces cerevisiae RecQ-like helicase
Similar to E.coli, S. cerevisiae only has one known RecQ homolog named Sgs1
(Slow Growth Suppressor 1). The 4344 bp long SGS1 gene encodes a 1447 residue
protein with a molecular weight of 163 kDa. Similar to RecQ of E.coli, the encoded
protein is a DNA helicase with 3’ to 5’ polarity (Bennett, Sharp et al. 1998). Sgs1 is most
closely related to the human BLM protein, which has led discoveries in Sgs1 to help
better understand many aspects of the BLM protein.
Sgs1 was first discovered when an sgs1 mutant strain suppressed the slow
growth observed in a top3 mutant strain (Gangloff, McDonald et al. 1994). Top3 is a
type IA topoisomerase and is able to relax negatively supercoiled DNA. This unique
interaction observed between Sgs1 and Top3 is evolutionarily conserved. First identified
as a genetic interaction in E.coli (Harmon, DiGate et al. 1999), in eukaryotes Sgs1 and
Top3 have evolved to physically interact (Gangloff, McDonald et al. 1994; Bennett,
Noirot-Gros et al. 2000; Johnson, Lombard et al. 2000; Fricke, Kaliraman et al. 2001).
An sgs1∆ mutant strain exhibits hypersensitivity when exposed to the DNA
damaging agent’s methyl methanesulfonate (MMS) or hydroxyurea (HU) (Yamagata,
Kato et al. 1998; Frei and Gasser 2000; Mirzaei, Syed et al. 2011). Upon treatment with
HU and MMS, Sgs1 has been shown to localize to stalled replication forks and physically
interact with Top3, Rmi1, and Rad53. This observation suggests that Sgs1 plays a role
in aiding with the restart of stalled replication forks (Frei and Gasser 2000). Moreover,
studies from the Brill laboratory have shown that there is a separation of function
between the amino terminus and the carboxyl terminus of the Sgs1 protein. They
demonstrated that the N-terminus is required for physical interaction with Top3 and has
no apparent catalytic function, whereas the C-terminal helicase domain is responsible for
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all catalytic activity. Nevertheless, both the C- and N-terminus are required for proper
function of this protein (Mullen, Kaliraman et al. 2000).
Similar to Bloom’s syndrome cells, sgs1∆ cells exhibit defective chromosome
segregation during mitosis and meiosis (Watt, Louis et al. 1995; Watt, Hickson et al.
1996). They also exhibit hyper-recombination between homologous chromosomes,
unequal sister chromatid recombination (Onoda, Seki et al. 2000), a moderate increase
in the rate of gross chromosomal rearrangement (Myung, Datta et al. 2001; Schmidt and
Kolodner 2006), and illegitimate recombination (Yamagata, Kato et al. 1998). In addition,
sgs1 mutants have a slightly suppressed growth rate and exhibit signs of premature
aging (Watt, Louis et al. 1995; Watt, Hickson et al. 1996; Sinclair, Mills et al. 1997).
The illegitimate recombination and hyper-recombination phenotype observed in
sgs1∆ cells is attributed to the absence of anti-recombinase activity normally associated
with Sgs1, similar to RecQ of E. coli and BLM (Gangloff, McDonald et al. 1994; Watt,
Hickson et al. 1996; Hanada, Ukita et al. 1997; Oh, Lao et al. 2007).
Sgs1 has also been demonstrated to play a role in processing double strand
breaks (DSBs) by aiding in resection and generation of ssDNA overhangs (Figure 1.5).
After recognition of the DSB by the MRX (Mre11, Rad50, Xrs2) complex, Sae2 in
collaboration with the MRX complex minimally process the break site producing
substrates for further resection by Exo1 or Sgs1/Dna2 (Mimitou and Symington 2008;
Cejka, Cannavo et al. 2010). In the proposed model, Sgs1 unwinds the DNA in the
presence of replication protein A (RPA) while exonuclease activity of Dna2 degrades the
5’ end of DNA.
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Figure 1.5. Resection by Sgs1/Dna2
This model demonstrates resection of the DNA at the site of DSB by collaboration
between Sgs1, Dna2, and RPA. In addition, provides an illustration of genetic interaction
between Sgs1/Dna2, Sae2 and Exo1. After recognition of a DSB by the MRX complex,
Sae2 collaborates with MRX to trim the ends of the break producing a substrate for Exo1
and Sgs1/Dna2. Illustration modified from Mimitou and Symington (2008).
In eukaryotes, DSBs are repaired by two major pathways: non-homologous end
joining (NHEJ) and homologous recombination (HR). In NHEJ, which is mostly active
during G1 phase of the cell cycle, the two ends of the break are minimally processed
and re-ligated. This type of repair is error-prone and can result in frame shifts. In
contrast, the HR pathway is considered mostly error-proof. HR pathway can be
subdivided into separate pathways, Synthesis Dependent Strand Annealing (SDSA) and
Double Strand Break Repair (DSBR). The main difference between the two pathways is
that repair by SDSA always results in non-crossover products (Figure 1.6). However, if
repair is completed by the DSBR, the resulting double Holliday junctions have a 50%
chance to generate non-crossover or crossover products (Figure 1.6).
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Figure 1.6. Double strand break repair by homologous recombination
After the ends of the site of DSB have been processed, the 3’ overhang invades a donor
molecule with the help of Rad51, the resulting D-loop is hypothesized to be processed in
one or all of the three possible models demonstrated here. The blue arrows illustrate a
path referred to as the Synthesis Dependent Strand Annealing (SDSA), the outcome of
which is always non-crossover products. In contrast, the red arrows show the path to
traditional repair by formation of a double Holliday junction, resolution of which can lead
to either non-crossover or crossover products. Last, the orange arrows show the path to
dissolution of the double Holliday junctions leading to only non-crossover products. BLM
and Sgs1 are thought to be involved in all three pathways but have a more important
role in SDSA pathway and those resulting in dissolution of double Holliday junction
leading to non-crossover products of the DSBR pathway. Green arrows represent Sgs1
or BLM while pink arrow represents Top3 or TopIIIα.
Sgs1 (and BLM) has been implicated in the dissolution of double Holliday
junctions (an intermediate of the DSBR pathway, Figure 1.6) leading to non-crossover
products. Although the details of the mechanism behind dissolution of double Holliday
junctions are not well understood, one model suggests that Sgs1 (and BLM) using
branch migration collides the two Holliday junctions. Once the Holliday junctions have
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merged, Top3 (or TopIIIα in humans) is able to decatenate and separate the two DNA
molecules (Wu and Hickson 2003; Johnson-Schlitz and Engels 2006; Branzei and Foiani
2007; Cejka, Cannavo et al. 2010). The Sgs1-Top3-Rmi1 complex is thought to be
responsible for this process in yeast. In humans, the BLM-TopIIIα-Rmi1/Rmi2 complex
(BRT) preforms this task (Ira, Malkova et al. 2003; Wu and Hickson 2003; Branzei and
Foiani 2007). More recently, biochemical studies have led to the hypothesis that Sgs1
(and probably BLM) aid in processing DSBs by repair through the SDSA pathway
(Figure 1.6). After formation of the D-loop and the joint molecule, the donor molecule is
used as template for synthesis of new DNA. Sgs1 assists by first unwinding the donor
DNA in front of the replication machinery and then by separating the two DNA molecules
after enough DNA has been synthesized. This process always results in non-crossover
products (Ira, Malkova et al. 2003; Cejka, Cannavo et al. 2010). The hypothesis is
further strengthened by the presence of elevated levels of sister chromatid exchange
and a shift towards crossover products in both sgs1∆ strains and BS cells.
Aside from Sgs1’s involvement in mediating repair of DSBs and the restart of
stalled replication forks, it has been suggested that Sgs1 might have a role in the
Alternative Lengthening of Telomeres (ALT) pathway. The ALT pathway also relies on
the HR machinery, and therefore it is hypothesized to involve Sgs1 (Cohen and Sinclair
2001; Johnson, Marciniak et al. 2001). The ALT repair pathway has two distinct products
referred to as type I and II. In type I repair, products are the result of subtelomeric
Y` element amplification while in type II products are the result of amplification of
TG-telomeric repeats. Sgs1 is assumed to have a role in bypassing cellular senescence
due to faulty telomerase by aiding in elongation of the TG-telomeric repeats (Cohen and
Sinclair 2001; Johnson, Marciniak et al. 2001).
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The Human RecQ-like homologs
Five homologs of the RecQ protein have been identified in humans: RecQL1,
BLM (RecQL2), WRN (RecQL3), RecQL4, and RecQL5 (Umate, Tuteja et al. 2011).
These five DNA helicases can be categorized into two classes based on protein size.
The smaller class is comprised of RecQL1 and RecQL5 (649 and 991 amino acids,
respectively) while the larger class is comprised of BLM, WRN and RecQL4 (1,417,
1,432 and 1,208 amino acids, respectively) (Umate, Tuteja et al. 2011). Interestingly, the
three RecQ-like proteins in the larger class are all associated with known genetic
disorders, while no diseases have yet been associated with members of the smaller
class. Defects in the BLM gene are associated with Bloom’s syndrome, while deleterious
mutations in the WRN gene are associated with Werner syndrome (Bachrati and
Hickson 2003). RecQL4 has been associated with three syndromes: RAPADILINO
syndrome, Baller-Gerold syndrome and Rothmund-Thomson syndrome (Dietschy,
Shevelev et al. 2007).

Bloom’s syndrome (BS)
Bloom’s syndrome (OMIM 210900)1 was first discovered and described in 1954
by David Bloom, a doctor of dermatology (Bloom 1954). Dr. Bloom described his patient
as a dwarf with a congenital telangiectatic erythema of the face resembling lupus
erythematosus and hypersensitivity to sunlight. The identification of two other patients
with almost identical characteristics including hypersensitivity to sunlight and butterflyshaped rash across the nose and cheeks, suggested a possibility of a syndrome entity
(Bloom 1954).

1

Online Mendelian Inheritance in Man, http://omim.org
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Since the discovery, 264 individuals have been diagnosed with this disease
(Ellis, Sander et al. 2008). BS caused by inactivation of the BLM gene, is an autosomal
recessive disorder with a founder effect identified in the Ashkenazi Jew population,
designated as BLMAsh. The BLMAsh mutation is present in the homozygous state in
almost all BS cases amongst this group, with a very high carrier frequency of 1%. This
allele is a result of a frame shift mutation caused by a six base deletion and a seven
base insertion upstream of the helicase domain (Straughen, Johnson et al. 1998).
BS is characterized by sun-sensitivity, proportionate pre- and postnatal growth
deficiency, telangiectatic erythema, hypopigmentation and hyperpigmentation, immune
deficiencies, infertility or subfertility, and an elevated predisposition to cancer (Sanz and
German 1993). Figure 1.7 provides a few examples of the symptoms observed in BS
individuals.

Other complications observed in individuals with BS include gastro

esophageal reflux, infection of the upper respiratory tract, middle ear infection, lung
infection, and type-II diabetes (Chaganti and German 1974; Sanz and German 1993;
Ellis and German 1996; Bachrati and Hickson 2003; Hickson 2003; Wu and Hickson
2003).
At the cellular level, BS cells present chromosomal instability in the form of
chromosomal breaks and gaps, structurally rearranged chromosomes, symmetrical
quadriradial

configurations,

translocations,

telomere-associated

breaks,

lagging

chromosomal fragments, and an elevated level of sister chromatid exchange (Figure 1.8)
(Chaganti, Schonber.S et al. 1974; German, Crippa et al. 1974). Both, elevated sister
chromatid exchange and formation of quadriradials are used as diagnostic tools for BS
(Sanz and German 1993)
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Figure 1.7. Select clinical features observed in Bloom’s syndrome individuals.
(A) Proportional dwarfism shown amongst two brothers. The one on the left has BS
while the brother on the right is unaffected (B) Hallmark butterfly-shaped rash across the
nose and cheeks (C) Hypopigmentation of the skin (D and E) congenital telangiectatic
erythema Photographs obtained from The Bloom’s Syndrome Registry2 and free online
collections (Bloom 1954; Sanz and German 1993).
.

2

http://med.cornell.edu/bsr/
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Figure 1.8. Chromosomal abnormalities observed in Bloom’s syndrome cells
(A) Chromosomal breaks. (B) Formation of symmetrical quadriradial configurations. (C)
Elevated level of sister chromatid exchange. (D) Normal levels of sister chromatid
exchange. (E) Chromosomal translocation. Photographs obtained from The Bloom’s
Syndrome Registry 3 and Carcinogenic Risk In Occupational Settings (CRIOS) 4
(Chaganti, Schonber.S et al. 1974; German, Crippa et al. 1974)
Although the exact function of BLM and the underlying cellular mechanism for the
appearance of chromosomal abnormalities observed in BS are unknown, in vivo and
in vitro studies have provided some explanation. As described earlier, appearance of
hyper- and illegitimate recombination observed in BS cells is thought to be the result of
the absence of anti-recombinase activity attributed to BLM (Gangloff, McDonald et al.
1994; Watt, Hickson et al. 1996). Evidence for BLM’s anti-recombinase activity is
provided by in vitro analysis, demonstrating BLM’s ability to disrupt homologous
recombination at two crucial steps of nucleoprotein filament and D-loop formation

3

4

http://med.cornell.edu/bsr/
http://goo.gl/Rb1zM
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(Figure 1.3A and B) (van Brabant, Ye et al. 2000; Bachrati, Borts et al. 2006; Bugreev,
Yu et al. 2007; Bugreev, Mazina et al. 2009). Briefly, Rad51 (a homolog of E.coli RecA)
forms a filament on the processed ssDNA at the site of a DSB. This nucleoprotein
filament is responsible for homology search and strand exchange (Park, Yoo et al.
2008), and can be displaced by BLM, thus preventing the initiation of homologous
recombination. Surprisingly, BLM has also been shown to stimulate Rad51 DNA
exchange activity depending on whether Rad51 is in the active ATP-bound or the
inactive ADP-bound form (Bugreev, Mazina et al. 2009). When Rad51 is in its inactive
form, BLM disrupts the filament; however, in the active form of Rad51, BLM interaction
with Rad51 stimulates DNA pairing (Bugreev, Mazina et al. 2009). Stimulation of Rad51
DNA pairing can be explained by the role of BLM in SDSA. It is hypothesized that similar
to Sgs1, BLM plays an important role in SDSA during which it aids formation of the joint
molecule and later helps by separating the two DNA molecules (Figure 1.6). This
function of BLM could explain the elevated sister chromatid exchange observed in BS
cells, which could be due to an increase in percent of crossover products when
non-crossover-yielding pathways are impaired in the absence of BLM.
Moreover, BLM has been demonstrated to promote Holliday junction branch
migration (Karow, Constantinou et al. 2000). Similar to Sgs1, BLM in complex with
TopIIIα and Rmi1/Rmi2 has been shown to be important in dissolution of double Holliday
junctions, resulting in non-crossover products (Figure 1.6) (Wu, Davies et al. 2001; Wu
and Hickson 2003; Yin, Sobeck et al. 2005; Raynard, Zhao et al. 2008). An elevated rate
of sister chromatid exchange observed in BS cells could also be explained partly due to
resolution of double Holliday junctions resulting in crossover products in the absence of
a functional BLM. Aside from BLM’s function in association with homologous
recombination machinery, in vitro studies have identified this proteins ability to unwind
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various DNA structures including those that may be encountered by moving replication
forks such as G-quadruplexes, hairpin structures (Figure1.4) (Karow, Chakraverty et al.
1997; Wu and Hickson 2003; Popuri, Bachrati et al. 2008).

Syndromes associated with RecQL4 defects
Defects in RecQL4 have been associated with three syndromes: RAPADILINO
syndrome, Baller-Gerold syndrome (BGS), and Rothmund-Thomson syndrome (RTS),
though there is some debate regarding whether they are actually variations of the same
disorder. This uncertainty is due to the fact that defects in RecQL4 specifically are
responsible for most reported cases of all three syndromes and because all three are
characterized by skeletal abnormalities, radial ray defects, growth deficiency, facial
dysmorphia, gastro-intestinal disturbance, and patellar abnormalities. RAPADILINO and
RTS individuals also present a higher occurrence of osteosarcoma in addition to the
above symptoms (Van Maldergem, Siitonen et al. 2006) (Figure 1.9).
Baller-Gerold syndrome (OMIM 218600) is a rare autosomal recessive disorder
characterized by radial aplasia/hypoplasia and craniosynostosis (premature fusion of
certain skull bones). BGS was named after Baller and Gerold who described the first
patients with radial hypoplasia associated with craniosynostosis in 1950 and 1959,
respectively (Van Maldergem, Siitonen et al. 2006; Siitonen, Sotkasiira et al. 2009).
Since the discovery, fewer than 20 cases of BGS have been reported, possibly
due to significant clinical overlap between BGS and other RecQL4-related syndromes
(RAPADILINO and Rothmund-Thomson syndrome) and non-RecQL4-related disorders
such as Fanconi anemia (OMIM 227650). Some of the overlapping Fanconi anemia
symptoms include: growth retardation, skeletal abnormalities, and radial ray defects.
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Figure 1.9. clinical features associated with RecQL4 Syndromes
Clinical features and overlaps associated with of the three syndromes caused by defects
in RecQL4. RecQL4 associated syndromes are RAPADILINO syndrome, Baller-Gerold
syndrome (BGS), and Rothmund-Thomson syndrome (RTS).
Rothmund-Thomson syndrome (OMIM 268400) was first described in 1868 by
German ophthalmologist Auguste Rothmund. At the time he was treating individuals of
an inbred family who presented a peculiar rash and bilateral juvenile cataracts (Wang,
Levy et al. 2001; Siitonen, Sotkasiira et al. 2009). In addition to the clinical symptoms
shared with RAPADILINO, RTS individuals present skeletal defects, dystrophic nails,
abnormal teeth, and cataracts. To varying degrees, they also show sensitivity to sunlight.
In some cases, radial ray hypoplasia or absent thumbs are observed (Wang, Levy et al.
2001). Clinical diagnosis of RTS relies predominately on the poikilodermatous rash. In
the event that onset or distribution of poikiloderma is atypical, diagnosis relies on two
additional features such as bone abnormalities, cataracts, or osteosarcoma (Wang, Levy
et al. 2001). Among all the reported cases of RTS, 60% are the result of a mutation in
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RecQL4, however the remaining 40% are a result of defects in unidentified genes
(Wang, Levy et al. 2001).
Similar to BGS and RTS, RAPADILINO syndrome (OMIM 266280) is a very rare
autosomal recessive malformation syndrome. The name of this syndrome is an acronym
referring to the main clinical features (Radial ray defect; Patellae hypoplasia or aplasia
and cleft or highly arched palate; Diarrhea and dislocated joints; Little size and limb
malformation; Nose slender and normal intelligence) observed in individuals with
RAPADILINO (Siitonen, Kopra et al. 2003). Similar to BGS, fewer than 20 individuals
have been reported with this disorder. Interestingly, 14 of these patients have been
diagnosed in Finland and only a few in other countries (Siitonen, Kopra et al. 2003).
Currently there are two RecQL4 mutant mouse models: Model 1, which has an
exon 13 deletion (Hoki, Araki et al. 2003), and Model 2, which is missing exons 9 to 13
(Mann, Hodges et al. 2005). Evaluation of the two mouse models has revealed that
deletion of exon 13 (a hot spot for RTS causing mutations) is far more detrimental to the
fate of the cell than deletion of exons 9 to 13; however, the reason for this difference is
unclear. For Model 1, only 5% of mutant mice survived the first 14 days, in contrast to
the 84% that survived to adulthood in Model 2 (Hoki, Araki et al. 2003; Mann, Hodges et
al. 2005; Dietschy, Shevelev et al. 2007)
Despite the multiple disorders attributed to RecQL4, very little is known about the
cellular function and underlying mechanisms that result in these disorders. RecQL4 is
the only one of the human RecQ-like homologs that possesses neither an RQC nor an
HRDC domain.
Original biochemical characterization of RecQL4 demonstrated only ATPase and
strand annealing activities, but no detectable unwinding activity (Sharma, Doherty et al.
2006). More recently, two independent studies of purified RecQL4 were able to display
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weak helicase activity (Suzuki, Kohno et al. 2009; Xu and Liu 2009). The authors were
only able to demonstrate helicase activity for RecQL4 in the presence of excess ssDNA,
which trapped the released strands (Suzuki, Kohno et al. 2009; Xu and Liu 2009). In
another study, it was demonstrated that the strand annealing activity of RecQL4 protein
is independent of its DNA unwinding activity (Rossi, Ghosh et al. 2010).
RecQL4 is highly expressed in the thymus and testis (Kitao, Ohsugi et al. 1998).
Interestingly, the expression profile of RecQL4 throughout the cell cycle is very similar to
yeast Sgs1 and BLM. All three helicases appear in S-phase, are maintained at similar
levels through G2/M, but have mostly disappeared by the time cells re-enter G1
(Dutertre, Ababou et al. 2000). Moreover, RecQL4 has been shown to not only
physically interact with BLM, but also to stimulate the helicase activity of BLM on
replication fork substrates in vitro (Singh, Popuri et al. 2012). Similarly, in vivo analysis
has demonstrated that interaction between the two proteins is enhanced during S-phase
in cells treated with ionizing radiation, reinforcing the evidence for interaction at DNA
break sites or stalled replication forks (Singh, Popuri et al. 2012). In cells lacking BLM
(BLM-/-) the presence of RecQL4 at the DNA break is shortened, and when RecQL4 is
depleted in these cells the frequency of sister chromatid exchange increases in
comparison to what is observed when RecQL4 is not depleted in BLM-/- cells (Singh,
Popuri et al. 2012). In the same study, the authors demonstrate that the interaction
between BLM and RecQL4 takes place at the N-terminus of both helicases (Singh,
Popuri et al. 2012).
Live cell imaging of tagged RecQL4 shows a nucleoplasmic localization that does
not change in the presence of DNA-damaging agents (Woo, Futami et al. 2006). In
contrast, BLM has been shown to relocate to specific foci after exposure to
DNA-damaging agents to aid in the restart of stalled replication forks (Bischof, Kim et al.
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2001). However, RecQL4 does respond to oxidative stress and localizes to the nucleolus
(Woo, Futami et al. 2006). In response to oxidative damage, RecQL4 has been shown to
interact with PARP1 [poly(ADP-ribose) polymerase-1]. PARP1 is a nuclear protein with
dynamic roles in the regulation of transcription, replication, and DNA repair (Diefenbach
and Burkle 2005). Moreover, nucleolus localization of RecQL4 is lost and RecQL4
returns to a nucleoplasmic localization when cells are treated with PARP1 inhibitors
even in the presence of oxidative damage (Woo, Futami et al. 2006), which further
supports the notion that these proteins function in the same manner to overcome
oxidative stress. It is not clear how RecQL4 aids in recovery from oxidative stress.
Further more
RecQL4 has also been suggested to be involved in repair of DNA DSBs. This
hypothesis is based on the identification of RecQL4 in a complex with Rad51 upon
induction of DSBs and the presence of RecQL4 foci in proximity of promyelocytic
leukemia (PML) bodies (Petkovic, Dietschy et al. 2005). PML bodies have been
previously demonstrated to be the sites of assembly for DSB repair proteins BLM,
RAD51, MRE11 and p53 during late S-G2 phase (Bischof, Kim et al. 2001; Carbone,
Pearson et al. 2002). More recently, it has been shown that RecQL4 deficient fibroblast
cells are slightly more sensitive to gamma radiation and accumulate ɣH2AX. Moreover,
upon live imaging of laser induced DNA damage, RecQL4 is recruited to damage sites
prior to BLM and WRN, but does not remain at the site for as long as BLM and WRN
(Singh, Karmakar et al. 2010).
Mass spectrometry analysis of stably transfected FLAG-tagged RecQL4 in 293T
cells places RecQL4 in complex with MCM10 and the MCM2-7 complex, which are
replicative helicases important for assembly of the pre-replication complex and
progression of the replication fork (Xu, Rochette et al. 2009). This interaction has been
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further confirmed with the aid of co-immunoprecipitation of MCM10 and MCM7 with
endogenous RecQL4 (Xu, Rochette et al. 2009). In the same study the authors
demonstrate that RecQL4 interacts directly with MCM10 and this interaction regulates
the unwinding activity of MCM10. Furthermore, the interaction between RecQL4 and the
members of the MCM helicase complex is controlled by the cell cycle and limited to G1
and S. This finding highlights RecQL4 as an essential component of the MCM complex
and by extension suggests that RecQL4 plays a role in DNA replication (Xu, Rochette et
al. 2009).
Additionally, in Xenopus laevis egg extracts it has been shown that
immunodepletion of the RecQL4 homolog, xRTS, from egg extracts leads to reduction of
chromatin replication. This phenotype can be rescued by expression of human RecQL4
(Sangrithi, Bernal et al. 2005). Further investigation into the role of xRTS revealed a
function to promote loading of replication factors at origins after formation of the
pre-replication complex (Sangrithi, Bernal et al. 2005; Dietschy, Shevelev et al. 2007).

Human RecQL1
RecQL1 is the most abundant and the least studied of the human RecQ-like
homologs (Kawabe, Tsuyama et al. 2000). Nevertheless, similar to other members of the
RecQ-like family, it is hypothesized to function in DNA metabolism pathways.
Biochemical analyses of RecQL1 have demonstrated that, in addition to possessing the
canonical ssDNA annealing and helicase activity with 3’ to 5’ polarity, this helicase can
unwind many structures including 5’ flaps, 3’ flaps, D-loops, and replication fork
structures (Sharma, Sommers et al. 2005; Popuri, Bachrati et al. 2008).
RecQL1 has been shown to have the ability to conduct branch migration and
process Holliday junctions (LeRoy, Carroll et al. 2005; Bugreev, Brosh et al. 2008;
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Popuri, Bachrati et al. 2008; Mazina, Rossi et al. 2012). A comparison of the branch
migration efficiency of RecQL1 and RAD54 indicates that RAD54 is more efficient in
promoting branch migration of homologous joint molecules. However, it has been
hypothesized that RecQL1 has an advantage in driving Holliday junctions when
encountering non-homologous sequences (LeRoy, Carroll et al. 2005; Mazina, Rossi et
al. 2012).
RecQL1 has also been identified to physically interact with Exo1 and mismatch
repair factors MSH2/MSH6, MLH1/PMS2 (Doherty, Sharma et al. 2005). The authors
utilized a candidate approach and identified interactions using both in vitro and
overexpression analyses in HeLa cells (Doherty, Sharma et al. 2005). Identification of a
physical interaction between RecQL1 and mismatch repair factors and Exo1 support the
hypothesis that this helicase is involved in DNA metabolism pathways, in particular DNA
damage repair. Mass spectrometry analysis has placed RecQL1 in association with
PARP1. This interaction has been further confirmed by co-immunoprecipitation analysis
of tagged RecQL1 and PARP1 (Sharma, Phatak et al. 2012). This finding indicates that,
similar to RecQL4, RecQL1 may play a role in the oxidative stress response.
When analyzing the oligomerization state of recombinant RecQL1, Cui et al.
have provided evidence suggesting that this helicase functions as a dimer in solution
(Cui, Arosio et al. 2004). Further analysis by the same group has demonstrated that
RecQL1 physically interacts with replication protein A (RPA), an essential component of
DNA metabolism. This interaction is shown to stimulate the helicase activity of RecQL1
(Cui, Klima et al. 2003; Cui, Arosio et al. 2004). Other groups have shown RecQL1 also
physically interacts with importin-α (also known as KPNA4 or Qip1) in a yeast-2 hybrid
assay (Seki, Tada et al. 1997) and TopIIIα in co-immunoprecipitations from HeLa cells
(Johnson, Lombard et al. 2000).
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Lastly, although RecQL1 has not been linked to any disorder, a patient study
conducted by the University of Texas, M.D. Anderson Cancer Center, to investigate
whether or not variants in DNA repair genes influence the clinical outcome of pancreatic
cancer has indicated a connection between RecQL1 and tumorigenesis. Patients were
treated and monitored for tumor progression and for overall survival over a five-year
period. Thirteen variants of eight DNA damage response and repair genes were
compared in this study. Their results demonstrate that one variant of RecQL1
(RECQL1-159) is associated with a poor prognosis and reduced pancreatic cancer
survival (Li, Frazier et al. 2006). The patient studies conducted at the M.D. Anderson
Cancer Center, together with the protein interacting partners discussed earlier and
characterization of RecQL1 catalytic activity, support the hypothesis that RecQL1,
similar to BLM and RecQL4, functions within DNA metabolism pathways.
This dissertation aims to further expand our knowledge of the role of the human
RecQ-like helicases, BLM, RecQL1 and RecQL4 by functional and mutational
characterization of these proteins in a yeast model.
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CHAPTER 2:
SGS1 TRUNCATIONS INDUCE GENOME REARRANGEMENTS
BUT SUPPRESSES DETRIMENTAL EFFECTS OF BLM
OVEREXPRESSION IN SACCHAROMYCES CEREVISIAE
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publisher (Appendix D). Mirzaei, H., S. Syed, et al. (2011). "Sgs1 truncations induce
genome rearrangements but suppress detrimental effects of BLM overexpression in
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Abstract
RecQ-like DNA helicases are conserved from bacteria to humans. They perform
functions in the maintenance of genome stability, and their mutation is associated with
cancer predisposition and premature aging syndromes in humans. Here, a series of
C-terminal deletions and point mutations of Sgs1, the only RecQ-like helicase in yeast,
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show that the Helicase/RNase D C-terminal domain and the Rad51 interaction domain
are dispensable for Sgs1's role in suppressing genome instability, whereas the
zinc-binding domain and the helicase domain are required. BLM expression from the
native SGS1 promoter had no adverse effects on cell growth and was unable to
complement any sgs1Δ defects. BLM over- expression, however, significantly increased
the rate of accumulating gross- chromosomal rearrangements in a dosage-dependent
manner and greatly exacerbated sensitivity to DNA-damaging agents. Co-expressing
sgs1 truncations of up to 900 residues, lacking all known functional domains of Sgs1,
suppressed the hydroxyurea sensitivity of BLM-overexpressing cells, suggesting a
functional relationship between Sgs1 and BLM. Protein disorder prediction analysis of
Sgs1 and BLM was used to produce a functional Sgs1-BLM chimera by replacing the
N-terminus of BLM with the disordered N-terminus of Sgs1. The functionality of this
chimera suggests that it is the disordered N-terminus, a site of protein binding and
posttranslational modification that confers species specificity to these two RecQ-like
proteins.

Introduction
RecQ-like DNA helicases, named after the DNA repair protein RecQ of
Escherichia coli, (Hegde, Qin et al. 1996; Morimatsu and Kowalczykowski 2003; IvancicBace, Salaj-Smic et al. 2005) are evolutionarily highly conserved. These 3’ to 5’
helicases function at the interface between DNA replication and recombination to
maintain genome integrity. Sgs1 is the only known member of this helicase family in
Saccharomyces cerevisiae (Gangloff, McDonald et al. 1994). Sgs1-deficient cells show
increased sensitivity to the DNA-damaging agents hydroxyurea (HU) and methyl
methanesulfonate (MMS), missegregate chromosomes, accumulate gross-chromosomal
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rearrangements (GCRs), and have a shortened life span (Sinclair, Mills et al. 1997;
Mullen, Kaliraman et al. 2000; Fricke and Brill 2003; Schmidt, Wu et al. 2006). In
contrast, five RecQ-like helicases (RecQL1, BLM, WRN, RecQL4, and RecQL5) are
known in humans, and mutations in the BLM, WRN, and RECQL4 genes are associated
with the rare, cancer-prone Bloom's syndrome (BS), Werner syndrome, and
Rothmund-Thompson syndrome, respectively (Ellis, Groden et al. 1995; Yu, Oshima et
al. 1996; Kitao, Ohsugi et al. 1998; Kitao, Shimamoto et al. 1999; German, Sanz et al.
2007). All RecQ-like helicases share a seven-motif helicase domain with Walker A and
DEAH motifs. The RecQ-helicase-conserved (RQC) domain, located C-terminal to the
helicase domain, is thought to be involved in DNA binding and conferring specificity of
binding to DNA structures, such as G4 tetrads (von Kobbe, Thoma et al. 2003; Guo,
Rigolet et al. 2005; Lee, Kusumoto et al. 2005; Huber, Duquette et al. 2006). The
Helicase/ RNase D C-terminal (HRDC) domain is the most C-terminal of the conserved
domains and resembles domains in other proteins that are involved in nucleic acid
metabolism, such as RNase D and UvrD; however, similar to the RQC domain, it is not
found in all RecQ-like helicases (Morozov, Mushegian et al. 1997; Kitano, Yoshihara et
al. 2007). The HRDC domain has been implicated in binding and resolving DNA
structures, such as Holliday junctions, and in mediating protein-protein interactions (Liu,
Macias et al. 1999; Bernstein and Keck 2005; Wu, Chan et al. 2005; Kitano, Yoshihara
et al. 2007; Killoran and Keck 2008). Two acidic regions have also been identified
N-terminal of the helicase domain and may be involved in mediating protein-protein
interactions (Kitao, Ohsugi et al. 1998; Miyajima, Seki et al. 2000; Bernstein, Shor et al.
2009). Sgs1 is found in a complex with Top3 and Rmi1, and there is also evidence of
physical interactions of the N-terminal half of Sgs1 with Top2, Srs2, and Rad16 and
interactions of the C-terminus with Mlh1 and Rad51(Watt, Louis et al. 1995; Bennett,
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Noirot-Gros et al. 2000; Duno, Thomsen et al. 2000; Fricke, Kaliraman et al. 2001;
Chang, Bellaoui et al. 2005; Chiolo, Carotenuto et al. 2005).
Defects in BLM, the human RecQ helicase considered to be most closely related
to Sgs1, cause BS, an autosomal recessive disorder characterized by chromosome
gaps and breaks, elevated sister chromatid exchange, mitotic hyper-recombination, and
aberrant DNA replication events (Chaganti, Schonberg et al. 1974; Hojo, van Diemen et
al. 1995; Bachrati and Hickson 2003). Affected individuals suffer from a high incidence
and wide variety of cancers, infertility, and dwarfism (reviewed in Ref. 33). BLM
catalyzes ATP-dependent 3’- to 5’-DNA unwinding, with a preference for DNA structures
that may arise spontaneously during DNA replication or as a result of homologous
recombination (HR) (Mohaghegh, Karow et al. 2001). For example, by unwinding
unusual secondary DNA structures, BLM may aid replication fork progression, prevent
illegitimate recombination during replication, and assist in restarting stalled forks (Ralf,
Hickson et al. 2006; Wu and Hickson 2006; Hanada and Hickson 2007). Evidence
supporting a role of BLM in maintaining genome integrity has been accumulating. For
example, BLM-defective cells exhibit a retarded rate of strand elongation during DNA
replication,(Hand and German 1975) accumulate abnormal replication intermediates,
(Lonn, Lonn et al. 1990) and are hypersensitive to agents that impair DNA
replication(Davies, North et al. 2004). BLM physically interacts with several proteins that
play important roles during DNA replication and repair, such as replication protein A, flap
endonuclease 1, chromatin assembly factor 1, the mismatch repair protein Mlh1, HR
factor Rad51, and topoisomerase III "(Brosh, Li et al. 2000; Johnson, Lombard et al.
2000; Langland, Kordich et al. 2001; Wu, Davies et al. 2001; Jiao, Bachrati et al. 2004;
Sharma, Sommers et al. 2004; Wu, Bachrati et al. 2006). BLM peaks in S phase and it
localizes to replication foci, most likely through its physical interaction with a subunit of
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DNA polymerase α (Dutertre, Ababou et al. 2000; Sanz, Proytcheva et al. 2000;
Yankiwski, Marciniak et al. 2000; Bischof, Kim et al. 2001; Selak, Bachrati et al. 2008).
Here, we have determined the role of C-terminal domains and protein interaction
sites of Sgs1 in suppressing GCR accumulation by expressing point mutants and
truncations of Sgs1, lacking as few as 20 residues and as many as 1428 residue’s
Human BLM cDNA was expressed under control of the native SGS1 promoter and
overexpressed from a galactose-inducible promoter to investigate BLM's ability to
complement sgs1Δ defects (such as increased genome instability and sensitivity to HU
and MMS), revealing that BLM could suppress sgs1Δ defects neither in haploid nor in
diploid cells. However, using computational protein disorder prediction tools, we have
designed a yeast-human chimera that consists of two nonfunctional segments of BLM
and Sgs1. The ability of this chimera to suppress all sgs1Δ defects that we tested
suggests a functional relationship between BLM and Sgs1, which is also supported by
our finding that short N-terminal fragments of Sgs1, which are devoid of all known
functional domains for helicase activity and DNA binding, suppress severely detrimental
effects of BLM overexpression in yeast.

Results
Requirement of the RQC domain of Sgs1, but not the HRDC
domain, for GCR suppression
Sgs1 contains a conserved DEAH helicase domain, a conserved HRDC domain,
two acidic regions (AR1 and AR2), and an RQC domain composed of zinc-binding and
winged-helix domains. Several protein interaction sites have also been located in the
1447-amino-acid-long protein (Figure 2. 1a). To determine the role of these domains in
the maintenance of genome stability, we generated systematic deletions to the 3’-end of
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the chromosomal SGS1 gene, such that truncations of the C-terminus of Sgs1, ranging
from 20 to 1428 amino acids, were expressed as fusions to a myc epitope. Truncations
of up to 80 amino acids were constructed to not affect any known functional domain of
Sgs1, while ΔC100 and ΔC200 deletions partially and completely re- moved the HRDC
domain and ΔC300 and ΔC400 deletions partially and completely removed the RQC
domain, respectively. The largest deletions (ΔC700, ΔC800, ΔC900, ΔC1000, and
ΔC1100) eliminate the entire helicase domain, including the Walker A motif (residues
803-812), with the ΔC800-ΔC1100 deletions also affecting the part of the N-terminal half
of Sgs1 that contains protein interaction sites (e.g., Rad16, residues 421-792; Top2,
residues 432-724; and Srs2, residues 422-722) and two acidic regions (AR1, residues
321-447; AR2, residues 502-648), whereas ΔC500 and ΔC600 deletions partially
remove the helicase domain while leaving the Walker A motif intact (Figure 2. 1a). All
truncation alleles were stably expressed from the chromosomal SGS1 locus under
control of the native SGS1 promoter (Figure 2. 1b). C- terminal fusion to the myc epitope
did not adversely affect Sgs1 function, as indicated by equal sensitivity to HU and MMS
of strains expressing tagged and untagged Sgs1 (wild type) (Figure 2. 2a). The largest
deletion, leaving intact only the 19 N-terminal amino acids of Sgs1 (sgs1ΔC1428), was
as sensitive to HU and MMS as a complete SGS1 deletion (sgs1Δ), thus behaving
similar to a null allele (Figure 2. 2a). Loss of up to 200 C-terminal amino acids did not
increase sensitivity to HU or MMS, whereas loss of 300 or more amino acids led to
sensitivity similar to that of the sgs1ΔC1428 and sgs1Δ mutants (Figure 2. 2a). The
construction of additional 20-amino-acid truncations extended the C-terminal region that
is dispensable for HU/MMS resistance to 240 amino acids (Figure 2. 2b).
It was previously shown that cells lacking the DNA helicase Srs2 (srs2Δ) depend
on functional Sgs1 for their viability.(Lee, Johnson et al. 1999) To assess the ability of
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sgs1 truncation alleles to support growth of the srs2Δ mutant, we constructed diploid
strains heterozygous for the srs2Δ deletion and heterozygous for the sgs1ΔC200,
sgs1ΔC260, or sgs1ΔC300 allele. The meiotic products of the sporulated diploids were
spread on nonselective, rich media [yeast-peptone-dextrose (YPD)], allowing all spores
to grow (Figure 2. 2c). Diploids heterozygous for the srs2Δ deletion and for the
sgs1ΔC200 truncation yielded spores that grew into colonies of the same size,
suggesting that the 200 C-terminal amino acid residues of Sgs1, which harbor the HRDC
domain and an interaction site with the HR factor Rad51, are not required for the viability
of the srs2Δ mutant. In contrast, sporulation of diploids heterozygous for the srs2Δ
deletion and sgs1ΔC260 or sgs1ΔC300 allele yielded mixtures of normal-sized and
small colonies. Genotyping revealed that the small colonies were srs2Δ sgs1ΔC260 or
srs2Δ sgs1ΔC300 mutants, whereas the normal-sized colonies corresponded to
wild-type spores or single mutants. Thus, Sgs1 that lacks 260 or more C-terminal
residues and therefore does not contain a complete RQC domain cannot support normal
growth of cells lacking Srs2.
When we tested the effect of the C-terminal deletions on the accumulation of
GCRs, we found that 240 C-terminal amino acids were dispensable for maintaining
genome integrity, whereas deleting as little as an additional 20 amino acids
(sgs1ΔC260) caused the GCR rate to increase to that exhibited by the null mutant
without a discernable intermediate phenotype (Table 2.1). Combining the sgs1ΔC300
truncation allele with a deletion of the DNA-damage checkpoint sensor MEC3 led to a
synergistic GCR rate increase, while, as expected, combining the sgs1ΔC200 allele with
a mec3Δ mutation did not.
Thus, these findings show that the HRDC domain and the previously reported
C-terminal interaction with Rad51 are not required for Sgs1's role in preventing the
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accumulation of GCRs and supporting normal growth of the srs2Δ mutant, whereas the
integrity of the RQC domain, which has been suggested to span residues 1075-1207
based on the alignment of three-dimensional structures (Kitano, Kim et al. 2010), is
essential.

BS-associated RQC domain mutations cause loss of Sgs1
function in vivo
Of the 32 exonic base substitutions that are causative of BS, 13 are missense
mutations (Ellis, Groden et al. 1995; Foucault, Vaury et al. 1997; Barakat, Ababou et al.
2000; German, Sanz et al. 2007), with 6 of these mutations affecting conserved residues
that have been shown in vitro to participate in zinc binding and G-tetrad DNA binding
activity (Figure 2. 3a). Studies, however, have been limited to biochemical and
biophysical analyses of mutant proteins and were hampered by the inability to purify
some mutant BLM proteins (Janscak, Garcia et al. 2003; Guo, Rigolet et al. 2005;
Huber, Duquette et al. 2006). Since the cysteine residues are highly conserved between
RecQ-like helicases, including Sgs1, we replaced the corresponding cysteine residue in
Sgs1 with the BS- associated mutation (sgs1-C1047F). Unlike BLM with mutations in
any of the three conserved cysteine residues C1036, C1063, or C1066, which degraded
upon purification and could therefore not be characterized(Janscak, Garcia et al. 2003),
the sgs1-C1047F mutant allele was stably expressed in vivo from the native SGS1 locus
(Figure 2. 3b). The sgs1-C1047F mutant showed an increased HU and MMS sensitivity,
which, however, did not reach the level of the sgs1Δ allele, and exhibited levels of GCR
accumulation comparable to the sgs1Δ mutant, demonstrating that the C1047F mutation
severely impairs Sgs1 function (Figure 2. 3c; Table 2.1). In addition to conserved
cysteine residues and immediately adjoining arginine (R1037) and aspartic acid (D1064)
residues, ClustalW2 alignments showed F1056 to be the only other fully conserved
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amino acid residue in the zinc-binding domain of Sgs1 (Figure 2. 3a). Although the
corresponding residue in BLM (F1045) is not associated with a BS mutation, the
BLM-F1045A mutation has been shown to cause a severe helicase defect and a
single-stranded DNA (ssDNA) binding deficiency in vitro(Janscak, Garcia et al. 2003).
When we introduced the corresponding mutation into Sgs1 (F1056A), however, the
mutant was no more sensitive to HU and MMS than wild-type cells (Figure 2. 3c) but
instead appeared fully functional with a wild-type GCR rate (Table 2.1).

Expression of human BLM cDNA from the endogenous SGS1
promoter does not complement sgs1Δ defects
RecQ-like DNA helicases are evolutionarily conserved from bacteria to humans.
Since cells from BS patients share defects seen in sgs1Δ cells, including increased
sensitivity to DNA-damaging agents, increased levels of aberrant genetic exchange, and
reduced life span, it has been suggested that RecQ- like DNA helicases from different
phyla or even kingdoms might complement each other, thus allowing the development of
simple model organisms for the functional and mutational characterization of
disease-associated human RecQ-like helicases, such as BLM and WRN(Yamagata,
Kato et al. 1998). Thus, to assess the ability of BLM to suppress genome instability in
the sgs1Δ mutant, BLM cDNA was inserted in-frame with the start codon of SGS1 at its
chromosomal locus (PSGS1BLM). We reasoned that insertion at the wild-type SGS1
locus would promote cell-cycle- dependent regulation of BLM expression and expression
levels similar to those previously shown for Sgs1(Frei and Gasser 2000). Stable
expression of BLM was confirmed by Western blot analysis, using a yeast strain
expressing myc-tagged BLM (Figure 2. 4a); however, all subsequent experiments were
carried out with untagged BLM. Expression of a single copy of BLM (PSGS1BLM) neither
led to a statistically significant difference in the GCR rate compared to the sgs1Δ mutant
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(Tables 1 and 2) nor alleviated HU sensitivity (Figure 2. 4b), demonstrating that BLM can
be successfully expressed in yeast under control of the native SGS1 promoter without
detrimental effects on cell growth, but is unable to complement the tested sgs1Δ defects
to any extent.

Overexpression of BLM leads to increased sensitivity to
DNA-damaging agents and rapid accumulation of GCRs
Since a single copy of BLM (PSGS1BLM) did not complement sgs1Δ defects, we
examined the effect of increasing BLM expression levels on sgs1Δ mutant phenotypes.
For this purpose, the native SGS1 promoter was replaced with a GAL1 promoter and
galactose-dependent expression of BLM was verified by fusing BLM to a myc epitope
tag (Figure 2. 4a). Overexpression of BLM did not compensate for the lack of Sgs1 when
cells were exposed to HU but instead led to a further increase in sensitivity to HU
compared to the sgs1ΔC1428 cells or cells expressing BLM under the SGS1 promoter
(Figure 2. 4b). We found that maximum induction of BLM expression led to a 1665-fold
increase in the GCR rate compared to wild type and a 34-fold increase compared to the
sgs1Δ mutant assayed under the same conditions (Table 2.2). In contrast,
overexpression of Sgs1 from the GAL1 promoter did not lead to GCR accumulation
(Table 2.2). The GCR rate increase upon BLM overexpression was dependent on
induction levels, with the GCR rate gradually decreasing to that of the sgs1Δ mutant as
the galactose concentration in the media decreased (Table 2.2). Thus, sgs1Δ defects
cannot be complemented by any level of BLM expression; in fact, increasing BLM
expression levels induce higher sensitivity to DNA-damaging agents and significantly
higher genome instability compared to that of the sgs1Δ mutant.
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N-terminus of Sgs1 suppresses detrimental effects of BLM
overexpression
Since Sgs1 is important for the suppression of illegitimate recombination
between identical sequences, such as those found in related genes, on homologous
chromosomes, and on sister chromatids, we tested the HU sensitivity of diploid strains
expressing truncated sgs1 alleles in the presence or in the absence of the SGS1
wild-type allele (Figure 2. 5). HU sensitivity was fully suppressed for all alleles if a single
copy of wild-type SGS1 was expressed from the other allele (Figure 2. 5a),
demonstrating that the sgs1 truncation alleles did not have a dominant effect. As in
haploid cells, only the sgs1ΔC200 allele complemented HU sensitivity of the sgs1Δ
diploid completely (Figure 2. 5b); however, cells expressing the sgs1ΔC300 to
sgs1ΔC900 alleles were less sensitive than diploids that expressed larger truncations or
the sgs1ΔC1428 null allele (Figure 2. 5b). This ability of sgs1Δ300-sgs1ΔC900
truncation alleles to at least partially suppress HU sensitivity indicates that there may be
N-terminal segments in Sgs1 that contribute to HU resistance.
Diploids expressing BLM from native SGS1 promoters on both alleles were as
sensitive to HU as diploids not expressing Sgs1, whereas diploids overexpressing BLM
from one allele or from both alleles were severely HU sensitive, with the highest
expression level lacking any growth on 100 mM HU (Figure 2. 5c), reflecting the severe
HU sensitivity of haploid cells expressing the PGALBLM allele (Figure 2. 4b). Diploids
overexpressing BLM also appeared to grow more slowly than any other diploid tested
here (Figure 2. 5c). Remarkably, expression of a single copy of SGS1 from its
endogenous promoter (SGS1/PGALBLM) completely eliminated the severe HU sensitivity
conferred by overexpression of BLM. To determine if full-length Sgs1 was required for
this suppression, we crossed the haploid strain overexpressing BLM with haploids
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expressing various Sgs1 truncations. We found that a single copy of the sgs1ΔC200
allele was as sufficient as wild-type Sgs1 in suppressing HU sensitivity and slow growth
of the BLM overexpressing strain, and as few as 547 N-terminal amino acids remaining
in the sgs1ΔC900 allele were sufficient for significant suppression of HU sensitivity and
slow growth caused by BLM overexpression (Figure 2. 5c). These findings suggest that
none of the known enzymatic activities or functional and conserved domains are
required for suppressing the HU sensitivity of the BLM overexpressing diploids but that
547 N-terminal amino acids are sufficient for suppressing the detrimental effects of BLM
overexpression in a diploid. That the sgs1ΔC1000 and sgs1ΔC1100 alleles were clearly
less effective at suppressing HU sensitivity shows that 447 N- terminal amino acids,
which contain the Top3 interaction site, are necessary but not sufficient for
complementation.

Design of a functional Sgs1-BLM chimera
Sgs1 and BLM share about 21% of their amino acid residues in a pairwise
alignment of the full- length proteins (ClustalW2), with most of the identical residues in
the helicase domain. In fact, the N-terminal segment of Sgs1 expressed by the
sgs1ΔC800 allele, which is able to suppress the HU sensitivity of BLM overexpressing
diploids, shares only 11% with the corresponding N- terminal segment of BLM. Devoid of
conserved domains and known enzymatic activities, the N- terminus of Sgs1 has been
shown to be required for physical interactions with Top3, Top2, Srs2, and Rad16(Watt,
Louis et al. 1995; Bennett, Noirot-Gros et al. 2000; Duno, Thomsen et al. 2000; Mullen,
Kaliraman et al. 2000; Fricke, Kaliraman et al. 2001; Chiolo, Carotenuto et al. 2005).
Using IUPred, an algorithm for the prediction of intrinsically disordered proteins, we
found that the 650 N-terminal residues contain a similar distribution of ordered and
intrinsically disordered segments (Figure 2. 6a and b). In disorder prediction algorithms,
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such as IUPred, (Dosztanyi, Csizmok et al. 2005) a score of N0.5 predicts a disordered
amino acid residue and a score of b0.5 predicts an ordered residue, with 30 consecutive
disordered amino acids commonly being used as a lower limit for detecting disorder in
whole proteome searches.(Ward, Sodhi et al. 2004; Dosztanyi, Csizmok et al. 2005;
Dosztanyi, Csizmok et al. 2005; Peng, Vucetic et al. 2005) The helicase domains of
Sgs1 and of BLM coincide with the predicted ordered regions in both proteins, starting at
around residue 648, and are surrounded by a long N-terminal and a short C-terminal
segment, which contain mostly disordered residues. In fact, based on the IUPred output
scores, 83% of the 648 N-terminal residues of Sgs1 (538/648) are disordered, with 70%
of all 648 residues being located in segments of more than 30 consecutive disordered
residues, whereas only 16% of the 800 C-terminal residues of Sgs1 are predicted to be
disordered, with only a single disordered segment that is longer than 30 residues
(residues 1396-1447). Based on the IUPred prediction, BLM can also be divided into a
disordered N- terminus and an ordered C-terminus (Figure 2. 6a and b). For BLM, 52%
of 648 N-terminal residues are predicted to be disordered, but only 15% of these
residues are found in stretches of more than 30 disordered residues. The difference in
the pattern of disorder predicted for the N-terminal segments of Sgs1 and BLM led us to
hypothesize that this region may be involved in conferring species specificity to BLM and
Sgs1 function and, thus, prevent BLM from functioning in yeast. This hypothesis is
supported by the fact that the N-terminus of Sgs1 is sufficient for the complementation of
the HU sensitivity induced by overexpression of BLM. To test this hypothesis, we
constructed a yeast-human chimera in which the 647 N-terminal residues of BLM were
replaced by the 647 N-terminal residues of Sgs1 (sgs1ΔC800- blmΔN647) (Figure 2.
6c). To express this chimera from the native SGS1 promoter, we replaced nucleotides
1941 to 4344 of the endogenous SGS1 gene with nucleotides 1941 to 4254 of BLM
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cDNA (Figure 2. 6e). Remarkably, the chimera was nearly as effective as wild-type
SGS1 in conferring resistance to HU, whereas the N-terminal segment of Sgs1 by itself
was ineffective (Figure 2. 6d). Moreover, when we combined the chimeric allele with a
mec3Δ mutation, GCRs accumulated at a significantly lower rate than in the mec3Δ
mutant carrying the GCR-deficient sgs1ΔC300 or sgs1ΔC800 allele, albeit not at the low
rate of the mec3Δ mutant carrying the GCR- proficient sgs1ΔC200 allele, signifying
partial functionality of the chimerical protein in the suppression of chromosomal
rearrangements (Table 2.1). Finally, besides Srs2, the sgs1Δ mutant also requires the
DNA helicase Rrm3 for viability. Synthetic lethality between sgs1Δ and rrm3Δ mutations
is suppressed by disrupting HR factors such as Rad51 and Rad55, suggesting that the
lethality is due to accumulation of aberrant HR intermediates(Ooi, Shoemaker et al.
2003; Schmidt and Kolodner 2004; Torres, Schnakenberg et al. 2004). To assess if the
Sgs1-BLM chimera was capable of preventing the accumulation of lethal levels of
aberrant recombination intermediates, we constructed a diploid heterozygous for the
rrm3Δ mutation and heterozygous for the sgs1ΔC800-blmΔN647 allele, expressing the
Sgs1-BLM chimera. Spreading of spores from this diploid on YPD, which allows all
spores to grow, showed that the rrm3Δ mutant expressing the chimera grows normally
with the diameter of double-mutant colonies measuring approximately 90% of that of the
single mutants (Figure 2. 6f). These findings indicate that the Sgs1-BLM chimera is
functional and, while not capable of fully suppressing chromosomal rearrangements,
prevents the accumulation of lethal levels of aberrant recombination intermediates when
Rrm3 helicase is absent.
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Discussion
Yeast cells that lack Sgs1 exhibit upregulated and aberrant recombination in
mitosis, increased sensitivity to DNA-damaging agents, accumulation of GCRs, synthetic
lethality with mutations in other DNA metabolic genes, such as the SRS2 and RRM3
helicase genes, and meiotic defects that lead to poor spore viability(Watt, Louis et al.
1995; Lee, Johnson et al. 1999; Frei and Gasser 2000; Miyajima, Seki et al. 2000;
Myung, Datta et al. 2001; Cobb, Bjergbaek et al. 2002; Ira, Malkova et al. 2003; Versini,
Comet et al. 2003; Schmidt and Kolodner 2004; Schmidt, Wu et al. 2006). Sgs1 contains
several conserved domains (DEAD helicase, RQC, HRDC, AR1, and AR2), and protein
interaction sites (Top2, Top3, Srs2, Rad16, Rad51, and Mlh1) have been identified by
two-hybrid screens.(Watt, Louis et al. 1995; Duno, Thomsen et al. 2000; Saffi, Feldmann
et al. 2001; Wu, Davies et al. 2001; Chiolo, Carotenuto et al. 2005) How the integrity of
these conserved motifs and protein-protein interaction sites affects the role of Sgs1 in
suppression of aberrant genome rearrangements has not been determined. The
requirement of some domains and/or protein interaction sites, but not others, may shed
light on the poorly understood mechanism(s) by which Sgs1 contributes to the
maintenance of genome integrity in yeast. Here, we find that the segment made up of
240 C-terminal amino acids, which contains Rad51 and Mlh1 interaction sites and the
conserved HRDC domain thought to be involved in DNA binding and in recognition and
processing of double Holliday junctions,(Liu, Macias et al. 1999; Wu, Chan et al. 2005) is
dispensable for Sgs1's role in suppressing GCRs. The integrity of the RQC domain,
however, is essential for GCR suppression. That zinc binding is crucial for Sgs1 activity,
as well as the fact that loss of function of the C- terminal truncation allele was not due to
disruption of protein structure/function because of such a large deletion, was further
confirmed by the finding that the point mutation of a conserved zinc-coordinating
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cysteine, which has also been observed in BS patients,(Foucault, Vaury et al. 1997) led
to the loss of Sgs1's ability to suppress HU sensitivity and GCR accumulation. This loss
of function was not due to degradation of the mutant protein as had been previously
observed for some cysteine mutants of BLM during attempts at overexpression and
purification from E. coli. However, we cannot exclude the possibility that the loss of
function resulted from intracellular mislocalization of the mutant protein. Previously,
modeling of the zinc- binding domain of BLM and instability of purified mutant proteins
had indicated that hydrogen bonds between three conserved residues, Y1029 (Y1040 in
Sgs1), R1037 (R1048 in Sgs1), and D1064 (D1070 in Sgs1), are required for the folding
of the zinc-binding domain and overall protein stability(Guo, Rigolet et al. 2005).
Although F1056 of Sgs1 does not appear to be involved in this zinc-domain stabilization
and the Sgs1-F1056A mutant protein appears stable in this study, F1056 is the only
other fully conserved residue in the zinc-binding domain of RecQ-like helicases,
suggesting functional significance. However, introduction of the F1056A mutation had no
effect on Sgs1 function in vivo when we assessed HU sensitivity, consistent with a
previous study,(Ui, Satoh et al. 2001) or GCR accumulation. That, in a previous in vitro
study,(Janscak, Garcia et al. 2003) the corresponding BLM mutation (F1045A) had
severely impaired helicase and ssDNA binding activities could be either due to
differences in the importance of this residue for enzymatic activity of BLM and Sgs1 or,
more likely, due to the fact that only the helicase-core segment of BLM, lacking 769
residues of N- and C-termini, was purified. The in vitro function of this isolated domain
could be more strongly affected by a mutation than the in vivo function of the full- length
Sgs1 mutant protein assessed here. Although nearly half of all BLM alleles that are
associated with single-amino-acid changes (7 of 17 alleles) in BS patients are located in
the RQC domain,(Ellis, Groden et al. 1995; Foucault, Vaury et al. 1997; Barakat, Ababou
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et al. 2000; German, Sanz et al. 2007) none affect F1045, consistent with our finding that
mutation of this conserved residue may not be associated with significant loss of function
in vivo.
We find that Sgs1 retains partial functionality even when it lacks the HRDC,
RQC, and DEAH helicase domains, as demonstrated by the greater HU resistance of
diploids that only express 547 N- terminal amino acid residues compared to those alleles
expressing fewer than 447 residues of Sgs1. One possible explanation for this finding is
that protein-protein interactions conferred by the N- terminus could contribute to the
structural stability of multi-protein complexes, such as the Sgs1-Top3-Rmi1(Chang,
Bellaoui

et

al.

2005) complex

or,

even

more

relevant

to

HU

resistance,

DNA-damage-specific complexes with Srs2 and Mre11(Chiolo, Carotenuto et al. 2005).
In these multi-protein complexes, enzymatic activity of Sgs1 may be dispensable.
Indeed, sgs1 alleles with point mutations in the helicase domain have been shown to be
capable of performing some functions of the wild-type allele, including those carried out
during meiosis and checkpoint activation(Miyajima, Seki et al. 2000; Bjergbaek, Cobb et
al. 2005).
In contrast to two previous reports,(Yamagata, Kato et al. 1998; Heo,
Tatebayashi et al. 1999) which both used the same yeast strain that constitutively
expressed BLM from a GAPDH promoter and showed partial suppression of some
sgs1Δ defects, including HU sensitivity, we found that neither BLM expression under
control of the natural SGS1 promoter nor varying levels of BLM expression under control
of a galactose-inducible promoter had any positive effect on the sgs1Δ mutant. That a
single copy of BLM, when expressed under control of the native SGS1 promoter, cannot
alleviate sgs1Δ defects initially suggested to us that BLM had no functionality in yeast. In
fact, the strong increase in genome instability, accompanied by severe HU sensitivity
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and some growth retardation upon overexpression of BLM, indicated that BLM
expression is detrimental to yeast cells. The absence of any GCR accumulation upon
Sgs1

overexpression

suggests

that

increased

accumulation

of

GCRs

in

BLM-overexpressing cells is not simply due to increased unwinding. Rather, we propose
that BLM may possess helicase activity in yeast, leading to increased unwinding upon
over-expression, but fails to elicit proper downstream responses, for example, due to
lack of proper N-terminal protein-protein interactions, which ultimately leads to an
overabundance of aberrantly repaired lesions. That endogenous levels of N-terminal
segments of Sgs1 as short as 547 residues suppressed the slow growth phenotype and
the severe HU sensitivity of BLM overexpressing cells argues in favor of a functional
relationship between Sgs1 and BLM. For example, co-expression of Sgs1 and BLM
could alleviate HU sensitivity in BLM overexpressing cells by acting as a bridge between
BLM and Top3 (and/or other protein complexes interacting with the Sgs1 N- terminus),
thereby linking enzymatic activity to appropriate upstream and downstream events.
Remarkably, even relatively short N-terminal fragments of Sgs1 are sufficient for the
suppression of the increased HU sensitivity of BLM overexpressing cells, further
supporting the importance of the Sgs1 N-terminus with its role in mediating interaction
with other DNA metabolic factors. HU resistance comparable to wild-type cells and
significantly reduced GCR accumulation of cells expressing a chimeric fusion of the
Sgs1 N- terminus, which is devoid of enzymatic function and dispensable for helicase
activity and ssDNA binding in vitro, and the BLM C-terminus, which contains
helicase/RQC and HRDC domains, are consistent with helicase activity of BLM in yeast
and a biologically significant, functional interaction between BLM and Sgs1. That fusion
of the Sgs1 and BLM segments provides HU resistance as well as co-expression of BLM
and Sgs1 polypeptides from separate alleles in the same cell may indicate that the
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N-terminus of Sgs1 can physically interact with BLM. Our findings also suggest that it is
the inability of the N-terminus of BLM to interact with or be modified by yeast proteins
that leads to the inability of BLM to function in yeast. A previous report that BLM
expression in yeast alleviates several sgs1Δ phenotypes, including partial suppression
of HU sensitivity(Yamagata, Kato et al. 1998; Heo, Tatebayashi et al. 1999), could be
explained by the fact that, in the earlier study, BLM was expressed from a GAPDH
promoter, whereas here it was expressed either from the native SGS1 promoter or from
a galactose-inducible promoter. However, in light of the findings presented here, there
could also be an alternative explanation. Since the GAPDH promoter-BLM construct
appears to have been inserted into the middle of the wild-type SGS1 gene, an
N-terminal segment of Sgs1 could have been expressed from the native SGS1 promoter
in addition to BLM being expressed from the GAPDH promoter. As shown here for
haploids expressing the chimera and for diploids co-expressing the N-termini of Sgs1
and full-length BLM, such co-expression of an N- terminal Sgs1 segment from the native
SGS1 promoter and BLM from the GAPDH promoter could be an explanation for the
reported increase in HU resistance of BLM-expressing cells compared to sgs1Δ cells.
Of the five human RecQ-like DNA helicases, BLM is considered to be most
closely related to Sgs1. Even though we show here that BLM cannot suppress any
defects of the sgs1Δ mutant, the functional chimera does provide evidence for a
functional relationship between the two RecQ-like helicases and provides a model
system for the further characterization of BLM functional domains in yeast. In fact, all
BS-associated missense mutations and numerous polymorphisms are located within the
770-residue C-terminal fragment of BLM that is part of the chimera, so that they are now
accessible to further functional and mutational characterization in yeast. The in vivo
functionality of the Sgs1-BLM chimera also demonstrates the remarkable utility of protein
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disorder prediction as a tool for the construction of functional mutants. It will be
interesting to see whether domains of any of the other human RecQ-like helicases, are
capable of forming functional chimeras with the Sgs1 N-terminus.

Materials and Methods
Yeast strains and media
All strains are derived from KHSY802, a derivative of S288C. Yeast strains
expressing truncations of Sgs1 helicase were constructed by HR-mediated integration of
PCR products, replacing the desired 3’-segment of SGS1 on chromosome VIII with a
myc epitope coding sequence (from pFA6a-13Myc.His3MX6,(Longtine, McKenzie et al.
1998) a gift from Mark Longtine, University of Washington) in-frame with the SGS1
coding sequence. The expression of all truncation alleles and the myc-epitope-tagged
wild-type allele of SGS1 was confirmed by Western blot analysis. All gene replacements,
insertions, and truncations were performed via the standard LiAc protocol,(Gietz and
Woods 2006) using PCR products with at least 50 nt on each end, which matched the
chromosomal target locus. A PCR fragment containing BLM cDNA (Open Biosystems)
and a HIS3 cassette was amplified by PCR from plasmid pKHS293 using primers that
include 50-nt homology to the chromosomal SGS1 locus to express BLM from the native
SGS1 promoter (PSGS1). This PCR product was fused to the native chromosomal SGS1
promoter by HR-mediated integration(Gietz and Woods 2006). A PCR fragment coding
for a 13Myc epitope tag was amplified from pFA6a-13Myc-kanMX6 (Longtine, McKenzie
et al. 1998) and integrated in-frame at the 3’-end of cDNAs or sgs1 alleles for detection
of protein expression by Western blot analysis. In strains KHSY3350 and KHSY3218,
galactose-inducible promoters amplified from plasmids pFA6a-kanMX6-PGAL1 and
pFA6a-TRP1- PGAL1, (Longtine, McKenzie et al. 1998)
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respectively, were used to

replace the native SGS1 promoter. To construct KHSY3355, we amplified the 3’-terminal
2313 bp of BLM cDNA linked to a HIS3 cassette by PCR from plasmid pKHS293 and
used them to replace the 3‘-terminal 2400 bp of SGS1 in KHSY802. The accuracy of
PCR-derived SGS1 or BLM integrations was confirmed by sequencing. Amino acid
changes C1047F and F1056A in Sgs1 were made by site-directed mutagenesis
(QuikChange, Stratagene) of pKHS360 and integrated at the sgs1∷HIS3 locus in
KHSY1338. All yeast strains used in this study are listed in Table 2.S1. Cells were grown
in YPD consisting of 10 g/l yeast extract (Fisher Scientific), 20 g/l Bactopeptone (BD
Diagnostic Systems), and 2% glucose (Fisher Scientific), unless indicated otherwise. For
plates, agar (BD Diagnostic Systems) was added at a concentration of 20 g/l.

Western blot analysis
Cells were grown to an OD600 = 0.5 in YPD, and whole-cell extracts were
prepared from 5 ml of culture (" 3.5 × 107 cells) by standard trichloroacetic acid (TCA,
Fisher Scientific) extraction to confirm expression of myc- epitope-tagged BLM and
SGS1 alleles(Foiani, Liberi et al. 1999). Five microliters of TCA extract was separated on
10% polyacrylamide gels, transferred to a PVDF membrane (Bio-Rad), probed with
anti-c-myc monoclonal antibody (9E10, Covance Research Products), and visualized by
chemiluminescence (ECL Plus, GE Healthcare). To confirm expression of SGS1 and
BLM from the GAL1 promoter, we used the same Western blot procedure, but cells were
grown overnight in yeast- peptone (YP) [(10 g/l yeast extract (Fisher Scientific), 20 g/l
Bactopeptone (BD Diagnostic Systems)] supplemented with 2% sucrose (Fisher
Scientific), diluted to an OD600=0.2 in YP supplemented with either 2% sucrose
(uninduced sample) or 2% galactose (induced sample), and harvested for TCA
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extraction when cultures reached OD600 = 0.5. Molecular weight marker (Broad Range)
was from Bio-Rad.

Sensitivity to DNA-damaging agents HU and MMS
Cell cultures were grown in YPD to an OD600 = 0.5, and 10-fold serial dilutions
were spotted on YPD supplemented with 0.05% MMS (Sigma Aldrich) or with 50 mM or
100 mM HU (US Biological), as indicated. For experiments that included strains
expressing BLM or Sgs1 from the GAL1 promoter (Figure 2. 5), cultures were grown in
YP-2% sucrose instead of YPD and spotted on YP-1% sucrose + 1% galactose (to
induce gene expression) supplemented with 100 mM HU or without HU as the growth
control.

GCR rate measurements
Rates of accumulating GCRs in YPD were determined as previously described.83
For GCR rate measurements of yeast strains expressing BLM or Sgs1 from the GAL1
promoter, the same procedure was followed, except that media were supplemented with
2% galactose to induce gene expression. Briefly, 10 ml of YP-2% galactose was
inoculated with a single colony, which had been grown on YPD agar for 3 days. After 3
days of growth in liquid media at 30 °C with vigorous shaking, cells were plated on GCR
plates(Schmidt, Pennaneach et al. 2006) supplemented with 2% galactose instead of 2%
glucose, and 10-6 dilutions were plated on YPD to obtain the viable cell count. Colonies
on GCR plates were counted after 5 days of incubation at 30 °C. For GCR rate
measurements in the presence of varying BLM expression levels (Table 2.2), 0.1% or
0.5% galactose instead of 2% galactose was added to liquid YP media and to GCR
plates, and sucrose was supplemented to reach a total of 2% sugar in the media. We
calculated 95% confidence intervals according to Nair (Nair 1940).
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Random spore analysis
Diploids heterozygous for the desired mutant alleles were grown overnight at 30
°C in YPD, washed, transferred to 0.1% potassium acetate (Fisher Scientific), and
incubated for 5 days at 30 °C with vigorous shaking. Asci were incubated in the
presence of 500µg/ml zymolase (MP Biomedicals) in 1 M sorbitol (Fisher Scientific) for
20 min at 30 °C and enriched for haploid spores as previously described(Rockmill,
Lambie et al. 1991). Spores were plated on YPD, incubated at 30 °C, and genotyped by
spotting on synthetic drop-out media (US Biological) to detect the presence of TRP1 and
HIS3 marker cassettes linked to the mutant alleles. The presence of mutant alleles
linked to the kanMX6 cassette was detected by the ability of haploids to grow on YPD
supplemented with 200 µg/ml G418 (Axxora LLC, San Diego, CA).
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Figures and Tables

Figure 2.1. C-terminal truncations of Sgs1 used in this study.
(A) Full-length Sgs1 contains a DEAH-helicase domain, an RQC domain and an HRDC
domain in its C-terminal half; interaction sites with Top3, Top2, Srs2, Rad51 and Rad16
are indicated. C-terminal truncations ranging in size from 200 residues to 1428 residues
were constructed by fusion to a myc-epitope tag. All truncations were introduced to the
endogenous SGS1 locus on chromosome VIII. (B) Expression of wild-type Sgs1 and
truncation alleles from the endogenous SGS1 promoter (PSGS1) was confirmed by
Western blotting, using a myc-antibody.
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Figure 2.2. Sensitivity of truncation alleles to the DNA damaging agents HU and
MMS.
Ten-fold dilutions of exponentially growing cultures (OD600 = 0.5) were spotted on YPD
for viable cell count and on YPD containing 100mM HU or 0.05% MMS, followed by
incubation at 30oC. (A) Haploid cells expressing sgs1 alleles lacking 300 or more
residues from the C-terminus are as sensitive to HU and MMS as the null allele. (B).
Additional incremental 20-amino-acid deletions reveal that cells expressing sgs1 alleles
lacking up to 240 residues are as resistant to HU and MMS as wild-type cells whereas
those lacking 260 or more residues are as sensitive as the sgs1Δ mutant. (C) Combining
the srs2Δ mutation with sgs1ΔC260 and sgs1ΔC300 mutations (lacking part of the RQC
domain) causes a synthetic fitness defect (very slow growth), whereas combination with
the sgs1ΔC200 allele (lacking the HRDC domain and Rad51 interaction site) does not.

52

Figure 2.3. Effect of zinc-binding domain mutations on Sgs1 function in vivo.
(A) Zinc-binding domain is conserved from bacterial to human RecQ-like helicases. At
least six different missense mutations in the zinc-binding domain are associated with
Bloom’s syndrome. (B) C1047F and F1056A mutations were introduced into Sgs1 and
expression was confirmed by Western blot using antibody against the C-terminal
myc-epitope. (C) Mutation of the highly conserved F1056 does not impair Sgs1 function
whereas the C1047F leads to an increase in sensitivity to HU and MMS, but not to the
level seen in the sgs1Δ mutant.
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Figure 2.4. BLM expression does not suppress sgs1Δ defects and BLM
overexpression is detrimental to yeast cells.
(A) Galactose-inducible expression of myc-epitope tagged Sgs1 and BLM in yeast cells
grown in 1% sucrose/1% galactose. (B) Cells expressing BLM from the SGS1 promoter
on chromosome VIII are as sensitive to HU as cells lacking Sgs1. Replacement of the
natural SGS1 promoter with a galactose-inducible promoter leads to BLM
overexpression and increased HU sensitivity. Ten-fold dilutions of cells were spotted on
media containing 1% sucrose/1% galactose with and without 100 mM HU. (C)
Gross-chromosomal rearrangements (GCRs) accumulate in BLM-overexpressing cells
(PGALBLM) in a dosage-dependent manner, whereas cells overexpressing Sgs1 do not
accumulate GCRs. Cells were grown in media containing indicated concentrations of
galactose supplemented with sucrose to reach a total of 2% sugar. As controls, GCR
rates of the sgs1Δ mutant and a strain overexpressing Sgs1 were determined in 2%
galactose.
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Figure 2.5. HU sensitivity of diploid cells expressing mutant alleles of SGS1 and
BLM.
(A) Ten-fold dilutions of exponentially growing diploids expressing truncation alleles of
Sgs1 in the presence of a wild-type allele were spotted on YPD media with and without
100 mM HU. (B) Ten-fold dilutions of exponentially growing diploids expressing
truncation alleles of Sgs1 in the absence of a wild-type allele were spotted on YPD
media with and without 100 mM HU. (C) Ten-fold dilutions of exponentially growing
diploids overexpressing BLM from a GAL1 promoter inserted at the native SGS1 locus
and expressing truncation alleles of Sgs1 under control of the native SGS1 promoter on
the other allele were spotted on media containing 1% galactose and 1% sucrose with or
without 100 mM HU.
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Figure 2.6. Construction of a functional chimerical protein composed of the
N-terminus of Sgs1 and the C-terminus of BLM.
(A - B) Protein disorder prediction of Sgs1 (red) and BLM (black) using the IUPred
algorithm. Values above 0.5 indicate a disordered residue whereas values below 0.5
indicate ordered residues; amino acid residue numbers (1-1447) are indicated on the
abscissa. Black lines above the graph show a simplified order and disorder distribution
along the length of the protein with values above 0.5 being assigned a “1” and values
below 0.5 being assigned a “0”. The vertical red line indicate the site in Sgs1, BLM and
the chimera where the disordered N-terminal segment transitions into the ordered
helicase domain at residue 647/648. This site was chosen as the fusion site for the
chimera. (C) Disorder prediction for the Sgs1-BLM chimera in which the N-terminal 647
residues of BLM (black) were replaced with the N-terminal 647 residues of Sgs1 (red).
(D) Ten-fold dilutions of exponentially growing haploids were spotted on YPD with or
without 100 mM HU. (E) The C-terminus of the Sgs1-BLM chimera was fused to a
myc-epitope tag and expression was confirmed by Western blotting. (F) A diploid
heterozygous for the rrm3Δ mutation and the sgs1ΔC800-blmΔN647 allele expressing
the chimera was sporulated and random spores were plated on YPD and genotyped. An
open circle indicates the haploid double mutant, and the open square and pentagon
indicate haploid sgs1ΔC800-blmΔN647 and rrm3Δ single mutants, respectively.
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Table 2.1. Accumulation of gross-chromosomal
expressing mutant alleles of SGS1.
Relevant Genotype

1

rearrangements

GCR Rate
r

r

95% CI
-10

r

in

2

r

-10

(Can 5-FOA x 10 )

(Can 5-FOA x 10 )

wild-type

1.1

< 1 – 6.2

sgs1Δ

251

80-310

sgs1ΔC200

7

<6-23

sgs1ΔC220

31

5-41

sgs1ΔC240

10

<6-27

sgs1ΔC260

159

85-362

sgs1ΔC280

244

166-387

sgs1ΔC300

145

76-204

sgs1ΔC400

106

60-180

sgs1ΔC500

102

53-252

sgs1ΔC600

152

26-283

sgs1ΔC700

189

49-271

sgs1ΔC800

133

71-225

sgs1ΔC1428

206

97-273

sgs1-C1047F

64

35-131

sgs1-F1056A

<16

<10-26

mec3Δ sgs1ΔC200

11

< 7 - 22

mec3Δ sgs1ΔC300

1003

691-1500

758

645-895

361

330-419

mec3Δ sgs1Δ C800
mec3Δ sgs1Δ C800-blmΔ N64

3

1

cells

All sgs1 truncations (sgs1ΔC) are C-terminally fused to a myc-epitope tag.
We calculated 95% confidence intervals (CI) according to Nair (Nair 1940).
3
The sgs1ΔC800-blmΔN647 allele expresses a chimeric protein that consists of the
N-terminal 647 residues of Sgs1 and the C-terminal 770 residues of human BLM.
2
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Table 2.2. Effect of BLM expression on GCR accumulation in the sgs1Δ mutant.
GCR Rate

concentration in media

(Can 5-FOA x 10 )

(Can 5-FOA x 10 )

wild-type

0%

1.1

< 1 – 6.2

PSGS1BLM

0%

70

56-151

PGALBLM

0%

61

30-153

PGALBLM

0.1%

335

233-576

PGALBLM

0.5%

382

170-777

PGALBLM

2%

1832

1090-2910

PGALSGS1

2%

< 11

< 9-12

sgs1Δ

2%

54

23-104

Relevant Genotype

1

r

r

95% CI

2

Galactose

1

-10

r

r

Human BLM cDNA was inserted at the endogenous SGS1 locus, fused to the native
SGS1 promoter (PSGS1) or fused to a galactose-inducible promoter (PGAL). In PGALSGS1,
the native SGS1 promoter region was disrupted by fusing the SGS1 ORF to a
galactose-inducible promoter. If strains expressing BLM or SGS1 genes from the
galactose-inducible GAL1 promoter were grown in less than 2% galactose (to lower
protein expression levels) media was supplemented with sucrose to reach a total sugar
concentration of 2%.
2
We calculated 95% confidence intervals (CI) according to Nair
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CHAPTER 3:
NON-BLOOM’S SYNDROME ASSOCIATED PARTIAL AND TOTAL
LOSS-OF-FUNCTION VARIANTS OF BLM HELICASE

Note to reader: This chapter has been previously published with permission of the
publisher (Appendix D). Mirzaei, H. and K. H. Schmidt (2012). "Non-Bloom syndromeassociated partial and total loss-of-function variants of BLM helicase." Proc Natl Acad
Sci U S A 109(47): 19357-19362
Hamed Mirzaei and Kristina H. Schmidt designed research. Hamed Mirzaei performed
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Kristina Schmidt, Department of Cell Biology, Microbiology and Molecular Biology,
University of South Florida, 4202 E. Fowler Avenue, ISA 2015, Tampa, FL 33620.
Phone: (813) 974-1592. Fax: (813) 974-1614. E-mail: kschmidt@usf.edu.

Abstract
Bloom’s syndrome (BS) is an autosomal recessive disorder caused by mutations in the
RecQ-like DNA helicase BLM, which functions in the maintenance of genome stability.
Using a humanized model of Saccharomyces cerevisiae that expresses a chimera of the
N-terminus of yeast Sgs1 and the C-terminus of human BLM from the chromosomal
SGS1 locus, we have functionally evaluated 27 BLM alleles that are not currently known
to be associated with BS. We identified nine alleles with impaired function when
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assessed for hypersensitivity to the DNA-damaging agent hydroxyurea (HU). Six of
these alleles (P690L, R717T, W803R, Y811C, F857L, G972V) caused sensitivity to HU
that was comparable to known BS-associated or helicase-dead alleles, suggesting that
they may cause BS and, in the heterozygous state, act as risk factors for
cancerogenesis. We also identified three alleles (R791C, P868L, G1120R) that caused
intermediate sensitivity to HU; while unlikely to cause BS, these partial loss-of-function
alleles may increase risk for cancers or other BS-associated complications if a person is
homozygous or compound heterozygous for these alleles or if they carry a known
BS-associated allele.

Introduction
Bloom’s syndrome (BS) is a rare genetic disorder with 264 affected individuals
worldwide currently included in the Bloom’s syndrome registry (Ellis, Sander et al. 2008).
BS is characterized by proportional dwarfism, erythema on sun-exposed skin, hyper- or
hypopigmented areas of skin, immunodeficiency, and subfertility (Bloom 1954; German J
& Ellis NA. Bloom syndrome. In: Vogelstein and Kinzler 1998). Persons with BS have a
striking predisposition to cancer development and increased risk for early-onset type-II
diabetes (German J & Ellis NA. Bloom syndrome. In: Vogelstein and Kinzler 1998). Life
expectancy is short, ranging from 1-49 years, with a mean age at death of 27 (German
and Passarge 1989; Ellis, Sander et al. 2008).
BS is caused by mutations in the BLM gene whose 22 exons encode a 3’-5’ DNA
helicase that is related to RecQ of Escherichia coli and Sgs1 of Saccharomyces
cerevisiae (Ellis, Groden et al. 1995; Bennett and Keck 2004). Nineteen recurring and 45
unique mutations in BLM have been identified as causative of BS (German, Sanz et al.
2007). BlmAsh, which occurs at a frequency of ~ 0.5% in the Ashkenazi Jewish
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population, is the most common BS-associated mutation - a frameshift caused by
deletion of six nucleotides and insertion of seven different nucleotides (Ellis, Roe et al.
1994; Ellis, Ciocci et al. 1998; Li, Eng et al. 1998; Straughen, Johnson et al. 1998). Most
other BS-associated mutations are also frameshifts or point mutations that lead to
premature termination of BLM upstream of or within the helicase domain, causing
complete loss of function. However, thirteen missense mutations - seven in the helicase
domain and six in the RecQ C-terminal (RQC) domain - have also been identified in
persons with BS (German, Sanz et al. 2007). Five of these missense mutations have
been characterized in vitro and were found to impair BLM’s ability to bind and hydrolyze
ATP or to bind DNA (Guo, Rigolet et al. 2007). Although a crystal structure of the BLM
helicase core has not yet been reported, modeling of known BS-associated mutations
onto the crystal structure of E. coli RecQ has revealed molecular and structural
explanations for these defects (Guo, Rigolet et al. 2007). Crystal structures of other
RecQ-like DNA helicases, most notably those of the helicase core of human RecQL1
and the winged-helix (WH) domain of WRN in a complex with DNA, have revealed that
even domains that show no significant sequence identity, such as the WH-domains, are
structurally and functionally conserved within the RecQ helicase family (Pike, Shrestha
et al. 2009; Kitano, Kim et al. 2010). Normal BLM function also depends on its physical
interaction with topoisomerase IIIα and Rmi1/Rmi2. Together they form the so-called
BRT complex, which is involved in dissolving homologous recombination intermediates
as noncrossovers (reviewed in reference (Hickson 2003). Interactions with Rad51, Mlh1,
p53 and ATM have also been reported (Wang, Cortez et al. 2000; Wu, Davies et al.
2001). Thus, BS cells are hypersensitive to DNA damaging agents, show elevated rates
of mitotic recombination, especially between sister chromatids, but also between
homologous chromosomes, and they accumulate abnormal replication intermediates
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(Chaganti, Schonberg et al. 1974; Groden, Nakamura et al. 1990; Lonn, Lonn et al.
1990; Groden and German 1992). Evidence that heterozygosity for BS-associated
mutations is associated with increased cancer risk comes from a study that showed a
greater than two-fold increase in colorectal cancer risk in carriers of the blmAsh mutation,
though this association is somewhat uncertain (Gruber, Ellis et al. 2002; Cleary, Zhang
et al. 2003). Associations between noncoding single nucleotide polymorphisms (SNPs)
in BLM and breast cancer and to a lesser extent bladder cancer, malignant melanoma,
acute myeloid leukemia and myelodysplastic syndromes have also been reported
(Broberg, Huynh et al. 2009; Ding, Yu et al. 2009), and it has been suggested that these
noncoding SNPs may be linked to functional SNPs in exons of BLM. However, it is
unknown which, if any, of the 75 currently known coding BLM variants alter BLM
function. Here, we have employed an S. cerevisiae system that expresses a chimera
composed of the N-terminus of Sgs1 and the C-terminus of BLM under control of the
chromosomal SGS1 promoter to functionally evaluate 27 variants of the BLM gene that
are not currently known to be associated with BS.

Results
Identification of Total Loss-of-Function BLM Alleles not Currently
Associated with BS
Like BS cells, yeast cells lacking Sgs1 are hypersensitive to DNA-damaging
agents (Mullen, Kaliraman et al. 2000). Deletion of the C-terminal 800 residues of Sgs1
eliminates the HRDC (Helicase and RNAase D C-terminal), helicase and RQC domains,
the latter two of which make up the helicase core of Sgs1. Hydroxyurea (HU) sensitivity
of cells expressing this Sgs1 truncation is suppressed by replacing the missing
C-terminal 800 residues of Sgs1 with the C-terminal half of human BLM (residues
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648-1417) (Mirzaei, Syed et al. 2011) (Figure 3. 1 A and B). Figure 3.1B shows that the
function of this chimera depends on enzymatic activity contributed by BLM since
mutating the conserved lysine in the Walker A motif of BLM (K695R) or introducing
mutations known to cause BS (C1036F, C1055S, D1064V) inactivated the chimera,
causing severe sensitivity to HU. The region of BLM included in the chimera contains 41
of the 75 missense mutations from dbSNP that are not currently known to be associated
with BS and two additional, rare variants (c.2069C>T, P690L; c.3970C>T, H1324T)
reported by German et al. (German, Sanz et al. 2007). Using PolyPhen (Adzhubei,
Schmidt et al. 2010), we first ranked these 43 variants according to their probability to
impair BLM function (Table 3.S1). The 11 variants predicted to be ‘probably damaging’
(score > 2.0) and the 11 variants predicted to be ‘possibly damaging’ (score > 1.5) were
selected for in vivo analysis (Table 3.1). In addition, we chose the three highest ranked
variants with a score < 1.5 (‘benign’) and two lower ranked variants for a total of 27
amino acid changes to be functionally evaluated in vivo (Table 3.1, Figure 3. 1A). These
27 variants were introduced into BLM cDNA and stably integrated at the chromosomal
SGS1 locus. Expression of the BLM variants from the endogenous SGS1 promoter
ensured cell-cycle-regulated expression and copy number control.
By assessing the ability to grow in the presence of HU, we identified six total
loss-of-function BLM alleles that are currently not associated with BS: P690L, R717T,
W803R, Y811C, F857L and G972V (Figure 3. 2). Expression of these BLM variants
caused cells to be as sensitive to HU as cells expressing the helicase-dead K695R allele
(Figure 3. 2) or known BS-associated alleles (Fig 1B). Yeast cells expressing these
alleles were also hypersensitive to the alkylating agent methyl methanesulfonate (MMS)
and 4-nitroquinoline 1-oxide (4NQO), which induces bulky DNA adducts (Figure 3. S1).
Three of these six mutations affect residues in conserved helicase motifs (Figure 3. 3A);
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P690 maps to the Walker A motif, R717 to motif Ia and G972 to motif VI. W803 is
located in a highly conserved aromatic-rich (AR) loop that follows the Walker B motif.
Y811 and F857 are located between motifs II and III, and motifs III and IV, respectively.
Only W803R affects a residue that is conserved in all five human RecQ homologs (BLM,
WRN, RecQL1, RecQL4, RecQL5), whereas the others affect residues that differ in at
least one of them. The arginine at position 717 is not conserved, with leucine or
isoleucine being present at those positions in the other four human RecQ-like helicases,
in Sgs1 and in RecQ. While the structure of the helicase domain of BLM has not been
solved, those of E. coli RecQ and human RecQL1 were recently reported (Bernstein,
Zittel et al. 2003; Pike, Shrestha et al. 2009). Based on ClustalW2 alignments P690,
R717, W803 Y811, F857, G972 of BLM correspond to P114, I141, W227, Y235, F281
and N397 of RecQL1 with no significant gaps in the alignment (Figure 3. 3A). Modeling
the BLM residues onto the RecQL1 structure revealed that P690, R717, W803 and Y811
are located in the first of the two RecA-like lobes of the helicase domain, whereas G972
is located in the second lobe, with F857 in the loop connecting the two lobes (Figure 3.
3C and D). Notably, all six affected residues are located near the surface of the deep
cleft between the two lobes. Residues exposed along this cleft, including those that
make up the conserved helicase motifs, are critical for ATP-binding and hydrolysis as
well as single-strand DNA binding (Korolev, Yao et al. 1998; Velankar, Soultanas et al.
1999; Bernstein, Zittel et al. 2003; Zittel and Keck 2005; Guo, Rigolet et al. 2007; Pike,
Shrestha et al. 2009).

Identification of Partial Loss-of-Function BLM Alleles
In addition to total loss-of-function alleles we identified three alleles (R791C,
P868L, G1120R) that caused slight growth inhibition on HU, suggesting a partial loss of
function (Table 3.1, Figure 3. 2). Cells expressing these alleles also showed slightly
64

increased sensitivity to 4NQO, and to a lesser extent to MMS (Figure 3. S1). These
partial loss-of-function mutations affect residues in the helicase core; however, they are
not on the surface of the cleft between the two lobes. Instead, R791 borders the stretch
of four hydrophobic residues that precedes the invariant aspartic acid (D795) and
glutamate (E796) residues of the Walker B motif (Figure 3. 3 A and D) whereas P868 is
furthest from the cleft in a loop that follows the first β-sheet of lobe 2 (Figure 3. 3E). The
third affected residue, G1120, is located in the α2-α3 loop of the WH-domain and
appears to be the only BLM variant that exhibits impaired function due to a missense
mutation in this domain (Figure 3. 3 B, F and G). The WH-domain of RecQ-like helicases
has recently been implicated in DNA recognition and strand separation (Pike, Shrestha
et al. 2009; Kitano, Kim et al. 2010). Although there is no significant sequence identity
between the WH-domains of RecQ helicases, ClustalW2 and structure-based
alignments show that G1120 is conserved in Sgs1, RecQ and all four human RecQ-like
DNA helicases that possess an RQC domain (Figure 3. 3B, Figure 3. S2 B) (Kitano, Kim
et al. 2010). When we changed G1120 to a different residue (G1120E) we observed the
same partial defect, further supporting the importance of G1120 for BLM function (Figure
3. S3).
Although predicted by PolyPhen to be ‘probably damaging’, the H1014R and
H660Y alleles did not cause hypersensitivity to HU. None of the BLM alleles predicted to
be ‘possibly damaging’ or predicted to be ‘benign’ impaired BLM function in the HU
sensitivity assay (Table 3.1, Figure 3. 2). Of the 17 amino acid changes that did not
impair BLM function, 13 are located in domains for which crystal structures or solution
structures have been determined in at least one member of the RecQ-like DNA helicase
family (Figure 3. S4). Seven of these amino acid changes map to the helicase domain
and affect residues along the periphery of lobe 1 or lobe 2 away from the cleft between
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the lobes where the conserved helicase motifs are located (Figure 3. S4 A). Three other
amino acid changes are located in the zinc-binding subdomain (Figure 3. S4 B) and two
are located in the α3-α4 loop of the WH subdomain, which in contrast to the α2-α3 loop,
where the partially defective G1120R mutation is located, is not known to be involved in
DNA binding (Figure 3. S4 C). Finally, one amino acid change that did not impair BLM
function maps to the HRDC domain (Figure 3. S4 D).

Corresponding Amino Acid Changes Impair Sgs1 Function
Of the five human RecQ-like DNA helicases, BLM is most closely related to
Sgs1. Alignments between both proteins show 50% identity across the helicase core
where the affected residues in all nine functionally impaired BLM variants are located. To
determine if the functional impairment was limited to BLM or if the equivalent mutations
also affected Sgs1 function we constructed nine sgs1 alleles that corresponded to the
nine partially or fully impaired BLM alleles (Fig 4 A, Figure 3. S2). Identifying the
equivalent residues in Sgs1 was unambiguous except for the proline residue at position
868, which in BLM is located in a lysine-rich loop (868PKKPKK873) recently suggested to
interact with DNA (Kitano, Kim et al. 2010). This proline is not present in Sgs1 and in the
absence of a crystal structure of Sgs1 it is unclear if the loop is conserved. However,
since the positive charge of the loop has been suggested to be functionally important for
DNA binding we decided to mutate the first of three lysines in this region (K881) to
leucine. The nine mutations were introduced into the SGS1 gene on a CEN/ARS
plasmid expressed under control of the native SGS1 promoter and then tested for their
ability to complement the HU hypersensitivity of an sgs1Δ mutant (Figure 3. 4 B). The
W816R and Y824C alleles could not suppress the HU hypersensitivity of the sgs1Δ
mutant whereas P701L, F870L and G1115R partially suppressed it, indicating impaired
function of these five sgs1 alleles. The I732T, R804C, K881L and G983V alleles
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appeared to fully suppress HU sensitivity of the sgs1Δ mutant, suggesting they retained
activity that was similar to that of the SGS1 wild-type allele. Taken together, five of the
six amino acid changes that caused a total loss of BLM function also impaired Sgs1
function, whereas one of the three partial loss-of-function mutations did (Table 3.2).
Notably, all BLM mutations that affected residues also conserved in Sgs1 and E. coli
RecQ impaired Sgs1 function whereas those that are not conserved in E. coli RecQ,
Sgs1 and BLM did not (Figure 3. 4 A, Figure 3. S2, Table 3.2).

Genetic Interactions between BLM Variants in Diploid Cells
To assess possible genetic interactions between BLM alleles we constructed
diploids with various combinations of wild-type, partial loss-of-function and total
loss-of-function alleles (Figure 3. 5, Figure3. S5). As expected, diploids homozygous or
compound heterozygous for total loss of function alleles were most sensitive to HU.
However, while we expected that diploids homozygous or heterozygous for wild-type
alleles would not be hypersensitive to HU regardless of the status of the second allele,
we observed that diploids heterozygous for total loss-of-function and wild-type alleles
(Figure 3. 5, rows 4-7) were more sensitive to HU than diploids that were biallelic for
wild-type alleles (Figure 3. 5, rows 1-3). We made similar observations when we
included additional total loss-of-function alleles (K695R, C1055S) in the analysis (Figure
3. S5). HU sensitivity of diploids homozygous for the partial loss-of-function P868L allele
or heterozygous for P868L and one of the total loss-of-function alleles fell between that
of diploids biallelic for wild-type or total loss-of-function alleles (Figure 3. S5). These
findings could be explained by insufficient wild-type BLM protein or a lower activity of
multimeric BLM helicase complexes that consist of a mixture of wild-type and
nonfunctional monomers.
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Discussion
In this study we have used S. cerevisiae to functionally evaluate 27 BLM variants
that are not currently associated with BS. The mutant BLM alleles were chromosomally
expressed from the endogenous SGS1 promoter. The advantage over plasmid based
approaches or expression from inducible or constitutive promoters is that BLM
expression in this system is cell cycle regulated and copy number controlled. Similar to
Sgs1, BLM appears in S-phase, is maintained at similar levels in G2/M, but has mostly
disappeared by the time cells re-enter G1 (Dutertre, Ababou et al. 2000). Regulation of
BLM expression by the chromosomal SGS1 promoter was critical since the goal of our
study was to evaluate BLM variants that are not known to cause BS. Therefore, the
experimental system had to be designed such that besides wild-type and null alleles it
could also detect partial loss-of-function alleles, which impair BLM function, but at a level
too weak to cause BS. The subtle defects exhibited by such weak alleles may be
compensated for and thus go undetected in overexpression systems or in the absence
of appropriate cell cycle regulation.
Using this approach, we identified six total loss-of-function BLM alleles (P690L,
R717T, W803R, Y811C, F857L, G972V) and three partial loss-of-function alleles
(R791C, P868L, G1120R). While biochemical analysis will uniquely identify the specific
defect of each of these BLM variants, previous structure-function analyses of RecQ and
other helicases as well as the in vitro characterization of known BS-associated mutations
allow us to make some predictions. For example, although the P690L mutation does not
affect one of the highly conserved GK(T/S) residues of motif I (Walker A), its location
within this motif most likely leads to loss of function because of an inability to bind ATP
and/or Mg2+. The R717T mutation affects a variable residue of motif Ia. The effect of
mutations in motif Ia has not yet been investigated, primarily because none of the
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missense mutations known to cause BS are located in this motif. However, structural
analyses have revealed that residues from motif Ia engage in ssDNA binding (Korolev,
Hsieh et al. 1997; Kim, Morgenstern et al. 1998; Korolev, Yao et al. 1998; Velankar,
Soultanas et al. 1999), and replacing the positively charged arginine with a neutral
threonine may weaken ssDNA binding in this critical region. The third loss-of-function
variant, W803, is located in an AR-loop that was originally described in the PcrA and
shown to be critical for coupling ATP hydrolysis to DNA binding and unwinding
(Dillingham, Soultanas et al. 1999; Velankar, Soultanas et al. 1999; Dillingham,
Soultanas et al. 2001). This AR-loop is conserved in RecQ-like helicases, including BLM,
Sgs1 and E. coli RecQ. The loss of function caused by mutating Y811, another aromatic
residue just outside the AR-loop, is likely due to a similar inability to coordinate ATP
hydrolysis with DNA binding/unwinding. F857 is located between motifs III and IV in the
flexible loop that connects the two RecA-like lobes that make up the helicase domain. A
mutation on this side of the interlobe cleft, which accommodates the ATP binding site,
may interfere with ATP binding/hydrolysis. In SF-1 helicases, an ‘arginine-finger’ motif VI
in lobe 2 also reaches into this site to interact with ATP (Soultanas, Dillingham et al.
1999; Velankar, Soultanas et al. 1999), and it is plausible that the conserved arginine
residues in motif VI of RecQ helicases (R978, R982 of BLM), which also reach into the
ATP-binding site (Killoran and Keck 2006), serve the same function. Mutation of G972,
which is located near this ‘arginine finger’, could therefore impair coordination between
lobe 2 and ATP binding in lobe 1.
Besides total loss-of-function mutations we identified three BLM alleles that retain
partial activity (R791C, P868L, G1120R). Instead of being at or near the surface of the
interlobe cleft where residues of the conserved motifs are exposed, the R791C and
P868L mutations affect residues within or adjacent to internal β-sheets (Figure 3. 3 D
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and E). However, R791 is close to the invariant D795 of the DExH motif II (Walker B)
and, thus, the partial loss of function is most likely due to decreased ATP hydrolysis. In
contrast, since the residue of REQL1 equivalent to P868 of BLM is not near the interlobe
cleft its mutation is unlikely to affect the function of the conserved helicase motifs.
Instead, its location near the bottom of lobe 2 where the zinc-binding domain adjoins the
helicase domain (Figure 3. 3 E) may weaken the interaction between these two
domains, which is thought to be important for DNA binding and protein stability. In fact,
P868 is the first residue in a lysine-rich loop (residues 869-873) that has been suggested
to play a role in stable DNA binding by BLM (Guo, Rigolet et al. 2007). Unlike R791C
and P868L, the G1120R mutation is located in the RQC domain of the helicase core. It is
the only known BLM variant whose defect is due to a missense mutation in the
WH-subdomain. A recent analysis of the crystal structure of the WH-domain of WRN
complexed with DNA indicates that in RecQ-like helicases two loops, one between the
α2 and α3 helices and one between the β2 and β3 strands, are involved in
sequence-independent DNA binding and strand separation, respectively, and undergo
conformational changes upon DNA binding (Kitano, Kim et al. 2010). The importance of
the conserved glycine in the α2-α3 loop is likely to stem from its low propensity (the
lowest next to proline) for α-helix formation and, thus, its ability to maintain the loop
structure and provide the flexibility needed for the conformational change (loop
extension) and exposure of residues for DNA binding. Mutation analysis has confirmed
the importance of the β-wing for DNA binding and helicase activity in WRN and RECQ1
(Pike, Shrestha et al. 2009; Kitano, Kim et al. 2010). The identification of the partially
defective G1120R and G1115R alleles now also provides in vivo support for the
functional importance of the α2-α3 loop in BLM and Sgs1, respectively. Similarly,
impairment of Sgs1 and BLM by the equivalent F870L and F857L mutations,
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respectively, suggests functional importance in both helicases of the β7- β8 loop where it
reaches into the interlobe cleft. Equivalent mutations in or near the AR-loop and the
Walker A motif also impaired the function of both BLM and Sgs1. However, K881L
(P868L in BLM) did not impair Sgs1 function, suggesting that the lysine-rich loop in lobe
2 of BLM and its role in helicase function is not conserved in Sgs1. Indeed, this finding
provides in vivo support for the recent proposal that the lysine-rich loop and its function
may be unique to BLM (Guo, Rigolet et al. 2007).
With the exception of the blmAsh allele, which occurs at a frequency of ~ 0.5% in
the Ashkenazi Jewish population, alleles known to cause BS are very rare (< 0.1%)
(Ellis, Roe et al. 1994; Li, Eng et al. 1998; German, Sanz et al. 2007). Indeed, most BS
mutations have only been found in a single individual with BS (German, Sanz et al.
2007). It is therefore likely that additional BS alleles exist in the human population that
have, due to their rarity and the autosomal recessive pattern of inheritance of BS, not yet
been identified in a person with BS. We propose that the six total loss-of-function alleles
may be candidates for new BS mutations. Based on the recent finding that the frequency
of P868L in the human population is ~ 4.6 % (Wirtenberger, Frank et al. 2006), we
further propose that partially defective BLM variants (R791C, P868L, G1120R) are
unlikely to be associated with full-scale BS as the predicted homozygosity for the P868L
allele in the human population far exceeds the incidence of BS.
Whether carriers for disease-causing BLM mutations also exhibit genome
instability and are at increased risk for cancerogenesis is only beginning to be
investigated. In one study, heterozygosity for the most common BS-associated mutation,
blmAsh, was associated with increased colorectal cancer risk, although this increase was
not seen in another study (Gruber, Ellis et al. 2002; Cleary, Zhang et al. 2003). Evidence
of a gene dosage effect (haploinsufficiency) for BLM in colorectal tumorigenesis in mice
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also indicates that heterozygosity for BLM plays a role in cancer predisposition (Goss,
Risinger et al. 2002). Similarly, we observed diploids heterozygous for loss-of-function
BLM alleles were more sensitive to DNA-damaging agents than wild-type diploids. This
hypersensitivity could be due to haploinsufficiency or decreased activity of helicase
complexes that consist of mixtures of wild-type and mutant BLM monomers. The
possibility that the defect may be specific to expression being controlled by the SGS1
promoter and may not apply to protein levels expressed from the endogenous BLM
promoter also cannot be excluded.
Besides the possibility of increased cancer risk for carriers of loss-of-function
BLM mutations, hypomorphic BLM alleles - those that are partially functional and
therefore do not cause all the clinical features of BS - may be associated with increased
cancer risk. With the identification of the P868L polymorphism as a hypomorphic BLM
allele candidate, it will now be possible to determine if such an association exists. A
recent report, which found an allele-dosage-dependent effect of P868L on rectal cancer
risk, does indeed point towards this possibility (Frank, Hoffmeister et al.). With an
estimated 1 in 10 individuals being carriers of P868L (Wirtenberger, Frank et al. 2006)
and, thus, ~ 1 in 500 individuals being predicted to be homozygous, an association
between P868L homozygosity and an elevated risk for cancer (or other risks associated
with genome instability, such as hypersensitivity to chemotherapeutics or other
genotoxic agents), would be significant. Despite the evidence from our yeast system, it
will remain unclear if R791C and G1120R are also hypomorphic alleles like P868L until
the frequency of these alleles in the human population is determined. Notably, carriers of
a known BS mutation (or one of the total loss-of-function alleles identified here) who also
carry a hypomorphic allele such as P868L, i.e. who have no fully functional BLM allele,
might also be at higher risk for cancers commonly associated with BS, such as
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leukemia, lymphoma or epithelial cancers (German 1997), or they may exhibit a BS-like
disorder, characterized by milder expression or later onset of a combination of
BS-associated symptoms.

Methods
Yeast strains, plasmids and media
Strains are derived from RDKY3615 (MATa, ura3-52, trp1Δ63, his3Δ200, leu2Δ1,
lys2Bgl, hom3-10, ade2Δ1, ade8, hxt13::URA3). Diploids were constructed by mating
haploids with the desired BLM allele. BLM cDNA was purchased from Open Biosystems
(clone MGC286) and the HIS3 cassette from pRS303 was inserted into a SpeI site
downstream of BLM. Variants were introduced into the cDNA by site-directed
mutagenesis. A PCR product comprising nucleotides 1942 to 4251 of BLM and the HIS3
marker cassette was used to replace nucleotides 1942 to 4341 of the chromosomal
SGS1 ORF in RDKY3615 by recombination-mediated integration (Gietz and Woods
2006), leading to expression of a fusion of the N-terminus of Sgs1 and the C-terminus of
BLM (Sgs1-BLM). In-frame fusion at nucleotide 1941, the integrity of the integrated BLM
cDNA sequence and the presence of the desired variant were confirmed by sequencing.
Mutations in plasmid-borne SGS1 were introduced by site-directed mutagenesis and
confirmed by sequencing of SGS1. Yeast strains and plasmids used in this study are
listed in Tables S2 and S3. Yeasts were cultured in liquid yeast extract/peptone/dextrose
(YPD) with shaking at 30°C or grown on YPD agar at 30°C.

Sensitivity to DNA damaging agents
Cell cultures were grown overnight in YPD (or in synthetic media lacking leucine to
maintain pRS415 derived plasmids), diluted to OD600 = 0.2 and incubated until they
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reached OD600 = 0.5-0.6. Tenfold dilutions were spotted on YPD and YPD supplemented
with HU, MMS or 4NQO as indicated.
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Figure 3.1. Location of 27 BLM variants evaluated in this study
(A) The C-terminal 770 residues of BLM were fused to the 647 N-terminal residues of
Sgs1 to construct a chimera (Sgs1-BLM) that confers resistance to hydroxyurea (HU) in
cells lacking Sgs1. Conserved domains are indicated by black boxes (helicase motifs)
and by horizontally (RQC) or vertically (HRDC) striped boxes (12). Disorder scores are
from IUPRED, with > 0.5 predicting disorder and < 0.5 predicting order (B) HU sensitivity
of yeast cells expressing the Sgs1-BLM chimera, the helicase-dead Sgs1-BLM-K695R
chimera and chimeras with mutations known to cause BS (C1036F, C1055S, D1064V).
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Figure 3.2. HU sensitivity of yeast cells expressing BLM variants
Variants were chromosomally expressed from the endogenous SGS1 promoter and
ten-fold dilutions of exponentially growing cultures were spotted on YPD with HU or
without HU. Variants that cause sensitivity equivalent to that of the helicase-dead variant
(K695R) are shown in red (total loss of function), those that grow as well as wild-type in
black and those that cause HU sensitivity intermediate between wild-type and the
helicase-dead variant in blue (partial loss of function). The asterisk marks a BLM variant
listed in dbSNP that was originally reported as a missense mutation (6), but
subsequently identified to be a deletion of exons 11 and 12, resulting in a premature
stop codon (3).
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Figure 3.3. Location of nine missense mutations found in this study to impair BLM
function
(A) ClustalW2 alignment between the helicase domain of human BLM and RecQL1.
Identical residues are shaded gray. Total and partial loss-of-function mutations are red
and blue, respectively. Helicase motifs and an aromatic-rich (AR) loop are indicated by
horizontal lines. (B) Structure-based alignment of WH-domains (partial) of BLM, RecQL1
and WRN, adapted from Kitano et al. (13). Structurally important residues are underlined
and functionally important residues in the α2-α3 loop and β-wing are shown in bold. The
glycine in the G1120R mutation is shaded blue. (C-F) Residues affected in BLM variants
are highlighted in the crystal structure of RecQL1 (14). (C) Location of the six total
loss-of-function mutations (pink spheres) along the cleft between the lobe 1 (blue) and 2
(green). ADP is shown as an orange stick model and Mg2+ is shown as a yellow sphere.
(D) R791 is located in lobe 1, with the nearby, invariant residue D795 (Walker B) shown
as a red stick model. (E) The residue corresponding to P868 is located at the base of
lobe 2 where the zinc-binding domain (yellow) adjoins. The loop connecting lobes 1 and
2 and the β-sheets flanking this loop are indicated in red. (F) G1120 is located in the
WH-domain (grey). The α2-α3 loop and β-wing are shown in green. (G) Location of the
residue equivalent to G1120 in the WH-domain of WRN crystallized with DNA (13). The
α2-α3 loop and β-wing are shown in green. Images were generated in PyMol.
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BLM
942
CQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFY
IAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFY
CATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFY
RecQ
289
LQIVVATVAFGMGINKPNVRFVVHFDIPRNIESYYQETGRAGRDGLPAEAMLFY
sgs1-R804C
SYYQETGRAGRDGLPAEAMLFY
RecQ
219
LMEKFKP---LDQLMRYVQEQRGKSGIIYCNSRAKVEDTAAALQSKGISAAAYHAGLENNVRADVQEK
RecQ
289
LQIVVATVAFGMGINKPNVRFVVHFDIPRNIESYYQETGRAGRDGLPAEAMLFY
VAFGMGINKPNVRFVVHFDIPRNIESYYQETGRAGRDGLPAEAMLFY
VATVAFGMGINKPNVRFVVHFDIPRNIESYYQETGRAGRDGLPAEAMLFY
Sgs1
BLM
RecQ

sgs1-W816R

951
IQVICATVAFGMGIDKPDVRFVYHFTVPRTLEGYYQETGRAGRDGNYSYCITYF
sgs1-Y824C
942

CQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFY

sgs1-F870L
289
LQIVVATVAFGMGINKPNVRFVVHFDIPRNIESYYQETGRAGRDGLPAEAMLFY
sgs1-K881L
sgs1-G983V
sgs1-G1115R

Figure 3.4. HU hypersensitivity of sgs1 mutants with amino acid changes
corresponding to those that impair BLM function
(A) ClustalW2 alignment of Sgs1, human BLM and E. coli RecQ. Amino acid changes in
Sgs1 are indicated in red if the corresponding BLM mutation causes total loss of
function, or in blue if the corresponding BLM mutation causes partial loss of function. (B)
sgs1 mutant alleles were expressed from pRS415 and the native SGS1 promoter to test
for their ability to suppress HU hypersensitivity of sgs1Δ cells. Empty vector (pRS415)
and vector expressing wild-type Sgs1 (pRS415-SGS1) served as negative and positive
controls, respectively.
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- HU

100 mM HU

HU
sensitivity

wildtype/wildtype

-

wildtype/V1198M

-

V1198M/V1198M

-

wildtype/C1036F

+

wildtype/W803R

+

V1198M/C1036F

+

V1198M/W803R

+

W803R/W803R

+++

Figure 3.5. Examination of sensitivity to HU Diploids heterozygous or
homozygous for total loss-of-function alleles
Diploids heterozygous or homozygous for total loss-of-function alleles (W803R, C1036F)
are more sensitive to HU than diploids homozygous for alleles exhibiting wild-type
function (wild-type, V1198M).
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Table 3.1. Coding, nonsynonymous BLM variants functionally evaluated in this
study.
Mutation

Domain

PolyPhen Score

HU

I658T
H660Y

HD
HD (motif 0)

1.860
2.211

-

P690L

HD (motif I)

2.724

+++

P707S

HD

1.951

-

R717T

HD (motif Ia)

2.008

+++

Q752H

HD

1.921

-

K755E

HD

1.493

-

S778C

HD

1.773

-

R791C

HD (motif II)

2.495

+

W803R

HD (AR loop)

3.757

+++

Y811C

HD

2.616

+++

T843I*

HD

1.796

+

F857L

HD

2.001

+++

P868L

HD

2.724

+

K873N

HD

1.649

-

G972V

HD (motif VI)

2.397

+++

Y995H

RQC (zinc)

1.716

-

H1014R

RQC (zinc)

2.360

-

A1043D

RQC (zinc)

1.440

-

G1120R

RQC (WH)

2.172

+

K1133E

RQC (WH)

1.550

-

E1143K

RQC (WH)

1.554

-

V1198M

-

0.375

-

E1213K

HRDC

1.470

-

H1324T

-

1.098

-

R1331G

-

1.787

-

Q1387K

-

1.569

-

Amino acid changes in BLM were identified in dbSNP and mapped to BLM. HD, helicase
domain; AR, aromatic-rich; RQC, RecQ C-terminal domain with zinc-binding and
winged-helix (WH) subdomains; HRDC, helicase and RNaseD C-terminal domain; HU,
hydroxyurea sensitivity. Polymorphisms Phenotyping (PolyPhen) scores (Adzhubei,
Schmidt et al. ; Adzhubei, Schmidt et al. 2010) estimate the probability of
nonsynonomous mutations to affect protein function (>2, probably damaging; <2,
possibly damaging; <1.5, benign). HU refers to Figure 3. 2 (+++ as sensitive as
helicase-dead K695R, + intermediate sensitivity between wild-type and K695R, –
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equivalent to wild-type). BLM variants P690L and H1324T were reported by German et
al. (German, Sanz et al. 2007). The asterisk indicates a variant originally reported in
dbSNP as a missense mutation, but later identified as deletion of exons 11 and 12,
resulting in a premature stop codon (Ellis, Groden et al. 1995; German J & Ellis NA.
Bloom syndrome. In: Vogelstein and Kinzler 1998).
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Table 3.2. HU hypersensitivity conferred by sgs1 alleles coding for amino acid
changes equivalent to those impairing BLM function.
Amino Acid
Change

HU
Hypersensitivity

BLM

Sgs1

Domain

BLM

Sgs1

P690L

P701L

HD (motif I)

+++

++

R717T

I732T

HD (motif Ia)

+++

-

R791C

R804C

HD (motif II)

+

-

W803R

W816R

HD (AR loop)

+++

+++

Y811C

Y824C

HD

+++

+++

F857L

F870L

HD

+++

++

P868L

K881L

HD

+

-

G972V

G983V

HD (motif VI)

+++

-

G1120R

G1115R

RQC (WH)

+

++
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Supplemental Figures and Tables

YPD

0.03% MMS

300 mM 4NQO

wildtype
K695R
P690L
R717T
R791C
W803R
Y811C
F857L
P868L
G972V
G1120R
C1055S

Figure 3.S1. Sensitivity of cells expressing BLM alleles to DNA damaging agents
Sensitivity of cells expressing total and partial loss of function BLM mutations to the
alkylating agent MMS and the UV mimic 4NQO, which induces bulky DNA adducts. Total
loss-of function mutations are indicated in red and partial loss of function mutations are
indicated in blue. The helicase-dead K695R allele was included as a total
loss-of-function control.
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A

659
648
8

motif Ia

motif I

motif 0
Sgs1
BLM
RecQ

TYPWSDEVLYRLHEVFKLPGFRPNQLEAVNATLQGKDVFVLMPTGGGKSLCYQLPAVVKSGKTHGTTIVISPLI
SFPHTKEMMKIFHKKFGLHNFRTNQLEAINAALLGEDCFILMPTGGGKSLCYQLPACVSP----GVTVVISPLR
VLNLESGAKQVLQETFGYQQFRPGQEEIIDTVLSGRDCLVVMPTGGGKSLCYQIPALLLN----GLTVVVSPLI

P701L
Sgs1
BLM
RecQ

733
722
78

SLMQDQVEHLLNKNIKASMFSSRGTAEQRRQTF--NLFINGLLDLVYISPEMISASEQCKRAISRLYADGKLAR
SLIVDQVQKLTSLDIPATYLTGDKTDSEATNIYLQLSKKDPIIKLLYVTPEKICASNRLISTLENLYERKLLAR
SLMKDQVDQLQANGVAAACLNSTQTREQQL--EVMTGCRTGQIRLLYIAPERLMLDNFLEH----L-AHWNPVL

R804C

AR loop
Sgs1
BLM
RecQ

805
796
145
879
870
219

motif III

IVVDEAHCVSNWGHDFRPDYKELKFFKREYPDIPMIALTATASEQVRMDIIHNLELKEPVFLKQSFNRTNLYYE
FVIDEAHCVSQWGHDFRQDYKRMNMLRQKFPSVPVMALTATANPRVQKDILTQLKILRPQVFSMSFNRHNLKYY
LAVDEAHCISQWGHDFRPEYAALGQLRQRFPTLPFMALTATADDTTRQDIVRLLGLNDPLIQISSFDRPNIRYM

W816R
Sgs1
BLM
RecQ

Y824C

951
942
289

F870L
motif V

motif IV

VNKK-TKNTIFEICDAVKSRFKNQTGIIYCHSKKSCEQTSAQMQRNGIKCAYYHAGMEPDERLSVQKAWQ-ADE
VLPKKPKKVAFDCLEWIRKHHPYDSGIIYCLSRRECDTMADTLQRDGLAALAYHAGLSDSARDEVQQKWINQDG
LMEKFKP---LDQLMRYVQEQRGKSGIIYCNSRAKVEDTAAALQSKGISAAAYHAGLENNVRADVQEKFQ-RDD

K881L
Sgs1
BLM
RecQ

I732T
motif II

motif VI

IQVICATVAFGMGIDKPDVRFVYHFTVPRTLEGYYQETGRAGRDGNYSYCITYF
CQVICATIAFGMGIDKPDVRFVIHASLPKSVEGYYQESGRAGRDGEISHCLLFY
LQIVVATVAFGMGINKPNVRFVVHFDIPRNIESYYQETGRAGRDGLPAEAMLFY

G983V

B

α2-α3 loop
Sgs1
BLM
RecQ
RECQL1
WRN

1076
1068
405
480
950

ANVINEERDVTEPAKKIVKLVESIQN-------------ERVTIIYCQDVFKGSRSSKIVQANHDTLEEHGIGK
KTKDYKTRDVTDDVKSIVRFVQEHSSSQGMRNIKHVGPSGRFTMNMLVDIFLGSKSAKIQSGIFGKGSAYSRHN
CLDPPKQYDGSTDAQIALSTIGRVN--------------QRFGMGYVVEVIRGANNQRIRDYGHDKLKVYGMGR
KDSAFERKNITEYCRDLIKILKQAEELN-----------EKLTPLKLIDSWMGKGAAKLRVAGVVAPTL----DDSEDTSWDFGPQAFKLLSAVDILG--------------EKFGIGLPILFLRGSNSQRLADQYRRHSLF-GTGK

Sgs1
BLM
RecQ
RECQL1
WRN

1137
1143
465
539
1009

SMQKSEIERIFFHLITIRVLQEYSIMNNSGFASSYVKVGPNAKKLLTGKMEIKM
AERLFKKLILDKILDEDLYINANDQAIAYVMLGNKAQTVLNGNLKVDFMETENS
DKSHEHWVSVIRQLIHLGLVTQN--IAQHSALQL-TEAARPVLAESSLQLAVPR
--PREDLEKIIAHFLIQQYLKEDYSFTAYATISYLKIGPKANLLNNEAHAITMQ
DQTESWWKAFSRQLITEGFLVEVSRYNKFMKICALTKKGRNWLHKANTESQSLI

β-wing

G1115R

Figure 3.S2. Mutations in Sgs1 corresponding to six total and three partial
loss-of-function mutations in BLM
The amino acid changes in Sgs1 are shown in red if the corresponding amino acid
change BLM caused a total loss of function, or in blue if the corresponding amino acid
change in BLM caused a partial loss of function. (A) ClustalW2 alignment between the
helicase domain of Sgs1, human BLM and E. coli RecQ. Identical residues are shaded
gray. Total and partial loss-of-function mutations are indicated in red and blue,
respectively. (B) Structure-based alignment of the WH-domain of Sgs1, E. coli RecQ and
human BLM, RecQL1 and WRN, adapted from Kitano et al. (Kitano, Kim et al. 2010).
Structurally important residues are underlined and functionally important residues in the
α2-α3 loop and β-wing are indicated in bold.
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- HU

100 mM HU

G972V
Y995H
H1014R
A1043D
G1120E
K1133E

Figure 3.S3. Intermediate sensitivity to HU of yeast cells expressing the G1120E
allele
Ten-fold dilutions of exponentially growing cultures were spotted on YPD with 100 mM
HU or without HU (-HU). Total loss-of- function allele G972V is shown in red, those
comparable to the wild-type chimera are shown in black and the allele intermediate
between wild-type and total loss-of-function alleles (G1120E) is shown in blue.
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A

Y811
Y803

S778

R717
G972
P690
K755
Q752

K873

P707

F857

I658

B

H660

C
Y995

D
E1143
K1133

E1213

α3-α4 loop
G1120
A1043
H1014

α2-α3 loop

Figure 3.S4. Location of 13 residues whose mutation did not to impair BLM
function
(A) Residues in the crystal structure of human RecQ1 (14) that are equivalent to mutated
residues in BLM variants that exhibit wild-type function are indicated by yellow spheres.
For reference, residues (from Fig 3C) whose mutation leads to total loss of BLM function
are indicated in red. Lobe 1 and 2 of the helicase domain are shown in blue and green,
respectively. The Mg2+ ion and ADP are shown as a pink sphere and stick model,
respectively. (B) Three residues in the zinc-binding subdomain of the RQC domain
whose mutation did not impair BLM function are indicated by yellow spheres. The
location of the residues was modeled onto the crystal structure of the helicase core of E.
coli RecQ (Bernstein, Zittel et al. 2003). The conserved cysteine residues coordinating
the zinc ion (pale brown) are shown in grey. (C) Two residues whose mutation did not
impair BLM function are located in the α3-α4 loop (dark blue) of the WH-subdomain and
are shown in yellow. For reference, location of the partial loss-of-function mutation
G1120R in the α2-α3 loop (from Figure 3. 3G), is indicated in red. The α2-α3 loop and
β-wing are highlighted in green. Residues were modeled onto the structure of human
WRN crystallized with double stranded DNA (13). (D) One missense mutation that did
not affect BLM function, E1213K, maps to a residue near the N-terminus of the HRDC
domain. The solution structure of the HRDC domain of human BLM is shown (Kim and
Choi 2010). All images were generated in PyMol.
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- HU

100 mM HU

wildtype/wildtype
wildtype/K695R
wildtype/W803R
wildtype/P868L
wildtype/V1198M
wildtype/C1055S
K695R/K695R
K695R/W803R
K695R/P868L
K695R/V1198M
K695R/C1055S
W803R/W803R
W803R/P868L
W803R/V1198M
W803R/C1055S
P868L/P868L
P868L/V1198M
P868L/C1055S
V1198M/V1198M
V1198M/C1055S
C1055S/C1055S
C1036F/wildtype
C1036F/K695R
C1036F/W803R
C1036F/P868L
C1036F/V1198M
C1036F/C1036F

Figure 3.S5. Sensitivity to HU of diploid cells homozygous or heterozygous for
BLM alleles
Sensitivity to HU of diploid cells homozygous or heterozygous for BLM alleles that
exhibit wild-type function (wild-type, V1198M), partial loss of function (P868L) or total
loss of function (K695R, W803R, C1055S, C1036F) in haploid cells. Ten-fold dilutions of
exponentially growing cultures were spotted on YPD with 100 mM HU or on media
without HU (- HU).
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Table 3.S1. Coding, nonsynonymous mutations in the human BLM gene 3’ half,
which encodes the helicase, RQC and HRDC domains, ranked according to their
Polymorphism Phenotyping (PolyPhen) score (28).
dbSNP ID

Location

Allele changes

PolyPhen
score

rs148394770

exon 12

T>C

3.757

W803R

c.2069C>T

exon 8

C>T

2.724

P690L

rs11852361

exon 13

C>T

2.724

P868L

rs145029382

exon 12

A>G

2.616

Y811C

rs55880859

exon 11

C>T

2.495

R791C

rs150475674

exon 15

G>T

2.397

G972V

rs145022945

exon 16

A>G

2.360

H1014R

rs139688226

exon 8

C>T

2.211

H660Y

rs139773499

exon 17

G>A

2.172

G1120R

rs28406486

exon 9

G>C

2.008

R717T

rs182115037

exon 13

T>G, T>A

2.001

F857L

rs146077918

exon 9

C>T

1.951

P707S

rs61752785

exon 10

G>C

1.921

Q752H

exon 8

T>C

1.860

I658T

exon 12

C>T

1.796

T843I

rs150631940

exon 21

A>G

1.787

R1331G

rs139610577

exon 11

C>G

1.773

S778C

rs142723411

exon 15

T>C

1.716

Y995H

rs146723808

exon 13

G>C

1.649

K873N

rs183438014

exon 22

C>A

1.569

Q1387K

rs140387675

exon 18

G>A

1.554

E1143K

rs145027663

exon 18

A>G

1.550

K1133E

rs142551229

exon 10

A>G

1.493

K755E

rs28385142

exon 19

G>A

1.470

E1213K

rs2229035

exon 16

C>A

1.440

A1043D

rs149754073

exon 11

C>T

1.435

L788F

rs151309611

exon 14

C>T

1.435

L896F

rs144021705

exon 17

C>T

1.373

T1074I

rs150034914

exon 22

G>A

1.370

R1407K

rs139115275

exon 22

G>A

1.348

S1375N

rs1801256

exon 19

T>A

1.323

S1209T

rs187379039
rs137853152

*
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Amino acid
change

Table 3.S1 continued
rs150784889

exon 17

G>A

1.249

G1104D

rs138329850

exon 15

A>C

1.245

E985D

rs190652985

exon 21

A>G

1.112

K1329E

c.3970C>T

exon 21

C>T

1.098

H1324T

rs7167216

exon 21

G>T, G>C

1.090

V1321L

rs144964365

exon 20

C>G

1.089

P1257A

rs191789336

exon 10

G>A

0.986

V765I

rs189925962

exon 15

A>G

0.960

I947V

rs28385141

exon 19

G>A

0.835

V1205I

rs142928725

exon 19

G>A

0.375

V1198M

rs141269464

exon 17

G>A

0.176

G1104S

rs7167216

exon 21

G>A

0.115

V1321I

dbSNP ID and data on base substitutions and amino acid changes are from NCBI
database dbSNP. Polymorphism Phenotyping (PolyPhen) scores were calculated with
PolyPhen software (28). c.2069C>T and c.3970C>T were reported in reference 5. An
asterisk indicates a variant listed in dbSNP that was reported as a missense mutation,
but subsequently identified to be a deletion of exons 11 and 12, resulting in a premature
stop codon (3,6).
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Table 3.S2. Yeast strains used in this study.
Strain
RDKY3615

Amino acid
change in BLM

Genotype
MATa ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl,
hom3-10, ade2Δ1, ade8, YEL069C::URA3

-

KHSY1338

RDKY3615, sgs1Δ::HIS3

-

KHSY3355

RDKY3615, sgs1ΔC800-blmΔN647.HIS3

-

KHSY3610

RDKY3615, sgs1ΔC800-blmΔN647-A2084G.HIS3

K695R

KHSY3819

RDKY3615, sgs1ΔC800-blmΔN647-G3164C.HIS3

C1055S

KHSY3820

RDKY3615, sgs1ΔC800-blmΔN647-A3191T.HIS3

D1064V

KHSY3953

RDKY3615, sgs1ΔC800-blmΔN647-G3107T.HIS3

C1036F

KHSY4072

RDKY3615, sgs1ΔC800-blmΔN647-A3041G.HIS3

H1014R

KHSY4073

RDKY3615, sgs1ΔC800-blmΔN647-C3128A.HIS3

A1043D

KHSY4074

RDKY3615, sgs1ΔC800-blmΔN647-G3427A.HIS3

E1143A

KHSY4076

RDKY3615, sgs1ΔC800-blmΔN647-G3592A.HIS3

V1198M

KHSY4077

RDKY3615, sgs1ΔC800-blmΔN647-G3637A.HIS3

E1213K

KHSY4079

RDKY3615, sgs1ΔC800-blmΔN647-C3970T.HIS3

H1324T

KHSY4085

RDKY3615, sgs1ΔC800-blmΔN647-T1973C.HIS3

I658T

KHSY4087

RDKY3615, sgs1ΔC800-blmΔN647-C2070T.HIS3

P690L

KHSY4089

RDKY3615, sgs1ΔC800-blmΔN647-G2150C.HIS3

R717T

KHSY4093

RDKY3615, sgs1ΔC800-blmΔN647-C2371T.HIS3

R791C

KHSY4096

RDKY3615, sgs1ΔC800-blmΔN647-T2407C.HIS3

W803R

KHSY4098

RDKY3615, sgs1ΔC800-blmΔN647-A2432G.HIS3

Y811C

KHSY4099

RDKY3615, sgs1ΔC800-blmΔN647-T2571A.HIS3

F857L

KHSY4100

RDKY3615, sgs1ΔC800-blmΔN647-A2263G.HIS3

K755E

KHSY4102

RDKY3615, sgs1ΔC800-blmΔN647-G2915T.HIS3

G972V

KHSY4103

RDKY3615, sgs1ΔC800-blmΔN647-C2333G.HIS3

S778C

KHSY4105

RDKY3615, sgs1ΔC800-blmΔN647-T2983C.HIS3

Y995H

KHSY4147

RDKY3615, sgs1ΔC800-blmΔN647-A3397G.HIS3

K1133E

KHSY4148

RDKY3615, sgs1ΔC800-blmΔN647-C2603T.HIS3

P868L

KHSY4233

RDKY3615, sgs1ΔC800-blmΔN647-C1978T.HIS3

H660Y

KHSY4234

RDKY3615, sgs1ΔC800-blmΔN647-C2119T.HIS3

P707S

KHSY4237

RDKY3615, sgs1ΔC800-blmΔN647-G2256C.HIS3

Q752H

KHSY4239

RDKY3615, sgs1ΔC800-blmΔN647-C2528T.HIS3

T843I

KHSY4241

RDKY3615, sgs1ΔC800-blmΔN647-G2619C.HIS3

K873N

KHSY4247

RDKY3615, sgs1ΔC800-blmΔN647-A3991C.HIS3

R1331G

KHSY4249

RDKY3615, sgs1ΔC800-blmΔN647-A4159T.HIS3

Q1387K
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Table 3.S2 continued
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63,
his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl, hom3-10/
KHSY4314

hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,

-

YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blmΔN647.HIS3
KHSY4316

KHSY4314, Wild-type / A2084G.HIS3

-/K695R

KHSY4318

KHSY4314, Wild-type / T2407C.HIS3

-/W803R

KHSY4320

KHSY4314, Wild-type / C2603T.HIS3

-/P868L

KHSY4322

KHSY4314, Wild-type / G3592A.HIS3

-/V1198M

KHSY4324

KHSY4314, Wild-type / G3164C.HIS3

-/C1055S

KHSY4326

KHSY4314, A2084G.HIS3 / A2084G.HIS3

K695R/K695R

KHSY4328

KHSY4314, A2084G.HIS3 / T2407C.HIS3

K695R/W803R

KHSY4330

KHSY4314, A2084G.HIS3 / C2603T.HIS3

K695R/P868L

KHSY4332

KHSY4314, A2084G.HIS3 / G3592A.HIS3

K695R/V1198M

KHSY4334

KHSY4314, A2084G.HIS3 / G3164C.HIS3

K695R/C1055S

KHSY4336

KHSY4314, T2407C.HIS3 / T2407C.HIS3

W803R/W803R

KHSY4338

KHSY4314, T2407C.HIS3 / C2603T.HIS3

W803R/P868L

KHSY4340

KHSY4314, T2407C.HIS3 / G3592A.HIS3

W803R/V1198M

KHSY4342

KHSY4314, T2407C.HIS3 / G3164C.HIS3

W803R/C1055S

KHSY4344

KHSY4314, C2603T.HIS3 / C2603T.HIS3

P868L/P868L

KHSY4346

KHSY4314, C2603T.HIS3 / G3592A.HIS3

P868L/V1198M

KHSY4348

KHSY4314, C2603T.HIS3 / G3164C.HIS3

P868L/C1055S

KHSY4350

KHSY4314, G3592A.HIS3 / G3592A.HIS3

V1198M/V1198M

KHSY4352

KHSY4314, G3592A.HIS3 / G3164C.HIS3

V1198M/C1005S

KHSY4353

KHSY4314, G3164C.HIS3 / G3164C.HIS3

C1055S/C1055S

KHSY4590

RDKY3615, sgs1ΔC800-blmΔN647-G3359A.HIS3

G1120R

KHSY4596

KHSY4314, G3107T.HIS3 / G3107T.HIS3

C1036F/C1036F

KHSY4598

KHSY4314, G3107T.HIS3 / Wild-type

-/C1036F

KHSY4600

KHSY4314, G3107T.HIS3 / A2084G.HIS3

C1036F/K695R

KHSY4602

KHSY4314, G3107T.HIS3 / T2407C.HIS3

C1036F/W803R

KHSY4604

KHSY4314, G3107T.HIS3 / C2603T.HIS3

C1036F/P868L

KHSY4606

KHSY4314, G3107T.HIS3 / G3592A.HIS3

C1036F/V1198M
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Table 3.S3. Plasmids used in this study.
Plasmid ID

Description

Source

pRS415

CEN/ARS, LEU2

reference (5)

pKHS481

pRS415-SGS1

reference (4)

pKHS560

pRS415-sgs1-P701L

this study

pKHS562

pRS415-sgs1-I732T

this study

pKHS564

pRS415-sgs1-R804C

this study

pKHS566

pRS415-sgs1-W816R

this study

pKHS567

pRS415-sgs1-Y824R

this study

pKHS569

pRS415-sgs1-F870L

this study

pKHS572

pRS415-sgs1-K881L

this study

pKHS574

pRS415-sgs1-G983V

this study

pKHS577

pRS415-sgs1-G1115R

this study
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CHAPTER 4:
IDENTIFICATION OF RECQL1 AND RECQL4 BINDING
PARTNERS USING A YEAST 2-HYBRID SCREEN

Note to reader: Unpublished data. Hamed Mirzaei and Kristina H. Schmidt designed
experiments. Hamed Mirzaei performed and analyzed all experiments and generated all
figures.

Rationale
Of the five RecQ homologs found in humans, defects in BLM, WRN, and RecQL4
result in disorders in which DNA repair and genome integrity are compromised.
Investigation of BLM and WRN proteins have led to the identification of several
interacting partners that link the RecQ-like family to a number of pathways (Figure 4.1).
BLM has been shown to physically interact with RPA (Brosh, Li et al. 2000), p53 (Wang,
Tseng et al. 2001), Rad51 (Wu, Davies et al. 2001), TopIIIα (Wu, Davies et al. 2000),
BRCA1, BRCA2, and ATM (Wang, Cortez et al. 2000) in the HR pathway, in addition to
interacting with MLH1 in the mismatch repair pathway (Pedrazzi, Perrera et al. 2001).
Likewise, WRN has been shown to physically interact with RPA (Brosh, Orren et al.
1999), p53 (Blander, Kipnis et al. 1999), PCNA (Lebel, Spillare et al. 1999), Fen1
(Brosh, Driscoll et al. 2002), Pol∂ (Kamath-Loeb, Loeb et al. 2001), and base excision
repair (BER) components (Mol, Parikh et al. 1999) during BER and DSB repair. WRN
has also been demonstrated to bind the heterodimeric Ku70/Ku80 complex (Cooper,
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Machwe et al. 2000) involved in NHEJ repair. In addition, BLM and WRN have been
shown to colocalize within the nucleus, and physically interact (von Kobbe, Karmakar et
al. 2002). Less is known about which proteins physically interact with RecQL1 and
RecQL4. Moreover, among the few known interacting proteins it is mostly unclear where
on RecQL1 and RecQL4 these interactions take place. Nevertheless, RecQL1 has been
shown to physically interact with importin-α (Seki, Tada et al. 1997), TopIIIα (Johnson,
Lombard et al. 2000), RPA (Cui, Klima et al. 2003; Cui, Arosio et al. 2004), Exo1,
mismatch repair factors MSH2/MSH6, MLH1/PMS2 (Doherty, Sharma et al. 2005), and
most recently PARP1 (Sharma, Phatak et al. 2012) (Figure 4.1). Similarly, RecQL4 has
been shown to physically interact with PARP1 (Woo, Futami et al. 2006), BLM (Singh,
Popuri et al. 2012), MCM10 and the MCM2-7 complex (Xu, Rochette et al. 2009) (Figure
4.1).
Additionally, among all the reported cases of RTS, only 60% are as a result of a
mutation in RecQL4, and the remaining 40% are a result of unknown defects (Wang,
Levy et al. 2001). Identification of new interacting proteins of RecQL4 could implicate
new genetic pathways and gene candidates, which are causative of RTS.
At the time of this study no group had attempted a genome-wide screen in
search for protein interacting partners for RecQL1 or RecQL4. We utilized a
yeast 2-hybrid assay for identification of novel protein-protein interactions for RecQL1
(Chapter 4.1) and RecQL4 (Chapter 4.2) by implementing two approaches. First, we
screened the yeast open reading frames (ORF) library. We reasoned that since BLM
and WRN are at least partially functional in yeast (Yamagata, Kato et al. 1998; Heo,
Tatebayashi et al. 1999; Mirzaei, Syed et al. 2011; Mirzaei and Schmidt 2012), RecQL1
and RecQL4 might be able to interact with the yeast proteome. Second, we screened a
human cDNA library.
94

Results5:
Chapter 4.1. A screen for RecQL1 interacting proteins
Screen of a yeast ORF library for potential RecQL1 binding
partners in yeast
To assess the interaction of RecQL1 with the yeast proteome, we utilized an
arrayed library of yeast ORFs that was constructed by the Fields laboratory (Uetz, Giot
et al. 2000). As described by Uetz, et al. (2000), this library contains approximately
6,000 yeast ORFs with each expressed in a separate yeast strain, allowing for efficient
and high-throughput screens.
The yeast 2-hybrid method used in this screen utilizes a GAL system in which a
GAL1 promoter is fused to a HIS3 ORF. Transcriptional activation of the GAL1 promoter
results in expression of the HIS3 gene. The prey plasmid pOAD (pKHS487, Appendix C)
harbors the GAL4 activation domain (AD) and the bait plasmid pBDC (pKHS392,
Appendix C) harbors the GAL4 DNA binding domain (DBD). A physical interaction
between the bait and prey proteins brings the DBD and the AD in close proximity of each
other. Interaction between the DBD and AD at the GAL1 promoter results in transcription
of the HIS3 reporter gene (Uetz, Giot et al. 2000). Yeast colonies are then selected for
on synthetic complete agar plates minus histidine (SC-HIS), with the subsequent growth
in the absence of histidine as an indication for a putative protein-protein interaction
between bait and prey.

5

General methods and media are described in the Chapter 8.
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Construction of the yeast ORF prey library
The arrayed yeast ORF prey library was obtained from the Fields lab (Uetz, Giot
et al. 2000). It was generated by first linearizing the pOAD plasmid using a double
restriction enzyme digestion (PvuII and NcoI) to avoid religation, and then cloning yeast
ORFs into the plasmid by recombinational cloning in yeast. Each ORF was amplified by
PCR from yeast using a gene-specific primer pair that possessed a common
20-nucleotide tail specific to the Forward and Reverse primers. After the initial step of
the ORF amplification, the common tails served as priming sites for a second round of
amplification. The 70-nucleotide long primers used in the second round of amplification
were comprised of 20 nucleotides homologous to the common nucleotide tail generated
by the first round of amplification and 50 nucleotides homologous to the pOAD plasmid
where the ORF was to be integrated. The amplicon from the second round of
amplification and the linearized plasmid were subsequently co-transformed into the
yeast strain PJ69-4a

(KHSY3558, Appendix A). This yielded an arrayed library of

approximately 6,000 independent clones, each expressing a different yeast ORF cloned
in-frame with the GAL4 AD in the pOAD plasmid. This prey library was stored in sixteen
384-well plates.

Construction and verification of RECQL1 bait plasmid and bait
reporter strain6
To construct the bait plasmid, we adopted a similar method used by the Fields
laboratory in construction of the prey library. Briefly, the bait plasmid pBDC (pKHS392,
Appendix C) was linearized using a double restriction enzyme digestion (PvuII and NcoI)
and RECQL1 cDNA was amplified by PCR from genomic DNA isolated from strain

6

This section only pertains to strains used in the screen of the yeast ORF library
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KHSY2046 (Appendix A) using primer pairs F1562/R15637 (Appendix B). These primers
contained 20 nucleotides homologous to RECQL1 and 50 nucleotides homologous to
the integration site of plasmid pKHS392. Using standard LiAc-mediated transformation8 `
were co-transformed into yeast strain KHSY2331 (Appendix A). Yeast strain KHSY2331
is NHEJ-deficient due to deletion of DNA ligase 4 (lig4∆). Lig4 is required for completion
of repair by NHEJ by ligating the two ends of the DSB. Utilizing this strain eliminated the
possibility of the pKHS392 plasmid re-circularizing by the NHEJ repair pathway and
forces circularization mediated by integration of RECQL1 through the HR pathway.
Yeast strains harboring pKHS392-RECQL1 plasmids were positively selected for
by spreading transformed cells on synthetic complete agar plates minus tryptophan
(SC-TRP). The resulting yeast strain KHSY3554 (Appendix A) was used to obtain
genomic DNA, which also contained the pKHS392-RECQL1 bait plasmid. The
pKHS392-RECQL1 bait plasmid was separated from genomic DNA by electroporation of
isolated genomic DNA into electro-competent E.coli 9 cells using a MicroPulser (Bio
LabTM). Subsequently, plasmid DNA was isolated from E.coli cells using QIAPrep
Miniprep Kit (Qiagen) and sequenced to confirm that the RECQL1 cDNA is mutation free
and integrated in-frame with the GAL4 DBD. Sequencing of the RECQL1 cDNA in
pKHS392 was carried out using primers F1274, F1300, F1301, F1276, F1277, and
R1278 (Appendix B). The resulting bait plasmid pKHS401 (Appendix C) was then
transformed into the strain PJ69-4α (KHSY3559, Appendix A) containing the reporter
constructs, using standard LiAc-mediated transformation (Schiestl and Gietz 1989). The
resulting yeast strains KHSY3604, KHSY3605, and KHSY3606 (Appendix A) harboring

7

F=forward, R=reverse
Standard LiAc-mediated transformation is described in Chapter 8
9
Protocol for preparing electro-competent E.coli cells is described in Chapter 8.
8
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pKHS401 expressed RECQL1 cDNA fused to the GAL4 DBD and were used as bait in
the yeast 2-hybrid screen of the yeast proteome.
To confirm expression of RecQL1 from bait strains KHSY3604, KHSY3605, and
KHSY3606, Trichloroacetic Acid (TCA) mediated whole cell protein extracts were
analyzed by Western blot as described in the Chapter 8. The resulting membrane was
probed with an anti-DBD monoclonal antibody (Santa Cruz), and as shown in Figure 4.2,
all three constructs express RecQL1 stably and abundantly.
Prior to conducting the screen, the bait strains KHSY3604, KHSY3605, and
KHSY3606 were tested for auto-activation of the HIS3 reporter gene (Figure 4.3). To do
so, each strain was tested on three separate agar plates: SC-TRP, synthetic complete
media lacking histidine and tryptophan (SC-HIS-TRP), and SC-HIS-TRP media
supplemented with 3 mM of 3-Amino-1,2,4-triazole (3-AT, MP Biomedicals), here after
referred to as SC-HIS-TRP+3AT. The SC-TRP medium only controls for the presence of
the bait plasmid, while the SC-HIS-TRP medium assesses activation of the HIS3
reporter gene. The 3-AT supplemented in SC-HIS-TRP+3AT is a competitive inhibitor of
histidine and at low concentrations will degrade potential expression of HIS3, thus
counteracting the effects of a “leaky” HIS3 promoter. As a positive control for
auto-activation, we utilized a pBDC-BLM construct, which we found to auto-activate the
HIS3 reporter gene (unpublished data). For a negative control, we utilized strain
KHSY3989 (Appendix A). KHSY3989 is a reporter strain containing an empty bait
plasmid. The test confirmed that pKHS392-RECQL1 (pKHS401) does not auto-activate
the HIS3 reporter gene (Figure 4.3).
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Screen of the yeast ORF prey library for RecQL1 interacting
proteins
In this screen, the bait strain KHSY3604 was mated to each of the 6,000 prey
strains and the resulting diploid cells were assessed for their ability to activate the HIS3
reporter gene. All mating, plating, and replica-plating of yeast strains on various selective
media were preformed on a Singer® instruments screening robot (RoToR). Briefly, on
day one, the yeast prey library was spotted from 16 individual 384-plates onto 16
synthetic complete agar plates lacking leucine (SC-LEU) and incubated at 30°C for two
days. Plating on SC-LEU allowed for continuous selection of the prey plasmid, which
harbors a LEU2 cassette. The bait strain KHSY3604 was streaked out on an SC-TRP
agar plate and incubated at 30°C overnight. On day two, a scoop of cells from the
SC-TRP agar plate were inoculated in 10 ml of liquid SC-TRP media and incubated
overnight in an orbital shaker at 30°C at 250 rpm. On day three, this culture was poured
onto the surface of an agar plate and spotted on a YPD agar plate on a 384-spot grid
followed by overnight incubation. On day four, the 384 individual colonies of KHSY3604
were mated to colonies on the 16 prey plates by mixing and pinning onto a fresh YPD
plate. The 16 resulting plates were then incubated at 30°C overnight and subsequently
(on day five) replica-plated onto synthetic complete agar plates lacking leucine and
tryptophan (SC-LEU-TRP). SC-LEU-TRP media allowed for continuous selection of
diploids with both bait and prey plasmids. After two days of incubation, the colonies were
replica-plated onto synthetic complete agar plates lacking leucine, tryptophan and
histidine (SC-LEU-TRP-HIS) to positively select for diploid yeast strains that can activate
the HIS3 reporter gene. To increase stringency of our selection against any false
positives that were as a result of “leaky” HIS3 expression, the colonies on all 16 plates
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were also replica-plated on SC-LEU-TRP-HIS agar plates supplemented with 3 mM
3-AT (SC-LEU-TRP-HIS+3AT). This yeast 2-hybrid screen was performed in duplicate.
Upon completion of the first replicate of the screen, we identified 37 putative
interactions (Table 4.1). After completion of the second replicate of the screen, we
identified 13 putative interactions (Table 4.2). Among our protein hit lists were HIS3 and
GAL4 and although these are not candidates for interaction with RecQL1, they indicate
that the yeast 2-hybrid was conducted correctly and the system is functional. Presence
of the HIS3 ORF will allow growth on SC-LEU-TRP-HIS+3AT agar plates without the need
for activation of the reporter gene. Similarly, the GAL4 ORF can interact with the reporter
construct and activate expression of the HIS3 gene resulting in growth on
SC-LEU-TRP-HIS+3AT agar plates albeit no physical interaction with the bait protein.
Nevertheless, after combining the protein hit lists, we did not observe any protein that
appeared in both replicates of the screen, suggesting that RecQL1 does not interact with
the yeast proteome present in the yeast prey library. Figures 4.4 and 4.5 show the 16
SC-LEU-TRP-HIS+3AT plates resulting from the first and second replicate of our screen,
respectively.

Construction and verification of the RecQL1 bait strain10 used to
screen the human testis cDNA library for RecQL1 interacting
proteins
To screen the human proteome for RecQL1 binding partners, we utilized the
Clontech Matchmaker® Gold Yeast Two-Hybrid System and the Clontech Mate & Plate™
Human Testis cDNA library. The testis cDNA library was specifically chosen since
RecQL1 is abundantly expressed in this tissue (Kitao, Ohsugi et al. 1998).

10

This section only pertains to strains used in the screen of human testis cDNA library
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Since both yeast 2-hybrid systems employed in this chapter utilized a GAL1
reporter, we were able to use the same bait plasmid (pKHS401) described earlier for
both screens. However, for the screen of the human testis cDNA library we utilized the
yeast strain AH109 (KHSY3130, Appendix A), which was part of the Clontech
Matchmaker® Gold Yeast Two-Hybrid System kit. This strain contains four independent
reporter genes, allowing for a more stringent screening and elimination of false positives
(Figure 4.6). Using standard LiAc-mediated transformation (Schiestl and Gietz 1989),
bait plasmid pKHS401 was introduced into strain KHSY3130 resulting in strains
KHSYR1-1, KHSYR1-2, and KHSYR1-3.
To confirm expression of RecQL1 from the bait strains KHSYR1-1, KHSYR1-2,
and KHSYR1-3, TCA-mediated whole cell protein extracts were analyzed by Western
blot. The resulting membrane was probed with an anti-DBD monoclonal antibody (Santa
Cruz) and as shown in Figure 4.2, all three bait strains express RecQL1 stably and
abundantly. Additionally, the three bait strains were evaluated for auto-activation as
described earlier and this test confirmed that in none of the bait strains the reporter
constructs are activated.

Screen of the human testis cDNA library for RecQL1 interacting
proteins
The yeast 2-hybrid screen was carried out as outlined in the Clontech
Matchmaker® Gold Yeast Two-Hybrid System manual. On day one, the bait strain
KHSYR1-1 was cultured overnight in 100 ml of SC-TRP liquid media. After reaching the
desired optical density (OD600=0.6), the overnight culture was spun down and subdivided
into eight aliquots. Using standard LiAc-mediated transformation (Schiestl and Gietz
1989), each aliquot was transformed with 600 ng of plasmid DNA from the Clontech
Mate & Plate™ Human Testis cDNA library. To calculate transformation efficiency, one
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half of an aliquot was plated on SC-LEU-TRP media. The remaining 7.5 aliquots were
plated on eight separate 150 mm SC-LEU-TRP-HIS+3AT agar plates, thus selecting for
colonies that activate the HIS3 reporter gene. All agar plates were incubated at 30°C.
SC-LEU-TRP agar plates were incubated for two days and SC-LEU-TRP-HIS+3AT agar
plates were incubated for 14 days. Over half a million transformants were estimated to
have been screened by adding the total number of transformants obtained on SC-LEUTRP agar plates.
Colonies that appeared on the SC-LEU-TRP-HIS+3AT agar plates were
re-streaked on fresh SC-LEU-TRP-HIS+3AT agar plates and incubated for an additional
two days. Each streak was then suspended in 40% glycerol and collected at -80˚C for
future analysis of these candidates of protein-protein interaction. A total of 96 candidates
were obtained from this screen. To verify the prey bait interaction in these 96
candidates, 20 µl of thawed stock was suspended in 100 µl of SC-LEU-TRP liquid media
followed by two days of incubation at 30˚C. The 96 candidates were then spotted on
SC-LEU-TRP,

SC-LEU-TRP-HIS,

and

SC-LEU-TRP-HIS+3AT

agar

plates.

The

SC-LEU-TRP agar plates controlled for the presence of both bait and prey plasmids, the
SC-LEU-TRP-HIS agar plates provided low stringency selection of protein-protein
interactions, and the SC-LEU-TRP-HIS+3AT agar plates provided a more stringent
selection of protein-protein interactions. From the original 96 candidates, 20 grew on all
three agar plates (Table 4.3).

Analysis of RecQL1 putatively interacting candidates
In order to identify the cDNA insert present in each isolate, we rescued the prey
plasmid as described in Chapter 8. Rescued plasmids were sequenced using primer
F1975 (Appendix B), which specifically binds to the sequence upstream of the cDNA
insert in the prey plasmid. The sequences were analyzed using NCBI’s BLAST
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database. From the NCBI BLAST analysis we identified sequences from the following
genes:
•

AIMP2 (aminoacyl tRNA synthetase complex-interacting multifunctional
protein 2)

•

RAN (RAs-related Nuclear protein)

•

RANBP9 (ran-binding protein 9)

•

The KPNA family (karyopherin alpha family)
o

KPNA1, KPNA2, KPNA4, KPNA5 and KPNA6

•

ZGLP1 (zinc finger, GATA-like protein 1)

•

TRAF3IP1 (TNF receptor-associated factor 3 interacting protein 1)

•

C10ORF137 (EDRF1; Erythroid differentiation-related factor 1)

•

RECQL1

Since complete sequence of the cDNA insert for genes AIMP2, TRAF3IP1 and
C10ORF137 could not be obtained by using primer F1975, we designed specific primers
for additional sequencing. Complete sequencing of these genes were carried out using
primers: F2012 and R2013 for AIMP2, F2118 and R2119 for TRAF3IP1, and F2120 and
R2121 for C10ORF137 (Appendix B, Table 4-3).
The 20 candidates were also examined for expression of the human cDNA insert.
To do so, TCA-mediated whole cell protein extract was analyzed by Western blot by
probing the membrane with anti-AD monoclonal antibody (Santa Cruz). The activation
domain and a linker sequence connecting it to the cDNA insert, has a molecular weight
of approximately 30kDa. Thus, for this study we chose those candidates that produced a
band larger than 40kDa11 as determined by Western blot analysis (Figure 4.7).

11

A follow-up study of those candidates that produced a band between 30 and 40kDa will be conducted.
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Among

the

candidates,

TRAF3IP1

(candidate

A6)

and

C10ORF137

(candidate A7) produced a band with a molecular weight of approximately 50kDa.
Candidates F5 (KPNA1), F6 (KPNA4), A8 (KPNA5), F4 (KPNA5), C6 (KPNA6), and A12
(RANBP9) produce a band with a molecular weight between 80 and 125kDa (Figure
4.7).

Verification of candidates suggest C10ORF137 and TRAF3IP1 as
strong candidates for interaction with RecQL1
To verify that activation of the reporter gene is due to a legitimate interaction
between the bait protein and the prey peptide and not due to auto-activation by the prey
plasmid, we retested our candidates (Figure 4.8). Each rescued prey plasmid was
transformed into strain KHSY3989 and the bait strains KHSYR1-1 and spotted on
selective

media,

SC-LEU-TRP,

SC-LEU-TRP-HIS,

SC-LEU-TRP-HIS+3AT,

SC-LEU-TRP-HIS+3AT minus adenine (SC-LEU-TRP-HIS-ADE+3AT).

and

In the first four

columns (columns 1-4) 10 fold serial dilutions of strain KHSY3989 harboring a prey
plasmid were spotted and on the second four columns (columns 5-8) 10 fold serial
dilutions of strain KHSYR1-1 harboring the same prey plasmid were spotted (Figure 4.8).
We observe that candidate A12 (RANBP9) is not able to activate the reporter genes.
Candidate F4 (KPNA5) and F11 (RecQL1) appeared to activate the reporter genes even
in the absence of the bait, indicating auto-activation. Candidates A11 (RAN), A9 and B10
(TRAF3IP1), and A2, B8, F2, and F10 (AIMP2) were omitted from analysis since
sequencing revealed that the insert is not in-frame with the GAL4 AD. Candidates A7
(C10ORF137), A8 (KPNA5), B11 (KPNA6), and F5 (KPNA1) were able to activate all
reporter genes in the presence of the bait (columns 5-8) but not in the absence of the
bait (columns 1-4). Moreover, candidate A6 (TRAF3IP1) and F6 (KPNA4) were able to
activate the reporter construct on SC-LEU-TRP-HIS media as well as the more stringent
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SC-LEU-TRP-HIS+3AT media. However, they do not activate the reporter construct on the
most stringent SC-LEU-TRP-HIS-ADE+3AT media. Similarly, candidate E12 (KPNA2) was
only able to activate the reporter construct on the SC-LEU-TRP-HIS media and not on
either of the SC-LEU-TRP-HIS+3AT or SC-LEU-TRP-HIS-ADE+3AT media.

Discussion
In this study we first sought to investigate the ability of the human RecQL1
protein to interact with the yeast proteome in a yeast 2-hybrid screen and found that
RecQL1 does not interact with any of the yeast ORFs in the arrayed library.
Second, we sought to identify interactions of the RecQL1 protein with the human
proteome by screening for interactions using a testis cDNA library. Among the
candidates many were members of the KPNA family: KPNA1, KPNA2, KPNA4, KPNA5
and KPNA6. In humans, there are a total of 6 KPNA genes, all of which appeared in our
screen except for KPNA3. In eukaryotes, karyopherins encoded by these genes are
involved in transporting molecules into the nucleus. KPNA4 (also known as Qip1) has
previously been identified as a RecQL1 interactor (Seki, Tada et al. 1997), thus acting as
a positive control in our screen. Since all the karyopherins are part of the same complex
at the nuclear pore, we chose not to investigate the other KPNA candidates further.
TRAF3IP1 is a protein that is conserved from worms to humans. The N-terminal
region of this protein is a microtubule-binding domain, while 100 residues of the
C-terminus constitutes the coiled-coil region that binds to TRAF3 (tumor necrosis factor
receptor-associated factor 3). The less well-conserved central region of the protein is
rich in lysine and glutamic acid residues and carries KKE motifs, which may be
necessary for tubulin-binding (Ling and Goeddel 2000). Clone A6, which codes for 149
residues of the C-terminal region of TRAF3IP1, contains the 100 residues encoding the
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coiled-coil region that binds to TRAF3 and matches both reported isoforms of the protein
(Figure 4.9). It has been shown that upon overexpression of both TRAF3 and TRAF3IP1
in HeLa cells, TRAF3IP1 is able to recruit TRAF3 to the microtubule network (Ling and
Goeddel 2000). In mice TRAF3 has been demonstrated to be required for postnatal
development and a competent immune system (Xu, Cheng et al. 1996). Upon
confirmation of the RecQL1/TRAF3IP1 interaction in a human system, further research
is needed to determine if RecQL1 also has a role in development and immunity in a
potential TRAF/TRAF3IP1 complex.
C10ORF137 is an erythroid differentiation-related factor known as EDRF1. Clone
A7, which encodes for 62 residues of C10ORF137, matches both reported isoforms of
the protein (Figure 4.10). While little is known about C10ORF137 (EDRF1) function, it
has been shown to regulate α- and γ-globin transcription by modulating DNA-binding
activity of the GATA-1 transcription factor (Wang, Li et al. 2002). Additionally, a variant of
C10ORF137 was found in a screen for predisposing mutations in somatic and germline
candidate cancer genes for a group of 45 familial colorectal cancers (Gylfe, Sirkia et al.
2010).
Since a predisposition to cancer is also a phenotype of other human RecQ-like
homolog defects (BLM, WRN, RecQL4), and since some variants of RecQL1 have been
suggested to be associated with reduced pancreatic cancer survival (Li, Frazier et al.
2006), a physical interaction between RecQL1 and C10ORF137 is plausible and may
further point towards a role for RecQL1 in cancer prevention.
In preparation for further investigation of these candidates, first the expression
profile of TRAF3IP1 and C10ORF137 should be examined to make certain that they are
present in the same cell cycle phases as RecQL1. Next, to confirm that TRAF3IP1 and
C10ORF137 physically interact with RecQL1 the interactions have to be verified in a
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human system. A standard co-Immunoprecipitation experiment could be used to test for
interaction of the endogenous proteins. If co-immunoprecipitation of endogenous
proteins does not yield the predicted result, overexpression of tagged proteins can be
employed to investigate physical interaction. However, an overexpression system alone
is not sufficient to confirm a physical interaction and would have to be validated by a
different method such as mass spectroscopy.

Results:
Chapter 4.2. Yeast 2-hybrid screen of RecQL4
Screen of a yeast prey library for potential RecQL4 binding
partners in yeast
The same yeast 2-hybrid system and yeast ORF prey library described in Chapter 4.1
was used for this screen.

Construction and verification of RECQL4 bait plasmid and bait
reporter strain12
The bait plasmid and bait strain were constructed as described in Chapter 4.1.
Briefly, the bait plasmid pKHS392 was linearized using a double restriction enzyme
digestion (PvuII and NcoI) and RECQL4 cDNA was amplified by PCR using primer pairs
F1564/R1565 from genomic DNA extracted from strain KHSY2177 (Appendix A). Using
standard LiAc-mediated transformation (Schiestl and Gietz 1989), linearized pKHS392
plasmid and RECQL4 PCR amplicon were co-transformed into the NHEJ-deficient yeast
strain KHSY2331. Transformants were spread on SC-TRP agar plates for positive

12

This section only pertains to strains used in the screen of yeast ORF library
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selection of yeast strains harboring pKHS392-RECQL4. The resulting yeast strain
KHSY3552 (Appendix A) was used to obtain genomic DNA, which also contained
plasmid pKHS392-RECQL4. Plasmid DNA was rescued and sequenced for confirmation
of mutation free integration of RECQL4 cDNA in-frame with the GAL4 DBD (using
primers R1307, F1269, F1270, F1271, F1272, and F1230, Appendix B). The resulting
bait plasmid pKHS402 (Appendix C) was then transformed into strain KHSY3559 using
standard LiAc-mediated transformation (Schiestl and Gietz 1989), yielding bait strains
KHSY3607, KHSY3608, and KHSY3609, which were utilized in the yeast 2-hybrid
screen. Bait strains KHSY3607, KHSY3608, and KHSY3609 were examined for
expression of RecQL4 from the bait plasmid. As described in Chapter 4.1, we utilized
TCA-mediated whole cell protein extract analyzed by Western blot and the resulting
membrane was probed with an anti-DBD monoclonal antibody (Santa Cruz). As shown
in Figure 4.2, all three constructs express RecQL4 stably and abundantly.
Furthermore, the bait strains KHSY3607 and KHSY3608 were tested for
auto-activation of the reporter HIS3 gene as outlined in Chapter 4.1. This test confirmed
that pKHS402 does not auto-activate the HIS3 reporter gene (Figure 4.3).

Screen of the yeast ORF prey library for RecQL4 interacting
proteins
The yeast 2-hybrid screen was carried out as outlined in Chapter 4.1 using strain
KHSY3607. 32 candidates were identified in the first replicate of the screen (Table 4.4).
While in the second replicate we identified 17 candidates (Table 4.5). However, after
combining the candidate hit list, we did not observe any protein that appeared in both
screens, suggesting that RecQL4 does not interact with the yeast proteome present in
the yeast prey library. Figures 4.11 and 4.12 illustrate the 16 SC-LEU-TRP-HIS+3AT agar
plates for the first and second replicate of our screen, respectively.
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Construction and verification of the RecQL413 bait strain used in
screen of the human testis cDNA library for RecQL4 interacting
proteins
To screen the human proteome for RecQL4 binding partners, we utilized the
same Clontech Matchmaker® Gold Yeast Two-Hybrid System and the Clontech Mate &
Plate™ Human Testis cDNA library described in Chapter 4.1. The testis cDNA library
was specifically chosen since RecQL4 is highly expressed in this tissue, similar to
RecQL1 (Kitao, Ohsugi et al. 1998).
The bait strain was constructed by introducing the bait plasmid pKHS402 into
strain KHSY3130 using standard LiAc-mediated transformation (Schiestl and Gietz
1989), resulting in strains KHSYR4-1, KHSYR4-2, and KHSYR4-3. To confirm
expression of RecQL4 from the bait plasmid, TCA-mediated whole cell protein extract
was prepared from all three strains and analyzed by Western blot. The resulting
membrane was probed with an anti-DBD monoclonal antibody (Santa Cruz) and, as
demonstrated in Figure 4.2, all three constructs express RecQL4 stably and abundantly.

Screen of the human testis cDNA library for RecQL4 interacting
proteins
The yeast 2-hybrid screen was carried out as outlined in the Clontech
Matchmaker® Gold Yeast Two-Hybrid System manual. In contrast to the procedure
outlined in Chapter 4.1, colonies that activated the HIS3 reporter gene were selected for
on SC-LEU-TRP-HIS agar plates instead on SC-LEU-TRP-HIS+3AT agar plates. This
slight modification lowered the stringency of the initial screen thus generating a larger
number of candidates.

13

We screened over 1.2 million colonies for protein-protein

This section only pertains to strains used in the screen of human testis cDNA library
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interaction as estimated by adding the total number of transformants obtained on
SC-LEU-TRP agar plates. We obtained 1200 candidates on SC-LEU-TRP-HIS agar
plates during this initial screen. To reduce the number of false positives, we re-evaluated
the

initial

1200

candidates

on

SC-LEU-TRP,

SC-LEU-TRP-HIS,

and

SC-LEU-TRP-HIS+3AT agar plates. As described in Chapter 4.1 the SC-LEU-TRP agar
plates controlled for the presence of both bait and prey plasmids, the SC-LEU-TRP-HIS
agar plates provided low stringency selection for protein-protein interactions, and the
SC-LEU-TRP-HIS+3AT agar plates provided a more stringent selection for protein-protein
interactions. From the original 1200 candidates, 166 grew on all three agar plates
(Appendix F). To confirm the expression of 166 human cDNA candidates TCA-mediated
whole cell protein extract was evaluated by Western blot analyses and the resulting
membrane was probed with anti-AD monoclonal antibody (Santa Cruz). As reasoned in
Chapter 4.1 the activation domain and a linker sequence connecting it to the cDNA
insert, has a molecular weight of approximately 30kDa. Thus, for this study14 we chose
to evaluate those candidates that produced a band larger than 40kDa as determined by
Western blot analysis. Among the candidates, 24 produced a band with a molecular
weight larger than 40kDa (Appendix F, Figure F.3).
To identify the cDNA insert present in each candidate, we rescued the 24 prey
plasmids from yeast and sequenced the insert using primer F1975, which anneals to the
sequence upstream of the insert in the prey plasmid. The resulting sequences were
analyzed using NCBI’s BLAST database. From the NCBI BLAST analysis we identified
the following 12 candidates to be in-frame with the GAL4 AD:
1. 10A10 - DNAJ homolog subfamily C member 7 (DNAJC7)
2. 10B7 - RAR-related orphan receptor C (RORC)

14

A follow-up study of those candidates that produced a band between 30 and 40kDa will be conducted.
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3. 13B2 - Glutamine synthase (GLUL)
4. 13B6 - CDK-activating kinase assembly factor MAT1 (MNAT1)
5. 12D8 - Zinc finger MYM-type 2 (ZMYM2)
6. 10B8 - Mediator of DNA damage checkpoint protein 1 (MDC1)
7. 12C2 - Clusterin (CLU)
8. 13A7 - Proteasome subunit beta type 9 (PSMB9)
9. 13A10 - Nischarin (NISCH),
10. 13A11 - Inhibin alpha (INHA)
11. 13A12 - Actin-like 7B (ACTL7B)
12. 13B1 - Mitochondrial ribosomal protein L38 (MRPL38)
Next we designed specific primers to cDNAs: DNAJC7 (F2287), RORC (F2288),
CLU (F2289), MNAT1 (F2290), NISCH (F2291), ACTL7B (F2292), MRPL38 (F2293),
and PSMB9 (F2294) for which complete sequence of the insert could not be obtained by
using primer F1975 (Appendix B) Table 4.6 indicates the length of the section of the
insert recovered from sequence analysis.

Verification of candidates for interaction with RecQL4
To verify that activation of the reporter gene is due to a legitimate interaction
between the bait protein and the prey peptide and not due to auto-activation by the prey
plasmid, we transformed the 12 candidate prey plasmids into strain KHSY3989 and
strain KHSYR4-1 and spotted on selective media (SC-LEU-TRP, SC-LEU-TRP-HIS, and
SC-LEU-TRP-HIS+3AT, Figure 4.13). 10 fold serial dilutions of strain KHSY3989 harboring
a prey plasmid were spotted on the first four columns (columns 1-4) and 10 fold serial
dilutions of strain KHSYR4-1 harboring the same prey plasmid were spotted on the
second four columns (columns 5-8, Figure 4.13). We observed that candidates 10A10
(DNAJC7), 10B7 (RORC), 13B2 (GLUL), 13B6 (MNAT1), and 12D8 (ZMYM2) were able
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to activate HIS3 reporter gene in the presence of the bait plasmid pKHS402 but not in
the absence of the bait plasmid. Moreover, candidates 10B7 (RORC) and 13B6
(MNAT1) were able to activate the HIS3 reporter gene on SC-LEU-TRP-HIS and on the
more stringent SC-LEU-TRP-HIS+3AT agar plates, suggesting a more robust interaction.
In contrast, candidates 10B8 (MDC1), 12C2 (CLU), 13A7 (PSMB9), 13A10 (NISCH),
13A11 (INHA), 13A12 (ACTL7B), and 13B1(MRPL38) were not able to activate the HIS3
reporter gene (Table 4.6, Figure 4.13). The recovered cDNA insert section of (DNAJC7),
(RORC), (GLUL), (MNAT1), and (ZMYM2) that were identified by sequencing is shown
in Figure 4.14 aligned to the corresponding full-length cDNA.

Discussion
In this study we utilized a yeast 2-hybrid assay to conduct a genome-wide screen
for novel protein-protein interactions for RecQL4. We screened a yeast prey library and
a human prey library and found that RecQL4 does not interact with any of the yeast
ORFs in the prey library. However, in our screen of the human testis cDNA library we
identified (DNAJC7), (MNAT1), (GLUL), (RORC), and (ZMYM2) as interacting
candidates.
DnaJ homolog subfamily C member 7 (DNAJC7) is an HSP40 homolog and
co-chaperone for the molecular chaperones HSP70. The Hsp40 family is defined by the
presence of the J domain, a conserved 70-residue domain homologous to the first 73
amino acids of the E.coli Hsp40 called DnaJ (Hennessy, Nicoll et al. 2005). Candidate
10A10 encodes 280 residues of the N-terminal region of DNAJC7, which does not
include the J domain this protein (Figure 4.14). However, the 280 residues includes the
tetratrico peptide repeat (TPR) region that mediates protein-protein interactions. Proteins
with TPR regions function in assembly of multiprotein complexes, but are not
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promiscuous in their protein interactions (D'Andrea and Regan 2003). The J domain of
DNAJC7 has been demonstrated to interact with cell-cycle checkpoint protein Rad9
(Xiang, Kumano et al. 2001). Rad9 is hypothesized to function at the early stages of the
cell-cycle checkpoint in a complex with Rad1 and Hus1 (Dufault, Oestreich et al. 2003;
Singh, Nurmohamed et al. 2007; Sohn and Cho 2009). Moreover, Rad9 has been
suggested to have a role in regulation of apoptosis by interaction with Bcl2 (Komatsu,
Hopkins et al. 2000). RecQL4 has been suggested to be involved in DSB repair,
oxidative damage repair and pre-replication assembly. Since DNAJC7 has been shown
to interact with the cell-cycle checkpoint machinery it is plausible that an interaction
between RecQL4/DNAJC7 could be at the interface of regulation of the cell-cycle phase
in response to DNA damage.
Candidate 13B6 (MNAT1) identified in our screen contained the complete cDNA
sequence of MNAT1 as reported in NCBI. MNAT1 (CDK-activating kinase assembly
factor MAT1), along with cyclin H and CDK7, forms the CDK-activating kinase enzymatic
complex. This complex activates several cyclin-associated kinases and can associate
with TFIIH to activate transcription by RNA polymerase II (Eki, Okumura et al. 1998).
MNAT1 has been demonstrated to interact with the tumor suppressor protein p53 (Ko,
Shieh et al. 1997), and it has been shown to be required for efficient phosphorylation of
p53 by CDK7-cyclin H, suggesting that MNAT1 functions as a factor for determining
specific substrate for CDK7-cyclin H (Ko, Shieh et al. 1997).
Previously, RecQL4 has been shown to interact with BLM (Singh, Popuri et al.
2012) and BLM has been shown to interact with p53 (Wang, Tseng et al. 2001). We
believe that it is plausible that MNAT1 and RecQL4 physically interact considering the
fact that MNAT1 also interacts with p53 (Ko, Shieh et al. 1997). Moreover, all three
mentioned proteins have been shown to directly be involved in the response or repair of
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DSBs. We hypothesize that the interaction between MNAT1 and RecQL4 would have a
role in regulation of transition between repair of DNA damage and apoptosis.
Glutamine synthase (GLUL, candidate 13B2,) has been demonstrated to have a
dynamic role in tumorigenesis in a tissue specific manner. GLUL catalyzes the synthesis
of glutamine from glutamate and ammonia. This gene is expressed during early fetal
stages, and plays an important role in controlling body pH by removing ammonia from
circulation Glutamine is involved in cell proliferation, inhibition of apoptosis, and cell
signaling. Increased glutamine catabolism in MYC-induced liver tumors in mice has been
shown to be associated with decreased levels of glutamine synthetase. However,
MYC-induced lung tumors result in increased expression of glutamine synthetase and
accumulate glutamine (Yuneva, Fan et al. 2012). Tissue specificity is likely due to the
metabolic profiles of tumors that depend on both the genotype and tissue of origin. RTS
and RAPADILINO both have high instances of osteosarcoma and despite lung and liver
tumors not being reported in these patients, regulation of tumorigenesis is an interface
where it is plausible GLUL and RecQL4 to interact.
Both (RORC) and (ZMYM2) have been identified as a transcription factors (He,
Deftos et al. 1998; Ren and Cowell 2011). RORC is a member of the subfamily of
nuclear receptors 1 (NR1) and has been shown to negatively regulate the Fas ligand,
which subsequently regulates Interleukin 2 (IL-2) production in T-cells (He, Deftos et al.
1998). ZMYM2 is a zinc finger protein; as such it contains a zinc-finger subdomain at the
N-terminus that has been shown to enable dimerization of fibroblast growth factor
receptor-1 (FGFR1) (Ren and Cowell 2011). ZMYM2-FGFR1 rearrangement have been
linked to development of T-cell lymphomas (Ren and Cowell 2011). Since
immunodeficiency and defects in development of T-cells have not been associated with
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RecQL4 associated diseases, at this time it is unclear why RORC or ZMYM2 would be
an interacting partner for RecQL4.
As described in Chapter 4.1, validity of the protein interaction between RecQL4
and

our

hits

DNAJC7,

MNAT1,

and

GLUL

should

next

be

verified

co-Immunoprecipitation experiment of the endogenous proteins in a human cell line.

115

by

Figures and Tables

A

Rmi1 Rmi2

Rmi1 Rmi2
Rpa

p53

TopIIIα

Helicase(

BLM
Rad51

RecQL4

Mlh1

Whip

BLM

RQC(

Rad51
Mlh1

Rpa

BLM
Helicase(

PCNA

HRDC(

ATM

Mlh1

WRN(
KU

TopIIIα

WRN

RQC(

HRDC(

Fen1

Pol∂

p53

70/80

B

KU
70/80

MCM10

BLM
Helicase(

RecQL4
Rad51

PARP1

TopIIIα

MCM2-7

Rpa

RecQL1

Helicase(

RecQL1
Mlh1

RQC(

KPNA4
HRDC(

MSH2/6

PARP1

Figure 4.1 Known interacting proteins BLM, WRN, RecQL1 and RecQL4
(A) Interacting proteins for BLM and WRN helicases. The proteins are shown in
approximate location of the interaction site. (B) Proteins identified to physically interact
with RecQL1 and RecQL4. This illustration does not indicate the location of the
interaction sites.
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Figure 4.2 Evaluation of expression of RecQL1 and RecQL4 from bait plasmids by
Western blot analysis
Yeast cells were grown to an OD600 = 0.5 in SC-TRP, and whole- cell extracts were
prepared from 5 ml of culture (3.5 × 107 cells) by standard TCA extraction to confirm
expression of RecQL1 and RecQL4 from bait plasmids pKHS401 and pKHS402,
respectively. 10 µl of TCA extract was separated on 10% SDS-PAGE, transferred to a
PVDF membrane (Bio-Rad), probed with anti-DBD monoclonal antibody (Santa Cruz),
and visualized by chemiluminescence (ECL Plus, GE Healthcare). Molecular weight
marker (Broad Range) was obtained from Bio-Rad. All samples indicate abundant and
intact expression of RecQL1 and RecQL4 proteins. Isolates KHSY3604, KHSY3605, and
KHSY3606 (expressing RecQL1) and isolates KHSY3607, KHSY3608, and KHSY3609
(expressing RecQL4) are bait constructs used in the screen of the arrayed yeast ORF
library. In addition, isolates KHSYR1-1, KHSYR1-2, KHSYR1-3 (expressing RecQL1)
and KHSYR4-1, KHSYR4-2, and KHSYR4-3 (expressing RecQL4) are bait constructs
used in the screen of the human testis cDNA library.
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Figure 4.3 Assessment of auto-activation of the HIS3 reporter gene by bait
plasmid
Three RecQL1 bait strains KHSY3604, KHSY3605, and KHSY3606 and two RecQL4
bait strains KHSY3607 and KHSY3608 were evaluated on SC-TRP, SC-HIS-TRP and
SC-HIS-TRP+3AT. Two different BLM bait constructs were used as positive control, and
strain KHSY3559 (harboring empty bait plasmid) was used as negative control. As
illustrated, neither RecQL1 nor RecQL4 constructs auto-activate the HIS3 reporter gene.
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Figure 4.4 Plates 1-16 of the RecQL1 yeast 2-hybrid screen of yeast prey library
(Replicate 1)
The 16 SC-LEU-TRP-HIS+3AT agar plates were used to identify putative interactions
between the RecQL1 bait strain KHSY3604 and the yeast prey library. We identified 37
putative positive interactions listed in Table 4.1.
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Figure 4.5 Plates 1-16 of the RecQL1 yeast 2-hybrid screen of yeast prey library
(Replicate 2)
The 16 SC-LEU-TRP-HIS+3AT agar plates were used to identify putative interactions
between the RecQL1 bait strain KHSY3604 and the yeast prey library. We identified 13
putative positive interactions listed in Table 4.2.
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Figure 4.6 The reporter constructs of bait strain AH109 (KHSY3130, Clontech)
The four reporter constructs present in the AH109 bait strain utilized in the Clontech
Matchmaker® Gold Yeast Two-Hybrid System. The reporter constructs include the HIS3
(in green) and ADE2 (in red) markers (James, Halladay et al. 1996) under the control of
Upstream Activating Sequence (UAS) and promoter elements GAL1 and GAL2,
respectivly. In addition, the lacZ (in blue) reporter is under the control of MEL1 UAS and
promoter element. MEL1 is an endogenous GAL4-responsive gene. Utilizing four
reporter genes allows for various degrees of stringency in selecting for putative protein
interacting partners. This strain was utilized in the screen of the human testis cDNA
library for both RecQL1 and RecQL4.
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Figure 4.7 Western blot analyses of the 20 candidates identified in the screen of
human testis cDNA library for RecQL1 interacting partners
Cells were grown to an OD600 = 0.5 in SC-LEU-TRP, and whole- cell extracts were
prepared from 5 ml of culture (3.5 × 107 cells) by standard TCA extraction to confirm
expression of the activation domain and the testis cDNA ORF (Foiani, Liberi et al. 1999).
10 µl of TCA extract was separated by 10% SDS-PAGE, transferred to a PVDF
membrane (Bio-Rad), probed with anti-AD monoclonal antibody (Santa Cruz), and
visualized by chemiluminescence (ECL Plus, GE Healthcare). Molecular weight marker
(Broad Range) was obtained from Bio-Rad. The activation domain and a linker
sequence connecting it to the cDNA insert has a molecular weight of approximately
30kDa. In this study we were interested in candidates that encoded a peptide with a
molecular weight larger than 40kDa as determined via Western blot.
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Figure 4.8 Verification of the RecQL1 putative interacting partners
Verification of candidates were carried out by transformation of each rescued prey
plasmid into strain KHSY3989 and the bait strains KHSYR1-1 and spotted four different
selective media: SC-LEU-TRP, SC-LEU-TRP-HIS, SC-LEU-TRP-HIS+3AT, and
SC-LEU-TRP-HIS-ADE+3AT. SC-LEU-TRP agar plates select for presence of both the
bait and prey plasmids, SC-LEU-TRP-HIS and SC-LEU-TRP-HIS+3AT agar plates select
for activation of the HIS3 reporter gene at low and high stringency, respectively.
SC-LEU-TRP-HIS-ADE+3AT agar plates are the most stringent by selecting for activation
of HIS3 and ADE2 reporter genes. 10-fold serial dilutions of strain KHSY3989 harboring
a prey plasmid was spotted on columns 1-4 and 10-fold serial dilutions of strain
KHSYR1-1 harboring the same prey plasmid was spotted on columns 5-8. Candidates
A12 (RANBP9) and A11 (RAN) cannot activate the reporter genes. Candidate F4
(KPNA5) and F11 (RecQL1) appear to activate the reporter genes even in the absence
of the bait, indicating auto-activation. Candidates, A9 and B10 (TRAF3IP1), and A2, B8,
F2, and F10 (AIMP2) can activate the reporter genes but were omitted from analysis
since sequencing revealed the insert to not be in-frame with the GAL4 AD. Candidates
A7 (C10ORF137), A8 (KPNA5), B11 (KPNA6), and F5 (KPNA1) were able to activate all
reporter genes in the presence of the bait (columns 5-8) but not in the absence of the
bait (columns 1-4). Candidates A6 (TRAF3IP1) and F6 (KPNA4) can only activate the
HIS3 reporter gene on SC-LEU-TRP-HIS and SC-LEU-TRP-HIS+3AT media. Candidate
E12 (KPNA2) can only activate the HIS3 reporter gene on the SC-LEU-TRP-HIS media.
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Colonies with different shades of red are indicative of inactive adenine pathway, while
white colonies indicate activation of the ADE2 reporter gene.
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Figure 4.9 cDNA insert fragment identified in the screen of the human testis cDNA
library for RecQL1 interacting proteins
(A) We identified nucleotides 1626 to 2076 of the TRAF3IP1 cDNA from sequencing of
Clone A6. This fragment encodes 149 amino acids of the C-terminus of the TRAF3IP1
protein, which includes the 100 residue coiled-coil region shown to interact with TRAF3.
(B) We identified nucleotides 3532 to 3717 of C10ORF137 cDNA from sequencing of
clone A7. This fragment encodes 62 amino acids of the C-terminus of the C10ORF137
protein.
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Figure 4.11 Plates 1-16 of the RecQL4 yeast 2-hybrid screen of yeast prey library
(Replicate 1).
The 16 plates of SC-Leu-Trp-His+3AT were used to identify putative interactions between
the RecQL4 bait strain KHSY3607 and the yeast prey library. Table 4.4 presents the 33
putative positive interactions identified in this replicate.
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Figure 4.12 Plates 1-16 of the RecQL4 yeast 2-hybrid screen of yeast prey library
(Replicate 2).
The 16 plates of SC-Leu-Trp-His+3AT were used to identify putative interactions between
the RecQL4 bait strain KHSY3607 and the yeast prey library. Table 4.5 presents the 17
putative positive interactions identified in this replicate.
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Figure 4.13 Verification of RecQL4 putative interacting partners
Each rescued prey plasmid is transformed into strain KHSY3989 and strains KHSYR1-1
and spotted on three selective media. SC-LEU-TRP agar plates select for presence of
both the bait and prey plasmids, SC-LEU-TRP-HIS and SC-LEU-TRP-HIS+3AT agar
plates select for activation of the HIS3 reporter gene at low and high stringency,
respectively. In columns 1-4, 10 fold serial dilutions of strain KHSY3989 harboring a prey
plasmid were spotted and in columns 5-8, 10 fold serial dilutions of strain KHSYR4-1
harboring the same prey plasmid are spotted. Candidates 10A10 (DNAJC7), 10B7
(RORC), 13B2 (GLUL), 13B6 (MNAT1), and 12D8 (ZMYM2) are able to activate HIS3
reporter gene in the presence of the bait plasmid pKHS402 but not in the absence of the
bait plasmid. Candidates 10B7 (RORC) and 13B6 (MNAT1) are able to activate the HIS3
reporter gene on SC-LEU-TRP-HIS and the more stringent SC-LEU-TRP-HIS+3AT agar
plates suggesting a more robust interaction. Candidates 10B8 (MDC1), 12C2 (CLU),
13A7 (PSMB9), 13A10 (NISCH), 13A11 (INHA), 13A12 (ACTL7B), and 13B1(MRPL38)
are not able to activate the HIS3 reporter gene
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A

DNAJC7

J domain

10A10
1

700

B

1486

MNAT1
13B6
1

804

C

RORC
10B7
1

174

953

D

1486

GLUL
13B2
1

E

434

1122

ZMYM2

ZMYM2
12D8

1

1402

2140

4134

Figure 4.14 cDNA insert fragment identified in the screen of the human testis
cDNA library for RecQL4 interacting proteins
(A) Clone 10A10 contains nucleotides 1-700 of DNAJC7 cDNA encoding the 280 amino
acids of the DNAJC7 protein. (B) Clone 13B6 contains the complete cDNA sequence of
MNAT1. (C) Clone 10B7 contains nucleotides 174-953 of cDNA RORC encoding 260
amino acids of the RORC protein (D) Clone 13B2 contains nucleotides 434-1122 of
cDNA GLUL encoding 688 amino acids at the C-terminus of the GLUL protein. (E) Clone
12D8 contains nucleotides 1402-2140 of cDNA ZMYM2 encoding 246 amino acids in the
middle of the ZMYM2 protein.
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Table 4.1 Thirty-seven candidates identified in the first replicate of the yeast
2-hybrid screen for RecQL1 interacting proteins of the yeast proteome
ORF
Plate #
384 well #
Name
YBR005W
YGL258W
YIL060W
YGR026W
YCL009C
YBR104W
YJL131C
YJL139C
YJL138C
YLR016C
YMR048W
YLR165C
YLR178C
YLL045C
YLL041C
YKR036C
YLR381W
YJR036C
YJR059W
YDR008C
YDR133C
YDR290W
YOR225W
YDR308C
YDR344C
YDR171W
YDR414C
YDR165W
YPR054W
YDR208W
YNL144C
YMR185W
YNL221C
YOR353C
YDR356W
YPL045W
YDR359C

1
1
1
3
3
3
5
5
5
7
7
7
7
7
7
9
9
9
9
11
11
11
11
11
11
13
13
13
13
15
15
15
15
15
15
15
15

A6
M18
P5
C17
M10
P5
A8
N5
P5
A8
F20
L11
M10
N5
P5
C11
M18
N5
P5
A6
A8
C11
M18
N5
P5
A8
C11
N5
O22
A6
C11
L11
M10
M18
N5
O22
P5

YBR005W
YGL258W
YIL060W
YGR026W
ILV6
YMC2
YJL131C
YUR1
TIF2
YLR016C
YMR048W
YLR165C
TFS1
RPL8B
SDH2
CAF4
YLR381W
YJR036C
PTK2
YDR133C
YDR290W
YOR225W
SRB7
YDR344C
HSP42
ERD1
YDR165W
SMK1
MSS4
YNL144C
YMR185W
POP1
YOR353C
NUF1
VPS16
YDR359C
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Table 4.2 Thirteen candidates identified in the first replicate of the yeast 2-hybrid
screen for RecQL1 interacting proteins of the yeast proteome
ORF
Plate #
384 well
Name
#
YGR026W
3
C17
YGR026W
YER118C
3
P8
SHO1
YIL176C
4
B2
YIL176C
YDR155C
11
D8
CPH1
YOR074C
12
D16
CDC21
YOR202W
12
K17
HIS3*
YDR423C
13
I10
CAD1
YNL189W
14
A12
SRP1
YLR206W
14
D9
ENT2
YKL210W
15
D10
UBA1
YPL248C
15
H21
GAL4*
YNL216W
15
O10
RAP1
YDR326C
16
O6
YDR326C

* HIS3 and GAL4 are not candidates for interaction with RecQL1 they are false positives.
Presence of the HIS3 ORF will allow growth on SC-LEU-TRP-HIS+3AT agar plates
without the need for activation of the reporter gene. Similarly, the GAL4 ORF can
interact with the reporter construct and activate expression of the HIS3 gene resulting in
growth on SC-LEU-TRP-HIS+3AT agar plates albeit no physical interaction with the bait
protein.

131

Table 4.3 Summary of the results of the yeast 2-hybrid screen of the human testis
cDNA library for RecQL1-interacting proteins

Candidate	
   cDNA	
  
A2
A6
A7
A8
A9
A10
A11
A12
B8
B10
B11
C6
E12
F2
F3
F4
F5
F6
F10
F11

AIMP2
TRAF3IP1
C10ORF137
KPNA5
TRAF3IP1
ZGLP1
RAN
RANBP
AIMP2
TRAF3IP1
KPNA2
KPNA6
KPNA2
AIMP2
AIMP2
KPNA5
KPNA1
KPNA4
AIMP2
RECQ1

In-‐frame1	
  	
  
No
Yes
Yes
Yes
No
Yes
No
Yes
No
No
Yes
Yes
Yes
No
No
Yes
Yes
Yes
No
N/A

Growth	
  
on	
  LTH2	
  
+
+
+
+
+
n/a
-‐	
  
-‐	
  
+
+
+
n/a
+
+
n/a
AA
+
+
+
AA

1

Growth	
  on	
   Growth	
  on	
  
LTH+3AT3	
  
LTHA+3AT4	
  
+
+
+
+
+
n/a
-‐	
  
-‐	
  
+
+
+
n/a
-‐	
  
+
n/a
AA
+
+
+
AA

+
-‐	
  
+
+
-‐	
  
n/a
-‐	
  
-‐	
  
+
+
+
n/a
-‐	
  
+
n/a
AA
+
-‐	
  
+
AA

MW5	
  
25kDa
45kDa
50kDa
125kDa
20kDa
-‐	
  
n/a
100kDa
25kDa
-‐	
  
125kDa
125
-‐	
  
20kDa
-‐	
  
n/a
90kDa
125kDa
25kDa
n/a

In-frame refers to in-frame with the GAL4 AD as determined by sequence analysis.
SC-LEU-TRP-HIS
3
SC-LEU-TRP-HIS+3AT
4
SC-LEU-TRP-HIS-ADE+3AT
5
Molecular weight as determined by Western blot analysis
2
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Table 4.4 List of the 32 putative interactions identified in the first replicate of the
yeast 2-hybrid screen for RecQL4
ORF
Plate # 384 well # Name
YGL121C
1 C3
YGL121C
YGL117W
1 N6
YGL117W
YFL026W
2 O19
STE2
YBL036C
3 C3
YBL036C
YGR026W
3 C17
YGR026W
YCR094W
3 N6
CDC50
YGR280C
3 O19
YGR280C
YHL003C
4 O19
LAG1
YIR018W
5 C3
YAP5
YJL049W
5 N9
YJL049W
YKL096W
5 O19
CWP1
YLR302C
6 J16
YLR302C
YGL099W
6 O19
YGL099W
YKL115C
7 C3
YKL115C
YKR087C
7 N6
YKR087C
YLR173W
8 J16
YLR173W
YMR067C
8 O19
YMR067C
YNL205C
9 N6
YNL205C
YNR012W
10 J16
URK1
YPL117C
10 O19
IDI1
YDR071C
11 N 6
YDR071C
YOR277C
11 O19
YOR277C
YOR174W
12 J15
MED4
YDL175C
13 C 3
YDL175C
YDR219C
13 N 6
YDR219C
YPL236C
13 O19
YPL236C
YOL164W
14 J16
YOL164W
YOR359W
14 O19
YOR359W
YDR430C
15 N 6
YDR430C
YPL164C
15 O19
YPL164C
YML048Wa
16 J16
YOR086C
16 O19
YOR086C
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Table 4.5 List of the 17 putative interactions identified in the second replicate of
the yeast 2-hybrid screen for RecQL4
ORF
Plate # 384 well # Name
YAL014C
1
A4
YAL014C
YAL008W
1
C4
YAL008W
YER121W
2
B10
YER121W
YER148W
2
D24
SPT15
YER109C
2
L8
FLO8
YGR026W
3
C17
YGR026W
YGR048W
3
N17
UFD1
YER028C
3
J8
YER028C
YCL016C
3
K10
YCL016C
YGL035C
4
C18
MIG1
YKL061W
4
L22
YKL061W
YLR159W
6
P10
YLR159W
YLR285W
7
P13
YLR285W
YER114C
10
C16
BOI2
YNR069C
14
E15
YNR069C
YPL248C
15
H21
GAL4
YOR290C
16
J21
SNF2
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Table 4.6 Summary of the results of the yeast 2-hybrid screen of the human
cDNA library for RecQL4-interacting proteins
Recovered
cDNA
Growth
Growth on
Clone ID
cDNA
section
2
3
length
(bp)
on
LTH
LTH+3AT4
(bp)1
10A10
DNAJC7
1-700
1486
+
10B7
ROROC
174-953
1494
+
+
13B2
GLUL
434-1122
1122
+
13B6
MANT1
1-804
804
+
+
12D8
ZMYM2
1402-2140
4134
+
10B8
MDC1
5905-6271
6271
12C2
CLU
55-719
1350
13A7
PSMB9
1-532
660
13A10
NISCH
3709-4430
4515
13A11
INHA
688-1101
1101
13A12
ACTL7B
577-1221
1248
13B1
MRPL38
1-710
1143
1

Recovered section of the insert identified by sequence analysis
Length of the cDNA as reported in NCBI
3
SC-LEU-TRP-HIS
4
SC-LEU-TRP-HIS+3AT
5
Molecular weight as determined by Western blot analysis
2
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testis
MW5
80
100
70
70
120
50
90
50
80
50
70
80

CHAPTER 5:
GENETIC CHARACTERIZATION OF RECQL1 AND RECQL4 IN
HUMANIZED SACCHAROMYCES CEREVISIAE

Note to reader: Unpublished data. Experiments were designed by Hamed Mirzaei and
Kristina H. Schmidt and were performed and analyzed by Hamed Mirzaei except for
initial construction and integration of the RECQL5 gene in yeast, which was performed
by Salahuddin Syed. All data analysis and figures were generated by Hamed Mirzaei.

Rationale:
As discussed in Chapter 1, the five human RecQ-like homologs are RecQL1,
BLM, WRN, RecQL4, and RecQL5 (Umate, Tuteja et al. 2011). Three out five, BLM,
WRN, and RecQL4, are associated with known syndromes. Syndromes associated with
RecQ-like proteins present a variety of clinical symptoms ranging from skeletal
abnormalities,

proportionate

dwarfism,

elevated

cancer

predisposition,

immune

deficiencies, infertility or subfertility, facial dysmorphia, gastro intestine disturbance,
patellar abnormalities, and premature aging (Bachrati and Hickson 2003).
Despite the three disorders attributed to RecQL4 (outlined in Chapter 1), very
little is known about the cellular function of this helicase, defects of which result in
severe complication. RecQL4 is the only member among the human RecQ-like
homologs to lack both the RQC and the HRDC domain (Figure 1.1 and Figure 5.4F).
RecQL4 has been demonstrated to have ATPase and strand annealing activities similar
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to other members of RecQ-like family (Sharma, Doherty et al. 2006), and while helicase
activity is observed in purified RecQL4, it is extremely weak (Suzuki, Kohno et al. 2009;
Xu and Liu 2009).
RecQL4 is highly expressed in the thymus and testis (Kitao, Ohsugi et al. 1998).
Interestingly, the expression profile of this protein through out the cell cycle is very
similar to yeast Sgs1 and human BLM, which appear during S-phase and are maintained
at similar levels in G2/M, but have mostly disappeared by the time cells re-enter G1
(Dutertre, Ababou et al. 2000). Moreover, post-treatment with ionizing radiation, the
N-terminus of RecQL4 has been shown to physically interact with the N-terminus of
BLM, and stimulate its helicase activity at stalled replication forks during S-phase (Singh,
Popuri et al. 2012). In addition to physical interaction with BLM, there is some evidence
suggesting RecQL4 is involved in the repair of DNA double strand breaks (DSB)
including its presence in a complex with Rad51 upon induction of DSBs, formation of foci
in close proximity of PML bodies, and lastly RecQL4 deficient fibroblast cells are slightly
more sensitive to gamma radiation and accumulate more ɣH2AX than RecQL4 proficient
fibroblast cells (Petkovic, Dietschy et al. 2005; Singh, Karmakar et al. 2010). In contrast
to BLM, RecQL4 demonstrates a nucleoplasmic localization both in presence and
absence of DNA damaging agents (Bischof, Kim et al. 2001; Woo, Futami et al. 2006).
However, in response to oxidative damage, RecQL4 does localize to the nucleolus. This
pattern of localization in combination with evidence for physical interaction with PARP1
has led to the hypothesis that this RecQ-like helicase aids in recovery from DNA
damage as a result of oxidative stress (Diefenbach and Burkle 2005; Woo, Futami et al.
2006).
In recent years, mass spectrometry and co-immunoprecipitation analysis have
shown interaction of RecQL4 with MCM10 and the MCM2-7 complex (Xu, Rochette et al.
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2009). Furthermore this interaction is shown to be controlled by the cell cycle and limited
to the G1 and S phases. This finding suggests that RecQL4 plays an important role in
DNA replication (Xu, Rochette et al. 2009).
Comparable to RecQL4, RecQL1 is highly expressed in the testis and thymus
(Kitao, Ohsugi et al. 1998) and is one of the least studied human RecQ-like helicases.
Among the human RecQ-like homologs, RecQL1 is the most abundant (Kawabe,
Tsuyama et al. 2000) and is not associated with any disorder. Consequently, very little is
known about the function of this helicase in humans. However, there is some evidence
suggesting that this helicase functions in similar DNA metabolism pathways as other
member of the RecQ-like family.
RecQL1 can unwind many secondary DNA structures 15 in addition to the
canonical 3’-5’ helicase activity and ssDNA annealing (Sharma, Sommers et al. 2005;
Popuri, Bachrati et al. 2008). This helicase also demonstrates branch migration and
processing of Holliday junctions (LeRoy, Carroll et al. 2005; Bugreev, Brosh et al. 2008;
Popuri, Bachrati et al. 2008; Mazina, Rossi et al. 2012). RecQL1 has been shown to
physically interact with DNA mismatch repair proteins (MSH2/MSH6 and MLH1/PMS2),
Exo1(Doherty, Sharma et al. 2005), RPA (Cui, Arosio et al. 2004), Importin-α (Seki,
Tada et al. 1997) and, TopIIIα (Johnson, Lombard et al. 2000). As in the case of
RecQL4, mass spectrometry and co-immunoprecipitation analysis of RecQL1 illustrate
interaction with PARP1 and suggest involvement in the oxidative stress response
pathway (Sharma, Phatak et al. 2012).
Due to the fact that very little is known about RecQL1 and RecQL4, we sought to
characterize these proteins in a yeast system. Since there are five RecQ-like homologs
in humans, we sought to assess their ability to complement the yeast homolog Sgs1.

15

Previously described in Chapter 1
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Previously, it has been reported that BLM and WRN helicases are capable of partially
complementing sgs1Δ defects when expressed in an sgs1Δ background (Yamagata,
Kato et al. 1998; Heo, Tatebayashi et al. 1999). Yamagata et al. demonstrated that
expression of BLM under the control of a GAPDH promoter fully suppressed premature
aging, rDNA hyper-recombination, and HU sensitivity of the sgs1Δ mutant (Yamagata,
Kato et al. 1998; Heo, Tatebayashi et al. 1999). Utilizing the same system, it was
demonstrated that the WRN protein was able to complement sgs1Δ defects to a lesser
extent in comparison to BLM (Yamagata, Kato et al. 1998).
We reasoned that since BLM and WRN are able to complement some of sgs1Δ
defects, RECQL1 and RECQL4 might be able to do the same at varying degrees. We
hypothesized that RECQL1, which possesses all the same conserved domains as BLM
(the 7 helicase motif, RQC, and HRDC domains), should be able to complement sgs1Δ
defects in the same manner as BLM. In addition, we predicted that RECQL4 should be
able to complement sgs1Δ defects to some level due its putative role in restart of stalled
replication forks. However, RECQL4 complementation will probably be less than BLM,
WRN or even RECQL1 since RECQL4 lacks both the RQC and the HRDC conserved
domains and has questionable helicase activity.
To

test

our

hypothesis,

RECQL1

and

RECQL4

cDNAs

were

cloned

independently in place of the yeast homolog SGS1. We examined the ability of RECQL1
and RECQL4 to complement sgs1Δ defects, including hypersensitivity to the DNA
damaging

agent

hydroxyurea

(HU)

and

accumulation

of

gross

chromosomal

rearrangements (GCR) when expressed under the control of the SGS1 promoter and
when overexpressed from a GAL1 inducible promoter. Taking advantage of the SGS1
promoter ensured that RecQL1 and RecQL4 are copy number controlled and are
expressed in the same cell phases as Sgs1, which corresponds to the expression profile
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of BLM and RecQL4 in human cells. The GAL1 promoter allowed us to examine effects
of overexpression of RecQL1 and RecQL4 in yeast in the event that expression from the
SGS1 promoter was not sufficient.
We further characterized RecQL1 and RecQL4 in our novel chimeric system,
which was described in Chapter 2 (Mirzaei, Syed et al. 2011). In addition we investigated
genetic interactions between RecQL1, RecQL4, RecQL5 and BLM in diploid yeast cells.

Results16
Construction of humanized yeast strains expressing RecQL1 and
RecQL4 at the SGS1 locus
For this investigation, we obtained RECQL1 and RECQL4 cDNAs as a clone in
vector pOBT7 from Open Biosystems (p2823112 and p3634266, respectively, here on
referred to as pKHS263 and pKHS264). It should be noted that there are two different
isoforms for RecQL4, a 1208 amino acid protein, which possess a long N-terminal region
and a 652 amino acid protein, with a very short N-terminal region. At the time of this
study the short isoform was the only available isoform.
In order to positively select for yeast strains expressing RecQL1 or RecQL4, a
selectable marker had to be cloned downstream of the plasmid-borne RECQL1 and
RECQL4 cDNAs. To achieve this, we utilized the HIS3MX6 cassette harbored in the
pRS303 plasmid (Appendix C) (Sikorski and Hieter 1989). A two-step cloning process
was adopted for efficient integration. In step one, the HIS3MX6 cassette was amplified
by PCR from the pRS303 plasmid using primers F1236/R1237 17 (Appendix B) and
cloned into vector pCR2.1-TOPO (Invitrogen), resulting in plasmid pKHS337 (Figure

16
17

General methods and material are described in Chapter 8
F= Forward, R=Reverse.
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5.1A). The primer combination F1236/R1237 flanks the HIS3MX6 cassette and
contains 5’ XhoI restriction sites. In step two, we took advantage of the unique XhoI
restriction site present downstream of both RECQL1 and RECQL4 cDNA in the pOBT7
plasmid (pKHS263 and pKHS264) and the engineered XhoI sites flanking the HIS3MX6
cassette in the pKHS337 plasmid. We subjected all three plasmids to XhoI digestion
followed by ligation of the HIS3MX6 cassette into the pOBT7 plasmid using DNA
Ligation Kit Ver. 2.1 (Takara) per manufacturer instructions. Subsequently, ligation
products were transformed into electro-competent E.coli cells18 and positively selected
for on LB agar plates (Trypton 10g/L, Yeast extract 5g/L, and NaCl 5g/L) supplemented
with 100ug/ml of Chloramphenicol (CMP).
Colony PCR was utilized to screen E.coli transformants for the presence of
plasmids pKHS263 or pKHS264 harboring a HIS3MX6 cassette. Primer combinations
F1229/R1032 and F1229/R1031 were used to analyze RECQL1 constructs while
primers F1230/R1032 and F1230/R1031 were used to analyze RECQL4 constructs
(Figure 5.1B, Appendix B).
Plasmid DNA was isolated using QIAGEN’s QIAprep Spin Miniprep Kit (per
manufacturer’s instructions) from E.coli transformants identified by the colony PCR
screen. Subsequently, isolated plasmid DNA was subjected to HindIII digestion to take
advantage of a unique restriction site that confirmed the presence of the HIS3MX6
cassette and its relative orientation with respect to the RECQL1 or RECQL4 cDNA
(Figure 5.1C). From the six isolates each that were analyzed by HindIII digestion, three
RECQL1 constructs (pKHS338, pKHS339, and pKHS340) and three RECQL4
constructs (pKHS344, pKHS345, and pKHS346) with the HIS3MX6 cassette in the
opposite orientation from the cDNA were selected for yeast integration (Appendix C).

18

Protocol for making electro-competent cells is described in Chapter 8.
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To ensure that the expression of RECQL1 (and independently RECQL4) is copy
number and cell cycle regulated, RECQL1 and RECQL4 cDNAs were integrated at the
chromosomal SGS1 locus in frame with the start codon, thus being under the control of
the SGS1 promoter. To construct the PSGS1.RECQL1.HIS3MX6 allele, we amplified the
RECQL1.HIS3MX6 fragment by PCR from plasmid pKHS338 using the primer
combination F1245/R1246 (Figure 5.1D, Appendix B). These primers are 70-nucleotides
long and are comprised of 20-nucleotides homologous to the template DNA and
50-nucleotides homologous to the integration site. Using standard LiAc-mediated
transformation19 (Schiestl and Gietz 1989), the RECQL1.HIS3MX6 PCR amplicon was
introduced into yeast strain KHSY1633 (Appendix A). The KHSY1633 strain is an sgs1Δ
strain in which the SGS1 gene has been replaced with a kanMX6 cassette conferring
resistance to G418-sulfate (Alexis Biochemicals). Transformants with stable genomic
integration of RECQL1.HIS3MX6 were selected for by plating of cells on synthetic
complete agar plates lacking histidine (SC-HIS).
Colonies were then examined for loss of resistance to G418-sulfate followed by
confirmation of RECQL1 cDNA integration at the SGS1 locus by PCR using primer
combinations F1143/R1278 and F1229/R1032 (Figure 5.1E, Appendix B). The
integrated RECQL1 cDNA was amplified by PCR from select verified yeast isolates and
subsequently sequenced to confirm no mutations were incorporated during the
transformation process. Sequencing of the genomic RECQL1 amplicon was carried out
using primers R1278, F1274, F1300, F1301, F1276, and F1277 (Appendix B). Three
independent clones KHSY2046, KHSY2047, and KHSY2048 (Appendix A) were
obtained for further functional characterization by GCR analysis, and evaluation of
sensitivity to HU.

19

Standard LiAc-mediated transformation is described in Chapter 8
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Similarly, RECQL4 was integrated at the chromosomal SGS1 locus, utilizing
pKHS345 to generate the RECQL4.HIS3MX6 PCR fragment using the primer
combination

F1253/R1254

(Figure

5.1F,

Appendix

B).

Confirmation

of

RECQL4.HIS3MX6 integration by PCR was carried out using primer combinations
F1143/R1273 and F1230/R1032 (Figure 5.1G, Appendix B). Select verified yeast
isolates were used to amplify genomic RECQL4 by PCR, which was subsequently
sequenced using primers R1307, F1269, F1270, F1271, F1272, and F1230
(Appendix B). While strain KHSY2177 was the only completely sequenced and
confirmed isolate, additional clones were obtained by mating of KHSY2177 to wild-type
strain KHSY802 (Appendix A). Briefly, diploid yeast strains are constructed by mixing
strains of the opposite mating-type (MATa or MATα) (Herskowitz and Jensen 1991),
which can then be sporulated to produce haploid cells (Rockmill, Lambie et al. 1991). By
coupling generation of diploids and sporulation of diploids, strains with different
genotypes could be combined to produce desired combinations of mutations in a haploid
cell, or in the case of RECQL4, expressing cells to generate additional clones.
To verify protein expression for both RECQL1 (KHSY2046) and RECQL4
(KHSY2177) from the humanized yeast strains, a myc-epitope tag was fused to the
3’ end of the cDNA, yielding strains KHSY2860 and KHSY2867, respectively
(Appendix A).
To fuse the myc-epitope tag to RECQL1 cDNA, the 13MYC.TRP1 cassette was
amplified by PCR from plasmid pFA6a.13MYC.TRP1 (Appendix C) (Longtine, McKenzie
et al. 1998) using primer combination F1281/R1283 (Figure 5.2A, Appendix B). Similarly
to fuse the myc-epitope tag to RECQL4 cDNA, the 13MYC.TRP1 cassette was amplified
by PCR using primer combination F1282/R1283 (Figure 5.2B, Appendix B). Next utilizing
standard LiAc-mediated transformation (Schiestl and Gietz 1989), the 13MYC.TRP1
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cassette amplicon for RECQL1 was transformed into strain KHSY2046, while the
13MYC.TRP1 cassette amplicon for RECQL4 was transformed into strain KHSY2177.
Transformed yeast cell with the stably integrated 13MYC.TRP1 cassette were selected
for on synthetic complete agar plates minus tryptophan (SC-TRP). Fusion of the
myc-epitope tag to the RECQL1 and RECQL4 cDNAs was first verified by PCR using
primer combinations F1277/R1029 for RECQL1 (Figure 5.2A, C and D, Appendix B) and
F1230/R1029 for RECQL4 (Figure 5.2B, Appendix B). Protein expression was then
confirmed by standard Western blot analysis using monoclonal anti-myc antibody
(Covance, Figure 5.2E) as described in Chapter 8.

Expression of RecQL1 or RecQL4 in an sgs1Δ strain does not
suppress accumulation of GCRs or reduce hypersensitivity to HU
The GCR assay was carried out as previously described (Schmidt, Pennaneach
et al. 2006). GCR rates were derived from 10 ml cultures of three or more independent
strain isolates. Statistical significance of differences between median GCR rates were
assessed by calculating 95% confidence intervals for all median GCR rates according to
the method of Nair (Nair 1940). Previous studies by our laboratory and others have
illustrated that an sgs1Δ strain has a moderate rate of GCR accumulation (Myung, Datta
et al. 2001; Schmidt and Kolodner 2006; Mirzaei, Syed et al. 2011) (Table 5.1). Our
hypothesis was that RECQL1 humanized yeast strains could lower this rate by
complementing Sgs1 function. However, unlike RecQL1or BLM, RecQL4 lacks both the
RQC and the HRDC domains. Thus the RECQL4 humanized yeast strain was not
expected to be able to lower the rate of GCR accumulation to the same degree.
Measurements of the rate of GCR accumulation in PSGS1.RECQL1.HIS3MX6 and
PSGS1.RECQL4.HIS3MX6 strains constructed above, illustrated that there are no
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statistically significant differences between an sgs1Δ strain and an sgs1Δ strain
expressing RecQL1 or RecQL4 under the control of an SGS1 promoter (Table 5.1).
Since expression of the RecQL1 and RecQL4 proteins under control of the
endogenous SGS1 promoter did not complement Sgs1 function, we next evaluated the
effects of overexpression of these proteins from a GAL1 promoter on accumulation of
GCRs in an sgs1∆ strain.
We constructed yeast strains with galactose inducible RecQL1 and RecQL4.
Briefly, TRP1.PGAL1 was amplified by PCR from the pFA6a.TRP1.PGAL1 plasmid
(Appendix C) (Longtine, McKenzie et al. 1998) for integration upstream of RECQL1 and
RECQL4 to replace the native SGS1 promoter in yeast strains KHSY2046 and
KHSY2676, respectively. Using standard LiAc-mediated transformation (Schiestl and
Gietz 1989), the TRP1.PGAL1 amplicon was introduced into yeast and selected for on
SC-TRP agar plates as described earlier. Chromosomal integration of the GAL1
promoter was confirmed by PCR utilizing primer combinations F1029/R1278 and
F1030/R1278 for verification of TRP1.PGAL1.RECQL1.HIS3MX6 and primer combination
F1029/R1273 and F1030/R1273 for verification of TRP1.PGAL1.RECQL4.HIS3MX6
(Figure 5.2F and G, Appendix B). By this method, we generated four isolates that
overexpressed RecQL1 (KHSY3726, KHSY3727, KHSY3728, and KHSY3729) and four
isolates that overexpressed RecQL4 (KHSY3771, KHSY3772, KHSY3773, and
KHSY3774) from a galactose inducible GAL1 promoter.
To

verify

inducibility

and

protein

expression

levels

of

the

TRP1.PGAL1.RECQL1.HIS3MX6 and TRP1.PGAL1.RECQL4.HIS3MX6 strains in the
presence of galactose, myc-epitope tags were fused to the 3’ end of the cDNA as
described earlier. However, since the GAL1 promoter is linked to a TRP1 cassette we
utilized a 13MYC.kanMX6 cassette instead of a 13MYC.TRP1 cassette. The presence of
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the 13MYC.kanMX6 cassette can be selected for on YPD media supplemented with
200 µg/ml of active G418-sulfate. As before the cassette was amplified by PCR from
pFA6a.13MYC.kanMX6 (Appendix C) (Longtine, McKenzie et al. 1998) using primer
combination F1281/R1283 for fusion to RECQL1 cDNA and primer combination
F1282/R1283

for

fusion

to

RECQL4

cDNA.

Using

standard

LiAc-mediated

transformation (Schiestl and Gietz 1989), the 13MYC.kanMX6 cassette amplicon was
introduced into yeast strain KHSY3726 and KHSY3771 and were selected for on YPD
agar plates supplemented with 200 µg/ml of active G418-sulfate. RecQL1 and RecQL4
expression in the resulting strains KHSY3730 (TRP1.PGAL1.RECQL1.HIS3MX6) and
KHSY3775 and KHSY3776 (TRP1.PGAL1.RECQL4.HIS3MX6), was verified by Western
blot analysis. In order to induce RECQL1 or RECQL4 cDNA under the control of the
GAL1 promoter, the 2% dextrose in media was replaced with 2% galactose or
1% sucrose and 1% galactose.
For this experiment, we slightly modified the GCR assay. After the initial
three-day incubation on YPD agar plates, a single colony was cultured in liquid
YP-Galactose (yeast extract 10g/L, peptone20g/L, 2% galactose) instead of YPD. After
reaching saturation, the cultures were spread on synthetic complete agar plates
containing 5-FOA (1 g/L), and canavanine (60 mg/L), lacking arginine as before but the
dextrose in the media was replaced with galactose (GCR/Gal agar plates).
Measurement of the rate of accumulation of GCRs in strains overexpressing
RecQL1 and RecQL4 from a GAL1 promoter illustrated there are no statistically
significant differences between an sgs1∆ strain and an sgs1∆ strain overexpressing
RecQL1 or RecQL4 (Table 5.1).
Because there is no statistically significant difference in the rate of accumulation
of GCRs between strains expressing RecQL1 or RecQL4 and an sgs1∆ strain, we chose
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to evaluate GCRs in a cell cycle checkpoint deficient background. Previous studies have
demonstrated that deletion of the DNA-damage checkpoint sensor MEC3 in an sgs1Δ
background leads to a synergistic increase in the accumulation of the GCR rate
(Schmidt and Kolodner 2006; Mirzaei, Syed et al. 2011). To generate mec3∆ sgs1∆
strains expressing RecQL1 or RecQL4, we first generated diploid heterozygous strains
by crossing desired mutant strains. The resulting diploid strains were sporulated and
genotyped on selective media for the presence of the desired combination of mutations,
as described in Chapter 8. Briefly, strains KHSY2046 and KHSY2676 were crossed to a
mec3∆ strain KHSY1346 (Appendix A), and the resulting heterozygous diploids were
sporulated and genotyped producing double mutant (sgs1∆ mec3∆) yeast strains
expressing RecQL1 or RecQL4. Double mutant strains KHSY2050, KHSY2051, and
KHSY2052 (Appendix A) expressing RecQL1, and strains KHSY3568, KHSY3569, and
KHSY3570 (Appendix A) expressing RecQL4 were analyzed for accumulation of GCRs.
When comparing the rate of accumulation of GCRs of an sgs1∆ mec3∆ strain
expressing RecQL1 or RecQL4 (under the control of an SGS1 promoter) to an sgs1∆
mec3∆ strain, we observed no statistically significant difference (Table 5.1). Thus
concluding that neither RECQL1 nor RECQL4 can complement sgs1∆ defects as
detected by the GCR assay.
Next, we sought to examine whether strains expressing either RecQL1 or
RecQL4 could reduce the hypersensitivity to HU observed in an sgs1∆ strain. We
assessed the ability of strains expressing RecQL1 or RecQL4 under the control of a
native SGS1 promoter and strains overexpressing these proteins from a GAL1 inducible
promoter to reduce the hypersensitivity to HU observed in sgs1∆ cells. We reasoned that
it was possible that the amount of RecQL1 or RecQL4 protein expressed from the SGS1
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promoter might be insufficient to compensate for the absence of SGS1. This hypothesis
was tested by evaluating strains overexpressing RecQL1 and RecQL4.
To assess hypersensitivity to the DNA damaging agent HU, an overnight culture
of the desired strain was diluted in YPD to OD600 = 0.2 and grown at 30°C to OD600 = 0.6.
Next a series of 10-fold dilutions was prepared from the yeast culture, and 2 µl aliquots
were spotted on YPD and on YPD containing different concentrations of HU. We
assessed sensitivity to 10 mM, 20 mM, 50 mM, 100 mM, and 200 mM HU. When
assessing hypersensitivity of strains expressing galactose inducible RecQL1 or RecQL4,
we substituted 2% dextrose with 1% sucrose and 1% galactose. As controls, we utilized
wild-type strain KHSY802 and sgs1∆ strain KHSY1633. In addition we used a PGAL1.BLM
strain, which was previously found to be hypersensitivity to HU20 (Mirzaei, Syed et al.
2011).
We observed that cells expressing either RecQL1 or RecQL4 under the native
SGS1 promoter are as hypersensitivity to HU as an sgs1∆ strain (Figure 5.3A).
Moreover, overexpression of neither RecQL1 nor RecQL4 helped to reduce the
observed hypersensitivity of an sgs1∆ strain to HU (Figure 5.3B). However, unlike yeast
strains overexpressing BLM, overexpression of RecQL1 or RecQL4 did not result in
elevated hypersensitivity to HU (Figure 5.3B).

Construction

of

Sgs1-RecQL1

and

Sgs1-RecQL4

chimeric

proteins
It has been previously reported from our laboratory that an Sgs1-BLM chimeric
protein is able to partially suppress the deleterious phenotypes associated with an sgs1∆
strain (Mirzaei, Syed et al. 2011). This Sgs1-BLM21 chimera was generated by fusing the

20
21

Described in Chapter 2
For simplicity, Sgs1 [1-647]-BLM [648-1447] is simply referred to as Sgs1-BLM
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N-terminal region of Sgs1 (amino acids 1-647), which is predicted to be disordered, to
the C-terminus catalytic region of BLM (amino acids 648-1417), which is predicted to be
ordered (Figure 5.4A, B, and C). Therefore, we sought to assess whether chimeric
proteins comprised of Sgs1 and RecQL1 or Sgs1 and RecQL4 are able to complement
sgs1∆ defects similar to the Sgs1-BLM chimera (Mirzaei, Syed et al. 2011). We
hypothesized that RecQL1 would complement sgs1∆ defects because, similar to BLM
and Sgs1, it possesses the RQC domain and the HRDC domain in addition to the 7 motif
helicase domain. In contrast, we reasoned that RecQL4 would not complement sgs1∆
defects because it lacks both the RQC and the HRDC domains.
The RecQL1 protein is 649 amino acids long and is only half the size of BLM due
to a very short N-terminal region that extends from the helicase core (Figure 5.4F). We
assessed disorder scores of RecQL1, BLM, and Sgs1 from a server for the prediction of
intrinsically unstructured regions of proteins (IUPred, http://iupred.enzim.hu/) and
observe that the majority of the RecQL1 protein is predicted to be structured, similar to
the C-terminus of BLM (Figure 5.4H and I). Consequently, we chose to fuse the same
647 residue long N-terminus of Sgs1 that was used in construction of the Sgs1-BLM
chimera (Chapter 2) to the full-length RecQL1 protein resulting in a 1296-amino-acid
long chimeric protein (Figure 5.4D).
The cDNA of RECQL4 obtained from Open Biosystems encodes a protein that
has a short N-terminal tail extending from the helicase core. The IUPred prediction of
disorder scores for this RecQL4 isoform revealed little similarity to RecQL1 or the
C-terminus of BLM (Figure5.4J). This was not unexpected since RecQL4 lacks both
C-terminal RQC and HRDC domains that are present in BLM and RecQL1 (Figure 5.4F).
Because this RecQL4 isoform lacks the long N-terminal tail, we decided to fuse the
same 647 residue long N-terminus of Sgs1 used in construction of the Sgs1-BLM
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chimera (Chapter 2) and the Sgs1-RecQL1 chimera to the full length RecQL4 yielding a
1299-amino-acid long chimeric protein (Figure 5.4E). For construction of the
above-mentioned chimeric proteins, RECQL1.HIS3MX6 and RECQL4.HISMX6 were
amplified by PCR from plasmids pKHS338 and pKHS345, respectively. Primer
combination F1690/R1246 where used for RECQL1.HIS3MX6 amplification (Appendix
B) and F1688/R1246 were used for RECQL4.HISMX6 amplification (Figure 5.1D and F,
Appendix B).
Subsequently, standard LiAc-mediated transformation (Schiestl and Gietz 1989)
was used to introduce each amplicon into yeast strain KHSY802, resulting in chimeric
genes that are expressed under control of the native SGS1 promoter. Positive
transformants

were

selected

for

the

presence

of

RECQL1.HIS3MX6

and

RECQL4.HIS3MX6 on SC-HIS agar plates. Select isolates were verified by PCR
analysis for chromosomal integration of RECQL1.HIS3MX6 and RECQL4.HIS3MX6 at
the SGS1 locus using primer combinations F1259/R1278 and F1259/R1273,
respectively (Figure 5.4G). Subsequently, the SGS1 fusion site and RECQL1 were
amplified by PCR and sequenced to ensure mutation free integration using primers
F1260, R1278, F1274, F1300, F1301, F1276, and F1277 (Appendix B). Similarly, the
SGS1 fusion site and RECQL4 were amplified by PCR and sequenced for mutation free
integration using primers F1260, R1307, F1269, F1270, F1271, F1272, and F1230
(Appendix B). The resulting strains were KHSY3686 expressing Sgs1 [1-647]-RecQL1
and KHSY3687 expressing Sgs1 [1-647]-RecQL4 (here on referred to as Sgs1-RecQL1
and Sgs1-RecQL4, Appendix A). Furthermore, as described earlier, in order to generate
additional yeast strains expressing chimeric constructs and to obtain yeast strains
expressing chimeric constructs in a mec3∆ background, we crossed strains KHSY3686
and KHSY3687 to strain KHSY1346 followed by subsequent sporulation and genotyping.
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Phenotypic

characterization

of

yeast

strains

expressing

Sgs1-RecQL1 and Sgs1-RecQL4 chimeric proteins
Since the Sgs1-BLM chimera22 (Mirzaei, Syed et al. 2011) does not exhibit a
statistically significant change in GCR rate in the Mec3-proficient strain (Table 5.1), we
decided to only evaluate yeast strains expressing Sgs1-RecQL1 and Sgs1-RecQL4
chimeric proteins in a mec3∆ strain. We assessed the rate of accumulation of GCRs of
strains KHSY3704, KHSY3705, KHSY3706 (expressing Sgs1-RecQL1) and strains
KHSY3707, KHSY3708, KHSY3709 (expressing Sgs1-RecQL4) (Appendix A). We found
no statistically significant difference between the rate of accumulation of GCRs in an
sgs1∆ mec3∆ strain and a mec3∆ strain expressing Sgs1-RecQL1 or Sgs1-RecQL4
chimeric proteins in contrast to a mec3∆ strain expressing Sgs1-BLM chimeric protein
(Table 5.1).
Next, we evaluated yeast strains KHSY3686 and KHSY3687 for the ability of
Sgs1-RecQL1 and Sgs1-RecQL4 chimeric proteins to suppress hypersensitivity to HU
observed in an sgs1∆ strain. As a control, we utilized a yeast strain expressing the
Sgs1-BLM chimera (Mirzaei, Syed et al. 2011) and a yeast strain expressing the
helicase-deficient mutant of Sgs1-BLM chimera (Sgs1-BLM.HD, described in Chapter 3)
(Mirzaei and Schmidt 2012). All strains were evaluated on YPD agar plates
supplemented with three different concentrations of 50mM, 100mM, and 200mM of HU.
We observed that, unlike the Sgs1-BLM chimera, neither Sgs1-RecQL1 nor
Sgs1-RecQL4 chimeric proteins are able to suppress hypersensitivity to HU. Strains
expressing either construct exhibit the same degree of sensitivity to HU as a yeast strain
expressing Sgs1-BLM.HD chimeric mutant (Figure 5.5).

22

Described in Chapter 2
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Diploid yeast cells expressing various gene combinations of BLM,
RECQL1, RECQL4, and RECQL5 hint to genetic interaction
between some members of the human RecQ-like family
Thus far, our findings have illustrated that yeast strains expressing RecQL1 and
RecQL4 from the native SGS1 promoter or a GAL1 promoter are not able to
complement defects observed in an sgs1∆ strain. Moreover, in Chapter 2 we
demonstrated that BLM overexpression results in elevated hypersensitivity to HU, and
that this phenotype can be rescued in a diploid strain expressing a single copy of SGS1
from the other chromosome (PSGS1.SGS1/PGAL1.BLM) (Mirzaei, Syed et al. 2011).
Here we wanted to evaluate whether diploid strains expressing RECQL1,
RECQL4, or RECQL5 from the native SGS1 promoter can complement defects
observed in an sgs1∆/sgs1∆ strain. Furthermore, if protein production from the SGS1
promoter is not sufficient, will overexpression of these genes from a GAL1 promoter
result in complementation or will it result in elevation of hypersensitivity as observed in
the case of overexpression of BLM (Mirzaei, Syed et al. 2011)?
We reasoned that an investigation in a diploid yeast system would better mimic
a mammalian system. Where these proteins might also act on homologous
chromosomes in addition to sister chromatids. Thus, we expressed various combinations
of RecQ-like genes in diploid yeast cells and evaluated hypersensitivity to the DNA
damaging agent HU.
For this analysis, we constructed two sets of diploid strains. In the first set, all
RecQ-like genes were controlled under the SGS1 promoter, while in the second set the
same genes were under the control of the inducible GAL1 promoter. This allowed us to
evaluate effects of endogenous levels of protein and overexpressed levels on
suppression of hypersensitivity to HU. The following gene combinations were evaluated:
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RECQL1/RECQL1,

RECQL4/RECQL4,

RECQL5/RECQL5,

RECQL1/RECQL5,

RECQL4/RECQL5,

BLM/RECQL1,

RECQL1/RECQL4,
BLM/RECQL4,

and

BLM/RECQL5. Multiple isolates for each gene combination were generated23. All diploid
strains were spotted on YP-sucrose/galactose agar plates

(YPD media in which

dextrose is replaced with 1% sucrose and 1%  galactose) supplemented with 50mM,
100mM, or 200mM HU. We observed that all combinations of RecQ-like genes appear to
be as sensitive as an sgs1∆/sgs1∆ strain, with the exception of the homozygous BLM
strain, which appeared slightly more sensitive to HU (Figure 5.6A). When evaluating the
sensitivity of the diploid yeast strains overexpressing RecQ-like gene combinations
under the control of the GAL1 promoter, we observed three levels of sensitivity to HU. At
level

one,

strains

expressing

PGAL1.RECQL4/PGAL1.RECQL4 or

PGAL1.RECQL5

/PGAL1.RECQL5 were as sensitive to HU as an sgs1∆/sgs1∆ strain. At level two, strains
expressing PGAL1.RECQL1/PGAL1.RECQL1 were slightly more sensitive in comparison to
an sgs1∆/sgs1∆ strain. At level three, strains expressing PGAL1.BLM/PGAL1.BLM were
most sensitive (Figure 5.6B) as previously reported (Mirzaei, Syed et al. 2011).
Moreover, in strains overexpressing a combination of PGAL1.RECQL4/PGAL1.BLM or
PGAL1.RECQL5/PGAL1.BLM we observed that hypersensitivity to HU is reduced in
comparison to strains that overexpress PGAL1.BLM/PGAL1.BLM (Figure 5.6B). This
observation hints to a possible genetic interaction between RECQL4 and BLM, and
RECQL5 and BLM. The same phenotype was not observed in strains overexpressing
PGAL1.RECQL1/PGAL1.BLM (Figure 5.6B).

23

For complete list refer to Appendix A.
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Discussion
The goal of this study was to evaluate yeast as a model for the functional
characterization of the human RecQ-like helicases RECQL1 and RECQL4. Although
BLM and WRN genes had been previously studied in a yeast system, this was the first
attempt to evaluate RecQL1 and RecQL4 in a yeast system. Due to the fact that there
are five RecQ-like homologs in humans, we sought to investigate redundancies in
functionality among yeast and RecQ homologs by evaluating their ability to complement
defects observed in an sgs1∆ strain (Yamagata, Kato et al. 1998; Heo, Tatebayashi et
al. 1999; Mirzaei, Syed et al. 2011).
We evaluated strains expressing RECQL1 or RECQL4 for their ability to lower
the rate of accumulation of GCRs and/or the suppression of hypersensitivity to HU,
which is observed in sgs1∆ strains. After examining strains expressing a single copy of
RECQL1 or RECQL4 chromosomally integrated at the SGS1 locus and under the control
of native SGS1 promoter and strains overexpressing chromosomally integrated RECQL1
or RECQL4 under the control of an inducible GAL1 promoter, we observed that similar to
BLM (Mirzaei, Syed et al. 2011), neither RECQL1 nor RECQL4 can complement defects
observed in an sgs1∆ strain. This is possibly due to divergence of function between the
yeast RecQ-like homolog, Sgs1, and human RecQL1 and RecQL4. Human RecQL1 and
RecQL4 are not able to interact with the yeast proteome to carryout Sgs1-mediated
functions. This hypothesis is supported by the fact that both RecQL1 and RecQL4
constructs utilized in this study lack the long N-terminal tail found in Sgs1, which
contains the Top3 binding site that is crucial for proper function (Watt, Louis et al. 1995;
Bennett, Noirot-Gros et al. 2000; Johnson, Lombard et al. 2000; Fricke, Kaliraman et al.
2001).
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Next, we evaluated chimeric constructs of Sgs1-RecQL1 and Sgs1-RecQL4 for
their ability to suppress hypersensitivity to HU and to lower the rate of accumulation of
GCR. As demonstrated in Chapter 2, a chimeric Sgs1-BLM protein was able to suppress
some of the defects observed in an sgs1∆ strain. However we found that strains
expressing chimeric constructs of Sgs1-RecQL1 or Sgs1-RecQL4 exhibited the same
level of hypersensitivity to HU as strains expressing the helicase-dead Sgs1-BLM
chimera, or an sgs1∆ strain. Moreover, GCR analysis of Mec3-deficient strains
expressing Sgs1-RecQL1 or Sgs1-RecQL4 showed no statistically significant difference
in accumulation of GCR when compared to an sgs1∆, mec3∆ strain.
Most likely, the inability of strains expressing RecQL4 or the Sgs1-RecQL4
chimera to complement sgs1∆ defects can be attributed to the lack of both conserved
RQC and HRDC domains. However, the same is not true for RecQL1. Although we were
not surprised when the full length RecQL1 did not complement sgs1∆ defects, since it
lacks the long N-terminal tail. We predicted that a chimeric Sgs1-RecQL1 protein would
be functional. The observed lack of function indicates a significant separation of function
between BLM and RecQL1.
Lastly, we evaluated diploid yeast strains expressing various combinations of
RECQL1, RECQL4, RECQL5, and BLM genes. While all diploid strains in which the
RecQ-like homologs were controlled by the SGS1 promoter showed the same level of
sensitivity to HU as an sgs1∆/sgs1∆ strain, different degrees of hypersensitivity to HU
were detected when the same constructs were overexpressed.

We observed that

strains expressing PGAL1.RECQL4/PGAL1.RECQL4 or PGAL1.RECQL5/PGAL1.RECQL5
depicted the same degree of sensitivity to HU as an sgs1∆/sgs1∆ strain. In contrast,
strains expressing PGAL1.RECQL1/PGAL1.RECQL1 showed a higher degree of sensitivity
to HU when compared to an sgs1∆/sgs1∆ strain, but not as sensitive as a
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PGAL1.BLM/PGAL1.BLM strain (previously demonstrated in Chapter 2). Again, the
observed results can be explained by the fact that RECQL4 lacks the RQC and the
HRDC domain while RECQL5 lacks the HRDC domain and both proteins have a very
short N-terminal tail extending from the helicase core, which most likely renders these
helicases mostly inactive in the yeast system. In contrast, the observed hypersensitivity
of the PGAL1.RECQL1/PGAL1.RECQL1 strain suggests that RecQL1 is able to functionally
interact in yeast (either with DNA substrates or other proteins), probably blocking
alternative pathways from resolving the replication stress caused by exposure to HU.
Previous studies from our laboratory have demonstrated that overexpression of
BLM results in extreme hypersensitivity to HU (Mirzaei, Syed et al. 2011). Therefore, we
predicted

that

strains

expressing

PGAL1.BLM/sgs1∆,

PGAL1.BLM/PGAL1.RECQL1,

PGAL1.BLM/PGAL1.RECQL4, or PGAL1.BLM/PGAL1.RECQL5 would be as sensitive as a
strain expressing PGAL1.BLM/PGAL1.BLM. Contrary to our hypothesis, strains expressing
PGAL1.BLM /PGAL1.RECQL4 or PGAL1.BLM /PGAL1.RECQL5 appeared to be less sensitive
to HU when compared to the PGAL1.BLM/PGAL1.BLM strain. To explain this phenomenon,
we hypothesize that BLM may be able to interact with DNA substrates (such as forks
and HR intermediates) in yeast, but may be unable to interact with Sgs1 binding partners
(yeast Top3, Top2, Srs2, Rad51, Rmi1, Rpa, Pol∂, and mismatch repair proteins) to
allow for proper functionality. As a result overabundance of BLM may cause it to
outcompete the endogenous yeast DNA repair pathways that could deal with stalled
replication forks and DSBs caused by exposure to HU. In the case of the diploid strains,
it is plausible that physical interactions between BLM and RecQL4 or RecQL5 results in
sequestration of BLM, which in return will allow alternative pathways to engage in DNA
repair, thus reducing the hypersensitivity observed in strains overexpressing BLM.
Moreover, recently RecQL4 has been shown to physically interact with BLM (Singh,
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Popuri et al. 2012). Although this interaction was shown to require the N-terminal region
of both proteins it is plausible that RECQL4 possess a secondary binding domain to
interact with BLM, and can interact when there is an overabundance of RecQL4.
Additionally, it is plausible that BLM interacts with downstream binding partners
of Sgs1 but is unable to carry out Sgs1 related tasks resulting in extreme hypersensitivity
to HU upon BLM overexpression. Consequently interaction between BLM and RecQL4
or RecQL5 would result in release of downstream Sgs1 binding partners and a reduction
of the hypersensitivity observed in overexpression of BLM.
To further elucidate the cause of the extreme hypersensitivity to HU upon BLM
overexpression in yeast additional investigation is required. Furthermore, the
protein-protein interaction between BLM and RecQL4 (Singh, Popuri et al. 2012) and the
possibility of interaction between RecQL5 and BLM merits further investigation. BLM has
been previously shown to also physically interact with WRN, another RecQ-like helicase
(von Kobbe, Karmakar et al. 2002), and immunocytochemistry studies using yeast
strains overexpressing PGAL1.BLM/PGAL1.RECQL4 or PGAL1.BLM/PGAL1.RECQL5 will allow
us to determine whether BLM colocalizes with RecQL4 and/or RecQL5 in yeast.
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Figure 5.1 Construction of PSGS1.RECQL1 and PSGS1.RECQL4 expressing yeast
strains
A) This diagram depicts the primer and XhoI restriction sites on the pCR2.1 TOPO
plasmid used to clone the HIS3MX6 cassette, which was amplified by PCR from plasmid
pRS303. B) An illustration of the primer annealing sites used in colony PCR verification
of the HIS3MX6 cassette linked to RECQL1 and RECQL4. C) An image of the gel
electrophoresis of the HindIII digestion of pOBT7 plasmids harboring RECQL1.HIS3MX6
or RECQL4.HIS3MX6. A HindIII digestion was used to confirm presence of the
HIS3MX6 cassette and its relative orientation to RECQL1 and RECQL4 cDNA. From left
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to right starting with the marker, lanes 1-6 are digestion products of RECQL1.HIS3MX6
constructs while lanes 7-12 are digestion products of RECQL4.HIS3MX6 constructs. In
lanes 1-6, the presence of the smaller 1 kb band signifies a HIS3MX6 cassette in a
reverse orientation in relation to RECQL1. In lanes 7-12, the presence of the smaller
2 kb band signifies the HIS3MX6 cassette in reverse orientation in relation to RECQL4.
Isolates 1, 2, and 4 for RECQL1 (pKHS338, pKHS339, pKHS340) and 10, 11, and 12 for
RECQL4 (pKHS344, pKHS345, pKHS346) were selected for use in this study. D) For
construction of PSGS1.RECQL1.HIS3MX6, the RECQL1.HIS3MX6 fragment was
amplified by PCR from plasmid pKHS338 using the primer combination F1245/R1246
depicted here. E) An illustration of the annealing sites of primer combinations
F1143/R1278 and F1229/R1032 used to verify integration of RECQL1 cDNA at the
SGS1 locus. F) To construct PSGS1.RECQL4.HIS3MX6, the RECQL4.HIS3MX6 fragment
was amplified by PCR from plasmid pKHS338 using the primer combination
F1253/R1254 as depicted. G) An illustration of the annealing sites of primer
combinations F1143/R1273 and F1230/R1032 used to verify integration of RECQL4
cDNA at the SGS1 locus
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Figure 5.2 Myc-tag epitope fusion and integration of GAL1 promoter in strains
expressing RecQL1 and RecQL4
(A) An illustration of the annealing sites of primers used to fuse the myc-epitope tag in
the form of the 13MYC.TRP1 cassette to RECQL1 cDNA, in addition to primers used to
confirm the integration by PCR. (B) An illustration of the annealing sites of primers used
to fuse the myc-epitope tag in the form of 13MYC.TRP1 cassette to RECQL4 cDNA, in
addition to primers used to confirm the integration by PCR. (C) An example of the gel
electrophoresis of the PCR products used in verification of fusion of the 13MYC.TRP1
cassette to the 3’ end of RECQL1. The primer combinations used for this experiment are
as follows: lane 1 = F1277/R1144, lane 2 = F1277/R1032, lane 3 = F1277/R1029,
lane 4 = F1030/R1144. (D) An illustration of the annealing sites for primers in the
RECQL1 construct that myc was not successfully integrated. (E) Representative
Western blot of strains expressing RecQL1 and RecQL4 fused with myc-tag epitope.
This membrane was probed with monoclonal anti-myc primary antibody (Covance). (F,
G) An illustration of the annealing sites of primers used in integration of the GAL1
promoter upstream of RECQL1 and RECQL4 in addition to primers used for confirmation
of this integration by PCR.
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Figure 5.3 HU sensitivity of strains expressing PSGS1.RECQL1, PSGS1.RECQL4,
PGAL1.RECQL1, and PGAL1.RECQL4
(A) Ten-fold dilutions of exponentially growing haploid cells expressing RECQL1 and
RECQL4 integrated at the native SGS1 locus under the control of the SGS1 promoter
were spotted on YPD media with and without 100mM HU. (B) Ten-fold dilutions of
exponentially growing haploids overexpressing RECQL1 and RECQL4 from a GAL1
promoter inserted at the native SGS1 locus were spotted on media containing
1% galactose and 1% sucrose with or without 100mM HU.
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Figure 5.4 construction of Sgs1-RecQL1 and Sgs1-RecQL4 chimerical protein
An illustration of the protein disorder prediction of Sgs1 (red), BLM (blue), RecQL1
(green), and RecQL4 (purple) using the IUPred algorithm. Values above 0.5 indicate a
disordered residue whereas values below 0.5 indicate ordered residues; (A, B) predicted
disorder plot of full-length Sgs1 and BLM proteins. (C,D, and E) The transition site
between the two colors in each disorder prediction plot indicates the site where the
disordered N-terminal segment of Sgs1 was fused to the C-terminal region of the
corresponding RecQ-like protein yielding the chimeric protein. (F) Pictorial
representation of the conserved domains of RecQ-like genes used in this study. (G) An
illustration of the primer annealing sites used for verification by PCR of Sgs1-RecQL1
and Sgs1-RecQL4 chimeric strains. (H, I, and J) A comparison of the predicted disorder
plot of the C-terminus of BLM to RecQL1 and RecQL4.
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- HU

+ HU

Sgs1-RecQL1
Sgs1-RecQL4
Sgs1-BLM
Sgs1-BLM.HD

Figure 5.5 HU sensitivity of yeast cells expressing the Sgs1-RecQL1 and
Sgs1-RecQL4 chimeric proteins
Ten-fold dilutions of exponentially growing haploid cells were spotted on YPD media with
and without 100mM HU. Yeast cells expressing the helicase-deficient mutant Sgs1-BLM
chimera are denoted by Sgs1-BLM.HD
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Figure 5.6 HU sensitivity of diploid cells expressing various combinations of
RECQL1, RECQL4, RECQL5, and BLM genes
(A) Ten-fold dilutions of exponentially growing diploids expressing various combinations
of RECQL1, RECQL4, RECQL5, and BLM genes integrated at the native SGS1 locus
under the control of the SGS1 promoter were spotted on YPD media with and without
100 mM HU. (B) Ten-fold dilutions of exponentially growing diploids overexpressing
various combinations of RECQL1, RECQL4, RECQL5, and BLM from a GAL1 promoter
inserted at the native SGS1 locus were spotted on media containing 1% galactose and
1% sucrose with or without 100 mM HU.
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Table 5.1 Rate of accumulation of Gross Chromosomal Rearrangements (GCR)
GCR rate
95% CI1
Relevant genotype
r
r
-10
r
(Can 5-FOA x 10 )
(Can 5-FOAr x 10-10)
Wild type
1
<1-6.2
sgs1Δ
96
58-206
BLM
75
56-264
2
sgs1Δc800.BLMΔn647
24
11-65
RECQL1
266
200-368
RECQL4
89
65-200
sgs1Δ, mec3Δ
1297
1120-2030
sgs1Δ, BLM, mec3Δ
1728
1440-2090
sgs1Δc800, mec3Δ
823
710-969
sgs1Δc800.BLMΔn647, mec3Δ
361
330-419
sgs1Δc800.BLMΔn647.HD
131
56-241
sgs1Δ, RECQL1, mec3Δ
721
624-1130
3
sgs1Δc800.RECQL1, mec3Δ
701
608-914
sgs1Δ, RECQL4, mec3Δ
954
720-1260
4
sgs1Δc800.RECQL4, mec3Δ
742
450-1270
5
PGAL1.SGS1
11
9-12
PGAL1.BLM
1832
1090-2910
PGAL1.BLM.HD
390
231-509
PGAL1.RECQ1
173
102-235
PGAL1.RECQ4
99
64-212

1

We calculated 95% confidence intervals (CI) according to Nair (Nair 1940).
The sgs1Δc800-BLMΔn647 allele expresses a chimeric protein that consists of the
N-terminal 647 residues of Sgs1 and the C-terminal 770 residues of human BLM.
3
The sgs1Δc800.RECQL1 allele expresses a chimeric protein that is comprised of the
N-terminal 647 residues of Sgs1 and full-length RecQL1.
4
The sgs1Δc800.RECQL4 allele expresses a chimeric protein that is comprised of the
N-terminal 647 residues of Sgs1 and full-length RecQL4.
5
All RecQ-like gene constructs are chromosomally integrated at the SGS1 locus under
the control of the SGS1 promoter, except when a GAL1 inducible promoter was used
denoted as PGAL1.
2
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CHAPTER 6:
A RANDOM MUTAGENESIS SCREEN FOR IDENTIFICATION OF
NOVEL REGIONS IN BLM THAT ARE CRUCIAL FOR PROTEIN
FUNCTION

Note to reader: Unpublished data. Hamed Mirzaei and Kristina H. Schmidt designed
experiments. Hamed Mirzaei performed and analyzed all experiments and generated all
figures.

Rationale
The known functional domains of BLM include the helicase domain, the RQC
domain and the HRDC domain (Bachrati and Hickson 2003; Hickson 2003; Umate,
Tuteja et al. 2011). The helicase domain is responsible for the ATP hydrolysis (Walker,
Saraste et al. 1982; Ye, Osborne et al. 2004) and single strand annealing activities of
this protein (Korolev, Hsieh et al. 1997; Korolev, Yao et al. 1998; Dillingham, Soultanas
et al. 2001). The RQC domain is comprised of the zinc-binding subdomain, which is
responsible for structural stability (Bernstein, Zittel et al. 2003; Janscak, Garcia et al.
2003) and the winged-helix subdomain, which is thought to aid in DNA unwinding as
demonstrated in the WRN protein (Kitano, Kim et al. 2010). However, others have
shown it is not required for unwinding activity (Gyimesi, Harami et al. 2012). The HRDC
domain has DNA binding properties (Kim and Choi 2010), but the function of this domain
is not yet fully understood. In Sgs1, the yeast homolog of BLM, the HRDC domain has
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been shown to be dispensable when evaluating yeast strains expressing a truncated
Sgs1 protein lacking the HRDC domain for accumulation of GCR or sensitivity to HU
(Mullen, Kaliraman et al. 2000; Mirzaei, Syed et al. 2011). Moreover, biochemical
analyses have shown that in BLM the HRDC domain is not required for its helicase
activity (Gyimesi, Harami et al. 2012).
Of

the

32

exonic

single-nucleotide

variants

that

are

causative

of

Bloom’s syndrome (BS), 13 are missense mutations and 19 possess a premature stop
codon (Ellis, Groden et al. 1995; Foucault, Vaury et al. 1997; Barakat, Ababou et al.
2000; German, Sanz et al. 2007). While premature stop codons are spread throughout
the disease-associated BLM allele, all missense mutations are located in the helicase
and RQC domains. The significance of both these domains for BLM function has been
shown by many groups including ours (Guo, Rigolet et al. 2005; Huber, Duquette et al.
2006; Sharma, Doherty et al. 2006; Mirzaei and Schmidt 2012).
As demonstrated in Chapter 3, our laboratory has developed a novel chimeric
system through which we have identified several additional amino acids that are critical
for proper function of BLM (Mirzaei and Schmidt 2012). Here we sought to further
investigate BLM in search for other functionally critical regions by conducting a random
mutagenesis screen.

Results
Design of the random mutagenesis screen
In Chapter 2 we illustrated that overexpression of BLM in yeast results in an
extremely elevated rate of accumulation of GCRs (1.8x10-7 with 95% confidence
intervals of 1.0 x10-7 - 2.9 x10-7, Table 2.2) (Mirzaei, Syed et al. 2011). For the random
mutagenesis screen, we hypothesized that if overexpression of functional BLM results in
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an elevated rate of accumulation of GCRs, inactivation of BLM as a result of a mutation
in a crucial region should lead to loss of this phenotype. We therefore developed a
system in which randomly mutagenize plasmid borne BLM cDNA was overexpressed in
yeast, and these yeast strains were then assayed for accumulation of GCRs. The BLM
cDNA was cloned into the plasmid pYES3 (Invitrogen, pKHS390, Figure 6.1, Appendix
C) and randomly mutagenized utilizing an E.coli mutator strain (XL1 Red, Agilent
technologies). Mutagenized plasmids were subsequently transformed into yeast strain
KHSY802 (appendix A).

Constructions of pYES3-BLM and random mutagenesis
For integration of BLM cDNA by recombinant cloning, plasmid pKHS390 was
linearized using double restriction enzyme digestion (NotI and SacI, Figure 6.1) and BLM
cDNA was amplified by PCR from genomic DNA extracted from strain KHSY1705
(Appendix A) using primer pairs F1617/R1618 (Figure 6.1, Appendix B). These primers
contained 20 nucleotides homologous to BLM cDNA and 50 nucleotides homologous to
the pKHS390 plasmid backbone. Next, standard LiAc-mediated transformation (Schiestl
and Gietz 1989) was used to co-transform the linearized plasmid and BLM amplicon into
strain KHSY2331 (Appendix A). The Lig4-deficient strain KHSY2331 is impaired in
NHEJ; thus, HR-mediated repair is utilized to recircularize the pKHS390 plasmid,
resulting in integration of the BLM amplicon into this vector. Since the pKHS390 plasmid
contains a TRP1 cassette, yeast transformants were selected for the presence of
pKHS390-BLM on SC-TRP agar plates. Genomic DNA was isolated from the resulting
yeast strain (KHSY3553, Appendix A) followed by rescue of plasmid DNA from the
isolated genomic DNA. The recovered pKHS390-BLM plasmid DNA was sequenced for
confirmation of mutation free, in-frame integration of BLM cDNA using primers R1189,
F1559, F1424, F1420, F1422, F1417, R1520, F1418, R1067, and F1423 (Appendix B).
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The resulting plasmid, pKHS404 (Appendix C), was then randomly mutagenized in the
XL1 red mutator strain.
The XL1 Red E.coli mutator strain (Greener, Callahan et al. 1997) has a mutation
rate of approximately 5,000-fold higher than wild-type. The high mutation rate of this
strain is due to deficiency in three of the primary DNA repair pathways. These cells are
mutD, mutT, and mutS deficient. As a result, they lack 3´ to 5´ exonuclease activity of
DNA polymerase III, resulting in loss proof reading, are impaired in their ability to
hydrolyze 8-oxodGTP, resulting in compromised base excision repair, and have an
error-prone mismatch repair pathway.
In order to obtain mutagenized candidates of the BLM cDNA, we transformed the
BLM overexpression vector pKHS404 into XL1 Red cells. Transformants were plated on
LB agar plates supplemented with 100 mg/ml of ampicillin and incubated at 30˚C for
30 hrs. After the incubation period, approximately 200 colonies were picked at random
from the agar plates, inoculated in one 10 ml culture of liquid LB media, and incubated
overnight. Subsequently, plasmid DNA was isolated from the overnight culture using
QIAPrep Miniprep Kit (Qiagen) and used in screening for loss of BLM function.

GCR screen of yeast cells harboring mutagenized plasmid borne
BLM
Using standard LiAc-mediated transformation (Schiestl and Gietz 1989), the
mutagenized pkhs404 plasmids were transformed into wild-type yeast strain KHSY802
(Appendix A). Transformants were selected for by growth for three days at 30˚C on
SC-TRP agar plates (Figure 6.2A). To induce expression of BLM from the GAL1
promoter, while positively selecting for presence of the pkhs404 plasmid, colonies were
picked at random from SC-TRP agar plates and streaked on SC/Gal-TRP agar plates
(synthetic complete media minus tryptophan with 2% galactose instead of 2% dextrose).
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All SC/Gal-TRP agar plates were incubated for four days at 30˚C (Figure 6.2B). Each
streak was then patched as a 1” by 1” square on a fresh SC/Gal-TRP agar plate and
incubated for another four days at 30˚C (this plate is referred to as the master plate,
Figure 6.2C). The SC/Gal-TRP agar plates with patched candidates were then replica
plated on GCR/Gal selective media and incubated for four days. The GCR/Gal agar
plates used for this screen differed from those previously described [Chapter 8,
(Schmidt, Pennaneach et al. 2006)], in that 2% galactose was substituted for 2%
dextrose. Substitution of sugar allowed for continuous expression of BLM from the GAL1
promoter. After the final incubation period, the number of colonies that appeared on
each patch were counted and compared to the number of colonies from a patch with
yeast strains harboring non-mutated pYES3-BLM plasmid (Figure 6.2D).

Yeast strains expressing PGAL1.BLM from a 2µ-plasmid, have a GCR rate higher
than chromosomally expressed PGAL1.BLM due to higher copy number (rate of 6.0x10-7,
95% confidence intervals of 4.8x10-7 – 7.2 x10-7). Consequently a 1” by 1” patch of yeast
strains harboring non-mutated pkhs404 plasmid produces between 14 to 60 colonies on
GCR/Gal agar plates. Therefore, in this screen we were interested in patches that
produced less than 14 colonies. Upon identification of a patch with less than 14 colonies,
a small scoop of cells from the corresponding patch on the master plate was saved for
future sequencing analysis of the BLM cDNA. Over 1,000 colonies were screened, which
produced approximately 100 potential candidates. A complete record of all random
mutagenesis experimental data is available in Appendix F.

Analysis of candidate yeast strains harboring mutant pKHS404
Plasmid DNA was rescued from each patch of interest and sequenced for
identification of the BLM mutation using primers R1189, F1559, F1424, F1420, F1422,
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F1417, R1520, F1418, R1067, and F1423 (Appendix B). Of the approximate 100
candidates, the first 58 were sequenced (Figure 6.3, Table 6.1). From the sequenced
candidates, 47 had incorporated a mutation in the BLM cDNA (a deletion or an insertion)
resulting in a truncated protein and loss of the helicase domain. Two candidates (54-10
and 47-3) had a mutation resulting in a stop codon that did not affect the helicase
domain but instead disrupted the RQC domain. Three candidates (82-5, 15-4, and
48-15) had mutations affecting the HRDC domain. We also identified six candidates that
did not have a mutation in the BLM cDNA. Inactivation of BLM in these candidates is
possibly due to a mutation affecting the GAL1 promoter.
To further evaluate the mutations, we took advantage of the chimeric system
described in Chapter 2 (Mirzaei and Schmidt 2012). Since the importance of the helicase
domain is well established, we excluded all candidates with a mutation affecting the
helicase domain from our analysis. Therefore, we examined alleles BLM-47-3 and
BLM-48-15 in the chimeric system. First, we evaluated the effects of a frame shift at
nucleotide 3028 as a result of a thymidine insertion affecting residues 1009 and onward
(BLM-47-3). Second, a deletion of a cytosine at nucleotide 3918, causing a frame shift
affecting residues 1306 and onward (BLM-48-15) was evaluated. Using site-directed
mutagenesis24, the desired mutations were introduced into plasmid pKHS293 (harboring
BLM.HIS3, Appendix C) and subsequently used in construction of the chimeric
Sgs1-BLM, as described in Chapter 2 (Mirzaei and Schmidt 2012). The resulting yeast
strains KHSY4082 and KHSY4083 expressing Sgs1-BLM-47-3, and strain KHSY4084
expressing Sgs1-BLM-48-15 were verified by sequencing using primers F1260, R1520,
F1418, F1419, R1067, and F1423 (Appendix B). Next, we evaluated yeast strains
KHS4083 and KHSY4084 for hypersensitivity to HU (Figure 6.3). When compared to the

24

Protocol for site-directed mutagenesis is outlined in Chapter 8
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wild-type Sgs1-BLM chimera and the mutant helicase-deficient Sgs1-BLM chimera
(Sgs1-BLM.HD), we observed that strain KHS4083 shows a total loss-of-function
phenotype, while strain KHSY4084 shows a partial loss-of-function phenotype.

Discussion
Here we sought to identify new regions within the BLM protein that are crucial for
its function. Utilizing the knowledge gained from previous studies in our laboratory
(Mirzaei, Syed et al. 2011; Mirzaei and Schmidt 2012), we developed a screen, which
would allow us to select for loss-of-function BLM mutants. Analysis of two of the newly
identified mutations in our chimeric system revealed that the BLM-47-3 allele which has
a frame shift at residue 1009 results in total loss-of-function of BLM protein, while the
BLM-48-15 allele with a frame shift at residue 1306 yields a partially functional BLM
protein.
The phenotype observed in yeast cells expressing Sgs1-BLM-47-3 did not come
as a surprise. The RQC domain is comprised of two subdomains: the zinc-binding and
the winged helix (WH). In the zinc-binding subdomain, there are four highly conserved
cysteine residues, which have been implicated to be responsible for coordination of the
Zn2+ ion (Bernstein, Zittel et al. 2003; Janscak, Garcia et al. 2003; Guo, Rigolet et al.
2005). Among the four cysteine residues, mutation of either C1036, C1055, or C1066
have been identified to be causative of Bloom’s syndrome. BLM-47-3 allele inserted a
thymidine at nucleotide 3028 (residue 1009) of BLM causing a frame shift and a
premature stop codon at nucleotide 3064 (residue 1015). Truncation of the BLM protein
at residue 1015 results in the loss of all three cysteine’s (C1036, C1055 and C1066)
causes the loss-of-function phenotype. We have previously demonstrated (in Chapter 3)
that a yeast strain expressing chimeric Sgs1-BLM with C1036, C1055F or C1066F
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mutations are as sensitive to HU as a yeast strain expressing Sgs1-BLM.HD (Mirzaei
and Schmidt 2012).
Structural analyses of the HRDC domain of RecQ-like helicase have predicted
the BLM HRDC domain to be between residues 1200 and 1315 (Wu, Chan et al. 2005;
Kitano, Yoshihara et al. 2007; Kim and Choi 2010). The BLM-48-15 allele has a frame
shift due to deletion of a cytosine at nucleotide 3918 (residue 1306). This deletion
disrupts the HRDC domain by altering the primary sequence of the protein after residue
1306, leading to a premature stop codon at nucleotide 4212 (residue 1404). Evaluation
of this change in our chimeric system demonstrates a partial loss-of-function phenotype.
This finding was unexpected since in this mutant the domains of the helicase core are
not affected. Moreover, studies in yeast Sgs1 from our laboratory and others have
previously shown that the HRDC domain of Sgs1 is dispensable when cells are
evaluated for GCR and sensitivity to HU (Mullen, Kaliraman et al. 2000; Mirzaei, Syed et
al. 2011). Moreover, in vitro studies of BLM have indicated the HRDC domain is not
required for DNA unwinding (Gyimesi, Harami et al. 2012). However, the HRDC domain
of BLM has been demonstrated to have an important role in dissolution of the double
Holliday junctions (Wu, Chan et al. 2005; Kim and Choi 2010). The HRDC domain is
widely assumed to assist BLM with binding to DNA, allowing for a more stable
association between the helicase domain and the DNA (Kim and Choi 2010). The HRDC
domain of Sgs1 has been suggested to regulate helicase function through additional
contact with DNA (Liu, Macias et al. 1999). Furthermore, three dimensional structure
analysis of BLM by NMR reveals that, similar to Sgs1 and RecQ of E.coli, the BLM
HRDC domain preferentially binds single stranded DNA (Bernstein and Keck 2005;
Kitano, Yoshihara et al. 2007).
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Although it has been shown that in Sgs1 the HRDC domain is dispensable when
evaluating yeast cells for sensitivity to HU (Mullen, Kaliraman et al. 2000; Mirzaei, Syed
et al. 2011), we only observe a partial defect when evaluating yeast cells expressing
Sgs1-BLM-48-15 for sensitivity to HU. One explanation for the phenotype observed in
our chimeric system may be that BLM has evolved in a way that its function more so
than Sgs1’s function depends on the interaction of the HRDC domain with DNA. Thus,
deletion of the HRDC domain in BLM, but not Sgs1, would result in a partial
loss-of-function phenotype when exposed to HU. Alternatively, the loss-of-function in
yeast could be not due to the disruption of the HRDC domain but due to the change of
the primary sequence downstream of this domain affecting a region not yet associated
with proper BLM function.
Previously, we identified G1120E as the most C-terminal single amino acid
mutation to date to have an impact on BLM function (Mirzaei and Schmidt 2012).
Residue 1120 resides in the winged helix subdomain of the RQC domain. Identification
of allele BLM-48-15 with a frame shift at nucleotide 3918 (residue 1306) leading to a
premature stop codon at nucleotide 4212 (residue 1404) suggests that there may be
other regions even more C-terminal to that have an important role in suppressing
sensitivity to DNA damaging agents.
This study has demonstrated that the random mutagenesis system in yeast can
be utilized to identify important regions within BLM, and evaluation of the remaining 42
candidates might lead to the identification of additional novel mutations that impair BLM
function. Moreover, the novel allele, BLM-48-15, will be further evaluated in a BLM
deficient human cell line for its ability to complement various cellular defects of Bloom’s
syndrome cells.
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Figures and Tables
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Figure 6.1 pKHS404 plasmid map
Utilizing recombinant cloning, BLM cDNA was integrated downstream of the GAL1
promoter in the plasmid pYES3 (Invitrogen), yielding plasmid pKHS404. Illustrated here
are the relative locations of restriction sites and primers used in the cloning procedure.
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Figure 6.2 Patch assay for the analysis of accumulation of GCRs
The previously described GCR assay (Schmidt, Pennaneach et al. 2006) was modified
for the purposes of this screen. (A) Yeast transformants harboring mutagenized
pKHS404 plasmids were positively selected for by plating on SC-TRP agar plates. (B)
To induce BLM expression from the GAL1 promoter, colonies were picked at random
from the transformation plate and streaked (1 cm long) on a SC/Gal-TRP plate followed
by four days of incubation at 30˚C. (C) Each streak was then patched as a 1” by 1”
square (indicated by blue lines) and incubated for four days. This plate is referred to as
the master plate and is used to recover the mutated plasmid of interest. (D) The patched
plates are then replica plated onto a GCR/Gal agar plate to screen for loss of
accumulation of GCRs. Yellow lines indicate the limits of each patch while blue stars
indicate patches with cells harboring inactivated BLM.
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PGAL1.BLM

blm48-15

Figure 6.3 BLM cDNA and relative location of mutations identified in the random
mutagenesis screen to impair BLM function
BLM cDNA in recovered plasmid pKHS404 was subject to sequence analysis in order to
identify the mutation responsible for inactivation of the BLM protein. Illustrated here is a
schematic representation of all the mutations identified in the sequenced samples. All
blue stars represent the relative location of mutations leading to a premature stop codon.
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Figure 6.4 HU sensitivity of yeast cells expressing Sgs1-BLM chimeric constructs
with mutations identified in isolates 47-3 and 48-15
Ten fold dilutions of exponentially growing haploid cells were spotted on YPD media with
and without 100 mM HU. Total loss-of-function was based on a phenotype similar to that
of yeast cells expressing the Sgs1-BLM.HD. A partial loss-of-function phenotype was
assessed based on sensitivity to HU to a degree that was between that of a yeast strain
expressing Sgs1-BLM.HD and that of a yeast strain expressing Sgs1-BLM.
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Table 6.1 Mutations identified by sequencing of the BLM cDNA in the mutagenized
pKHS404 plasmid
Plate	
  #1	
   Isolate	
  #2	
   ID	
  #3	
  
Nucleotide	
  #	
   Mutation	
   Nucleotide	
   Effected	
  
Domain	
  
4	
  
3	
  
4-‐3	
  
1353	
  
insertion	
  
A	
  
helicase	
  
6	
  
1	
  
6-‐1	
  
563	
  
deletion	
  
A	
  
helicase	
  
7	
  
5	
  
7-‐5	
  
1544	
  
deletion	
  
A	
  
helicase	
  
15	
  
4	
  
15-‐4	
  
3400	
  
Insertion	
  	
  
A	
  
HRDC	
  
19	
  
5	
  
19-‐5	
  
1544	
  
deletion	
  
A	
  
helicase	
  
20	
  
5	
  
20-‐5	
  
1523	
  
insertion	
  
A	
  
helicase	
  
21	
  
2	
  
21-‐2	
  
1526	
  
insertion	
  
A	
  
helicase	
  
23	
  
5	
  
23-‐5	
  
2610	
  
insertion	
  
A	
  
helicase	
  
27	
  
2	
  
27-‐2	
  
1251	
  
insertion	
  
A	
  
helicase	
  
28	
  
4	
  
28-‐4	
  
1523	
  
Insertion	
  	
  
A	
  
helicase	
  
30	
  
1	
  
30-‐1	
  
2269	
  
insertion	
  
A	
  
helicase	
  
31	
  
3	
  
31-‐3	
  
2269	
  
insertion	
  
A	
  
helicase	
  
38	
  
4	
  
38-‐4	
  
2360	
  
deletion	
  
A	
  
helicase	
  
41	
  
6	
  
41-‐6	
  
1545	
  
insertion	
  
A	
  
helicase	
  
41	
  
16	
  
41-‐16	
  
1462	
  
insertion	
  
T	
  
helicase	
  
43	
  
19	
  
43-‐19	
  
2269	
  
insertion	
  
	
  
helicase	
  
44	
  
4	
  
44-‐4	
  
No	
  BLM	
  Mutations	
  
45	
  
3	
  
45-‐3	
  
1544	
  
deletion	
  
A	
  
helicase	
  
45	
  
9	
  
45-‐9	
  
1544	
  
deletion	
  
A	
  
helicase	
  
46	
  
6	
  
46-‐6	
  
1337	
  
insertion	
  
A	
  
helicase	
  
46	
  
9	
  
46-‐9	
  
1544	
  
deletion	
  
A	
  
helicase	
  
46	
  
12	
  
46-‐12	
  
1544	
  
deletion	
  
A	
  
helicase	
  
46	
  
13	
  
46-‐13	
  
2916	
  
insertion	
  
G	
  
helicase	
  
46	
  
14	
  
46-‐14	
  
1544	
  
deletion	
  
A	
  
helicase	
  
46	
  
17	
  
46-‐17	
  
1544	
  
deletion	
  
A	
  
helicase	
  
46	
  
19	
  
46-‐19	
  
563	
  
insertion	
  
A	
  
helicase	
  
47	
  
3	
  
47-‐3	
  
3064	
  
insertion	
  
T	
  
RQC	
  
47	
  
6	
  
47-‐6	
  
1544	
  
deletion	
  
A	
  
helicase	
  
47	
  
17	
  
47-‐17	
  
1544	
  
deletion	
  
A	
  
helicase	
  
47	
  
18	
  
47-‐18	
  
1544	
  
deletion	
  
A	
  
helicase	
  
48	
  
15	
  
48-‐15	
  
3918	
  
deletion	
  
C	
  
HRDC	
  
49	
  
11	
  
49-‐11	
  
No	
  BLM	
  Mutations	
  
50	
  
5	
  
50-‐5	
  
1544	
  
deletion	
  
A	
  
helicase	
  
52	
  
18	
  
52-‐18	
  
No	
  BLM	
  Mutations	
  
52	
  
20	
  
52-‐20	
  
1544	
  
deletion	
  
A	
  
helicase	
  
53	
  
8	
  
53-‐8	
  
2629	
  
insertion	
  
T	
  
helicase	
  
53	
  
11	
  
53-‐11	
  
2886	
  
insertion	
  
T	
  
helicase	
  
53	
  
18	
  
53-‐18	
  
1392	
  
insertion	
  
T	
  
helicase	
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Table 6.1 continued
54	
  
10	
  
55	
  
11	
  
56	
  
19	
  
57	
  
2	
  
57	
  
7	
  
57	
  
13	
  
57	
  
14	
  
57	
  
20	
  
58	
  
18	
  
60	
  
7	
  
61	
  
4	
  
61	
  
5	
  
63	
  
2	
  
63	
  
3	
  
72	
  
3	
  
73	
  
14	
  
78	
  
12	
  
79	
  
9	
  
82	
  
5	
  

54-‐10	
  
55-‐11	
  
56-‐19	
  
57-‐2	
  
57-‐7	
  
57-‐13	
  
57-‐14	
  
57-‐20	
  
58-‐18	
  
60-‐7	
  
61-‐4	
  
61-‐5	
  
63-‐2	
  
63-‐3	
  
72-‐3	
  
73-‐14	
  
78-‐12	
  
79-‐9	
  
82-‐5	
  

3163	
  
1544	
  
1544	
  
2269	
  
874	
  
1070	
  
2269	
  
2609	
  
1544	
  
1544	
  
1544	
  
1544	
  
1544	
  
563	
  

deletion	
  
T	
  
deletion	
  
A	
  
deletion	
  
A	
  
insertion	
  
A	
  
insertion	
  
T	
  
insertion	
  
A	
  
insertion	
  
A	
  
deletion	
  
A	
  
deletion	
  
A	
  
deletion	
  
A	
  
deletion	
  
A	
  
deletion	
  
A	
  
deletion	
  
A	
  
insertion	
  
A	
  
No	
  BLM	
  Mutations	
  
No	
  BLM	
  Mutations	
  
No	
  BLM	
  Mutations	
  
deletion	
  
A	
  
insertion	
  
C	
  

1544	
  
3380	
  

1

RQC	
  
helicase	
  
helicase	
  
helicase	
  
helicase	
  
helicase	
  
helicase	
  
helicase	
  
helicase	
  
helicase	
  
helicase	
  
helicase	
  
helicase	
  
helicase	
  

helicase	
  
HRDC	
  

The plate # refers to the master plate from which the mutagenized plasmid was
recovered.
2
The isolate # refers to the patch location on the master plate from which the
mutagenized plasmid was recovered
3
ID # is the given name by which each isolate is identified.
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CHAPTER 7:
FINAL THOUGHTS AND FUTURE DIRECTIONS
Final thoughts
The maintenance of genome stability is a fundamental requirement of every living
organism.

Failure to maintain the integrity of the genome from one generation to

another can lead to chromosome aberrations that may manifest into developmental
abnormalities, cancer progression, and premature aging. Highly conserved DNA repair
mechanisms have evolved to protect the genome from a variety of genotoxic elements
that lead to destabilization of genetic material. Genotoxic stress can manifest as a
byproduct from cellular metabolism as in the generation of reactive oxygen species, or
from environmental factors such as radiation and chemical toxicants. The RecQ-like
family of helicases has proven to be critically involved in genome surveillance and DNA
repair mechanisms.
Since RecQ was discovered in E. coli 30 years ago, the role and function of
RecQ-like helicases at the interface of replication and repair has been extensively
investigated. However much is still unknown regarding the details of the molecular
function of these proteins. A better understanding of the RecQ-like family may provide a
means to develop a therapeutic approach to help individuals affected by syndromes
associated with defects in BLM, WRN, and RecQL4. Further investigation of these
proteins will lead to a better understanding of the mechanisms behind processes that
result in accumulation of mutations, chromosomal instability, tumorigenesis and cancer.
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In this dissertation we sought to further investigate BLM, RecQL1, and RecQL4
by using yeast as a model. We constructed humanized yeast strains and evaluated the
ability of these genes to complement defects observed in sgs1∆ mutants.

Future directions
Functional and mutational characterization of BLM
In our characterization of BLM, we developed a novel chimeric yeast system
(Chapter 2) that allowed us to investigate 41 known BLM variants found in the general
population (Chapter 3). We identified six total loss-of-function BLM alleles that are
currently not associated with BS: P690L, R717T, W803R, Y811C, F857L and G972V.
Furthermore, we identified three alleles (R791C, P868L, G1120R) that partially impaired
BLM function. Although modeling of these mutations on the crystal structure of RecQL1
and WRN have provided some insight on the probable cause of the impaired BLM
function, further biochemical analysis will identify the specific defect for each of these
BLM variants. Moreover, the effect that these newly identified alleles have in a human
system is yet to be verified. Finally, as presented in Chapter 3, our studies investigated
variants that mapped to the C-terminal region of BLM, which was used in construction of
the chimeric protein. Consequently, none of the variants of the N-terminal region of BLM
have yet to be evaluated. The following specific aims outline experiments to first
characterize the nine BLM alleles identified in Chapter 3 in addition to evaluation of the
remaining BLM variants in a human system:

Aim 1: Evaluate BLM variants in BLM-/- human cell line for the presence of chromosomal
abnormalities observed in BS cells.
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1.1. Perform mutagenesis and expression of plasmid borne BLM in a human cell
line.
1.2. Determine the levels of sister chromatid exchange in the presence of BLM
variants in a human cell line.
1.3. Determine the presence and frequency of chromosomal gaps, breaks, and
formation of quadriradial structures in BLM variants in a human cell line.
Aim 2: Perform biochemical analysis of the BLM variants
2.1. Construct a eukaryotic expression vector for purification of BLM variants.
2.2. Perform site-directed mutagenesis and protein purification of BLM variants.
2.3. Assess ATP hydrolysis activity of BLM variants.
2.4. Assess the DNA binding of BLM variants
2.5. Assess the helicase activity of BLM variants

In Chapter 6 we sought to identify other regions of importance for BLM function. We
described a BLM random mutagenesis screen that led to the discovery of a BLM48-15
allele. We further suggested that identification of this allele demonstrates that the BLM
HRDC domain has an important role in its function. As explained in Chapter 6, only 58
out of the 100 candidates have been analyzed, thus the remaining 42 candidates should
be sequenced. If sequencing analysis indicates a novel mutation affecting a region of
BLM other than the helicase core, those alleles should be evaluated in a human system
as outlined in Aims above.

Novel protein-protein interaction for RecQL1 and RecQL4
In this dissertation we described multiple yeast 2-hybrid screens in search for a
novel protein-protein interaction for RecQL1 and RecQL4 (Chapter 4). From these
screens, we have identified C10ORF137 and TRAF3IP1 to putatively interact with
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RecQL1 and DNAJC7, MNAT1, and GLUL1 to putatively interact with RecQL4. The
following aims outline the future directions of this project:
Aim 1: Evaluation of legitimacy of these interaction in a human cell culture.
1.1. Co-immunoprecipitation of endogenous proteins
1.2. Determine the interaction domain on each protein by strategic placement of stop
codons using site-directed mutagenesis and evaluation in a yeast system
In the event that Aim 1.1 is not possible the following alternatives will be preformed
1.3. Co-immunoprecipitation of tagged protein
1.4. Determine the protein-protein interactions by Mass spectrometry
Mass spectrometry will also allow for identification of the interacting region of
each protein. However, it is limited to the availability of a database.
Aim 2: Determine the role of RecQL1 and RecQL4 in the pathway associated with the
identified interacting partner.
Assuming all identified putative interacting partners are true interactors for RecQL1 and
RecQL4, this aim will provide five independent projects in which each candidate is
characterized to elucidate the role of the RecQ-homolog in the corresponding pathway.

Genetic interaction between BLM and RECQL4, RECQL5, or both
In Chapter 5, functional characterization of RecQL1, BLM, RecQL4, and RecQL5
in yeast suggested genetic interaction between BLM and RecQL4 and RecQL5 in diploid
cells. Recently it has been shown that BLM and RecQL4 physically interact and that
RecQL4 stimulates the helicase activity of BLM (Singh, Popuri et al. 2012). However, a
comparable interaction has not been identified between RecQL5 and BLM. The following
experiments will elucidate possible interactions between BLM and RecQL5.
First, Co-immunoprecipitation of endogenous proteins from human cell line will
confirm physical interaction between the two helicases. Second, if physical interaction is
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not present, genetic interaction can be extrapolated by a co-localization assay of tagged
BLM and RecQL5 in a human cell line. Last, In the event of discovery of a physical
interaction between BLM and RecQL5 the interaction domains can be mapped in a yeast
system using truncation studies.
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CHAPTER 8:
MATERIAL AND METHODS
Yeast strains
All haploid strains used in this study are derived from KHSY802 (MATa, ura3-52,
trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1, ade8, hxt13::URA3), or
KHSY2583 (MATα, ura3-52, trp1∆63, his3∆200, leu2∆1, lys2Bgl, hom3-10, ade2∆1,
ade8, hxt13::URA3) background. Similarly all diploid strains in this study are derived
from

KHSY2599

his3Δ200/his3Δ200,

(ura3-52/ura3-52,
lys2ΔBgl/lys2ΔBgl,

leu2Δ1/leu2Δ1,

trp1Δ63/trp1Δ63,

hom3-10/hom3-10,

ade2Δ1/ade2Δ1,

ade8/ade8, YEL069C::URA3/YEL069C::URA3) background.

Media
Media used in this study includes: YPD (yeast extract10g/L, peptone 20g/L, and 2%
glucose), YPD-G418 (YPD with 200 mg/L of active G418), SD-LEU, SD-HIS or SD-TRP
(appropriate synthetic dropout mix 2 g/L, yeast nitrogenous base without amino acid
7.6 g/L, and peptone 20 g/L), and LB (yeast extract 5g/L, Trypton 10g/L, and NaCl
5 g/L). For all experiments involving galactose inducible GAL1 promoter, 2% glucose in
media is substituted with 2%galactose or 1% sucrose and 1% galactose.
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Colony PCR
Colony PCR is performed to expedite the process of screening a large number of E.coli
transformants for those that contain plasmids with the insert of interest. Transformants
are streaked on fresh LB agar plates, supplemented with the antibiotic selecting for the
presence of the plasmid, and incubated over night at 37°C. After incubation a small
scoop from each isolate is inoculated in 100µl of dH2O and boiled at 100°C for 10
minutes. Next samples are centrifuged for 2 min at 14000 rpm and 2µl from the cleared
supernatant is used as template for a standard PCR reaction instead of purified DNA.

Homologous-recombination-mediated yeast transformation
(LiAc method)
In all yeast transformations desired gene insertions or deletions are introduced in the
parental strain employing homology-mediated integration of PCR products by the LiAc
method as previously described by Gietz (Gietz and Woods 2006). Briefly, the insert of
interest is amplified by PCR with 70-nucleotide primers that provide 20 nucleotides of
homology to the template and 50 nucleotides homology to the chromosomal locus of
insertion or plasmid locus of interest in the case of gap repair mediated transformation.
In preparation for transformation, the yeast strain of choice is streaked out from the
yeast strain collection on a fresh YPD agar plate and incubated at 30°C for 48 hours.
Next, a 2-ml liquid YPD culture from a single colony of the parental strain is prepared.
After incubation at 30°C with vigorous shaking overnight, the culture is diluted to an
OD600=0.2 in desired amount of fresh YPD (or appropriate selective media incase of
strains harboring plasmid) and incubated in an orbital shaker at 30°C until
OD600=0.8 ± 0.04 is reached. Next, the cells are collected by centrifugation at 2000 rpm
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and washed first with dH2O and then with 100mM LiAc and aliquoted into 1.5 ml tubes.
Next 50% PEG, 1M LiAc and DNA/dH2O mixture are added to each aliquot and boiled
salmon sperm DNA (10 mg/ml) is added as carrier DNA to each sample. Samples are
incubated at 30°C for 30 minutes, heat shocked at 42°C for 15 minutes, and plated on
media selecting for the presence of the insert followed by two hours of incubation at
30°C.

Recombination mediated plasmid cloning in yeast
The gene or cDNA of interest is amplified from genomic DNA by PCR using primers that
contained 20 nucleotides homologous to the template and a tail of 50 nucleotides
homologous to the plasmid. Plasmid of interest is linearized using two restriction
enzymes to avoid relegation. To increase efficiency a blunt end cutter is combined with a
3’ or 5’ overhang cutter. Furthermore a NHEJ-deficient strain is utilized for recombination
cloning to eliminate the possibility of the plasmid re-circularizing via the NHEJ pathway.
Recombinant cloning is carried out using 100 ng of linearized plasmid and 50 µl of PCR
product. Standard LiAc-mediated transformation (Schiestl and Gietz 1989) is used and
transformants are selected for on appropriate selective media, thus allowing selection for
yeast cells containing circularized plasmids repaired by HR containing the PCR insert.

Determination of the mating type of haploid yeast cells
To determine mating type of haploid strain or to identify diploid strains, mating type
tester strains are used. These strains have the following genotype: KHSY1345 (MATa,
∆thr4) and 1346 (MATα, ∆thr4). To conduct this test, a single colony from each of the
tester strains are inoculated in a 50µl of dH2O and plated on separate YPD plates
pre-warmed at 30°C. Next, the strain of interest is spotted on each of the plates to allow
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mating and incubated overnight at 30°C. Following incubation the YPD plates are replica
plated on synthetic minimal media and incubated overnight at 30°C. Since the tester
strains are deficient in th4 they can’t grow on minimal plates. Similarly since all strains
derived from KHSY802 or KHSY2583 are deficient in lys2Bgl, hom3-10, ade2∆1, and
ade8, they can’t grow on minimal plates either. Consequently, by analyzing the minimal
plates we can conclude that the strain of interest is mating type MATα if it grew on plates
containing KHSY1345 while it is mating type MATa if it grew on plates containing
KHSY1346. Additionally if the strain of interest is a diploid it won’t be able to mate with
either of the mating type tester strains and consequently cannot grow on either minimal
plates.

Construction of diploid yeast strain
To construct a diploid strain, two desired haploid strains with opposite mating types are
selected, and a single colony (or small scoop of cells) from each strain are mixed in 50 µl
of dH2O and 10 µl of the cell mixture is then spotted on fresh YPD plate followed by
overnight incubation at 30°C. The spot is then streaked out for single colonies on a fresh
YPD plate and incubated for two days at 30°C. Single colonies are genotyped by
spotting on selective media and their diploidy is verified by their inability to mate with the
tester yeast strains KHSY1345 and KHSY1346 (Appendix A).

Sporulation of heterozygous diploids
Diploid yeast strains heterozygous for the desired mutant (or human cDNA alleles)
grown overnight at 30°C in YPD medium are washed and transferred to 0.1% KAc and
incubated for five days at 30°C in an orbital shaker. To harvest spores, asci are
incubated in the presence of zymolase (500 µg/ml in 1M sorbitol) for 20 minutes at 30°C
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and enriched for haploid spores as previously described by Rockmill (Rockmill, Lambie
et al. 1991). Next spores are plated on YPD agar plates followed by incubation at 30°C
for two days and genotyped by spotting on selective media and their diploidy is verified
by their inability to mate with the tester yeast strains KHSY1345 and KHSY1346.

Determination of the doubling time of yeast strains
For this assay, Overnight cultures of three independent isolates for each construct are
diluted in 5 ml of YPD to an optical density of OD600= 0.2. Next, OD600 is measured for
each culture in 60-min or 120-min intervals for 6 to 8 hours. Subsequently average
doubling times of two or three independent strains for each genotype are compared in
minutes.

FACS analysis
For FACS analysis, cells are grown overnight at 30°C in liquid YPD medium. Cultures
will then be diluted in YPD to an OD600 of 0.2, and incubation is continued until cultures
reach an OD600 of 0.6 to 0.8. Cells are then fixed in 70% ethanol for 1 hour at room
temperature and are sonicated in 50 mM sodium citrate (pH 7). The cells are
subsequently washed once in 50mM sodium citrate (pH 7), and RNase A is added to a
final concentration of 250 µg/ml. After overnight incubation at 37°C, the cells are washed
twice in 50mM sodium citrate. To stain the DNA, Sytox green (Molecular Probes) is
added to a final concentration of 1 µM and the cells are incubated in the dark at room
temperature for 1 hour immediately prior to fluorescence-activated cell sorting (FACS)
on a BD LSR II analyzer. The distribution of cells throughout the cell cycle phases is
quantified with the FlowJo v8.3.3 software program. The mean is obtained from
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measurements of at least three cultures and standard deviations are recorded for every
strain.

Protein extraction by the trichloroacetic (TCA) method and
detection by Western blot analysis
Cells are grown to OD600=0.5 in YPD or for galactose-inducible protein expression in YP
supplemented with 1% galactose and 1% sucrose. Whole cell extract is prepared from
5 ml of culture by standard trichloroacetic (TCA) extraction as previously described
(Foiani 1999).

Protein detection by Western blot analysis
To detect protein expression, TCA extracted protein samples are separated on a 10%
polyacrylamide gel at 120 V for 90 minutes in 1x running buffer (250 mM Tris, 1.92M
glycine, 1% SDS). The samples are then transferred to a PVDF (Methanol activated)
membrane at 4oC in 1x transfer buffer (250 mM Tris, 1.92 M glycine, 20% Methanol).
After Transfer the membrane is blocked with 4% Difco skim milk (Becton, Dickinson and
Company) for minimum of 3hrs. Next membrane is incubated with the primary antibody
in 4% skim milk (Or BSA in the case of anti-AD monoclonal antibody, Santa Cruz) for an
1.5 hrs at room temperature on a shaker followed by three washes at 15 min intervals
with 1x wash buffer (1.5M NaCl, 100mM Tris, pH7.6) at room temperature.
Subsequently, membrane is incubated with the secondary antibody (1:5000 ECL
anti-mouse IgG, horseradish peroxidase linked whole antibody (from sheep), GE
Healthcare) in 4% skim milk for 1 hour at 4oC followed by three washes at 15 min
intervals with 1x wash buffer at 4oC. For visualization membrane is incubated with
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Amersham ECL Plus (or prime) Western Blotting Detection Reagent (GE Healthcare) for
2 minutes and developed using Kodak film.

Determination of sensitivity of yeast cells to DNA damaging
agents
For this assay an overnight culture of the desired strain is diluted in YPD to OD600 = 0.2
and grown at 30°C to OD600 = 0.6. Next a series of 10-fold dilutions is prepared from the
liquid yeast culture, and 2 µl are spotted on YPD and on YPD containing different
concentrations of DNA damaging agent. Colony growth is documented after two days,
two days of incubation at 30°C using the Gel-Doc system (UVP). For all experiments
appropriate wild-type and mutant yeast strains are included as controls.

Determination of the rate of accumulating gross chromosomal
rearrangements (GCR)
The laboratory of Dr. Richard Kolodner (UCSD) has developed an assay for the
detection of a broad spectrum of gross chromosomal rearrangements (GCRs) (Schmidt,
Pennaneach et al. 2006). This assay measures the rate of accumulating 5-fluoroorotic
acid

resistant

(5-FOAr),

canavanine

resistant

(Canr)

yeast

colonies

due

to

rearrangements within a nonessential region of chromosome 5. This region contains the
CAN1 and URA3 genes (Figure 7.1). Cells in which both CAN1 and URA3 have been
inactivated can be selected on media containing canavanine and 5-FOA. The rate of
accumulating 5-FOAr Canr cells is determined by fluctuation analysis and the mutation
rate is calculated by the method of the median (Lea and Coulson 1949). After growing
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cultures for 2-3 day’s cells are plated on agar plates25 containing 5- FOA (1g/L) and
canavanine (60mg/L) to select for GCRs and on YPD to determine the viable cell count.

Figure 7.1 Chromosome V modifications for the GCR assay.
The nonessential HXT13 gene on the left arm of chromosome V is replaced with the
URA3 cassette, resulting in a chromosome V with two counter selectable markers,
CAN1 and URA3. The location of the first essential gene, PCM1, is indicated by a black
box (Schmidt, Pennaneach et al. 2006)

Plasmid rescue and sequencing
To rescue plasmid DNA from yeast strains, genomic DNA is isolated from the
desired strain harboring plasmid. Next the plasmid containing genomic DNA is
transformed in to electrocompetent E.coli using a Bio LabTM MicroPulser. E.coli cells
containing plasmid DNA are selected for on LB agar plates supplemented with
appropriate antibiotic. An over night culture of cells containing plasmid is then used for
plasmid DNA isolation and subsequently sequenced. All sequencing services were
outsourced and completed by MWG Operan.

25

Here on referred to a GCR media
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Preparation of electrocompetent E.coli cells
This protocol is adapted from Dower 1998, (Dower, Miller et al. 1988). Briefly, to
prepare cells for electrocompetency , an overnight culture of E.coli strain DH5α is
incubated in 100ml of LB media till mid-exponential growth phase is reached
(OD600 = 0.6), and cold-shock on wet ice for 30-min. Next, cells are pelleted at 4°C and
washed three times with ice-cold %10 sterile glycerol. Afterwards, washed cells are
re-suspended in 400µl of ice-cold GYT buffer (Tung and Chow 1995) (10% Glycerol,
0.125% Yeast Extract, and 0.125% Trypton) and aliquot into 10 tubes of 40ul each. Last,
20µl of %40 sterile glycerol is added to each aliquot and stored at -80°C for future use.

Site-directed mutagenesis
Site-directed mutagenesis of plasmid DNA was carried out as recommended by
the QuikChange kit

(Stratagene). Briefly, a pair of 31-nucleotide long primers is

designed with the desired nucleotide change in the middle of the primer sequence. Next,
a 50 µl PCR reaction if prepared with the following reagents and program:
Reagents

Program

5 µl of 10× reaction buffer

1 cycle at 95°C for 2 min

X µl (5–50 ng) of template

30 cycles of

plasmid

95°C for 30 sec

X µl (125 ng) of forward primer

Primer TM-5°C for 30 sec

X µl (125 ng) of reverse primer

72°C for t min (t = (length

1 µl of dNTP mix (2 mM)

of the plasmid/1000) + 1)

1 µl of Pfu Ultra DNA

One final cycle of 72°C for

polymerase (2.5 U/µl)

10 min

ddH2O to a final volume of 50 µl
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APPENDICES

Appendix A: Strain Table
Strain
Named
KHSY802

Genotype
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3

KHSY1435

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
mec3::G418
thr4-

KHSY1436

thr4-

KHSY1346

KHSY2009
KHSY2043
KHSY2044
KHSY2045
KHSY2046
KHSY2047
KHSY2048
KHSY2049
KHSY2050
KHSY2051
KHSY2052
KHSY2053
KHSY2177
KHSY2178
KHSY2179

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::ura3::TRP1/YEL069C::URA3,
SGS1/sgs1::RECQL1.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::ura3::TRP1/YEL069C::URA3,
SGS1/sgs1::RECQL1.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::ura3::TRP1/YEL069C::URA3,
SGS1/sgs1::RECQL1.HIS3, MEC3/mec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL1.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL1.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL1.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL1.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL1.HIS3, mec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL1.HIS3, mec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL1.HIS3, mec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL1.HIS3, mec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::ura3::TRP1/YEL069C::URA3,
SGS1/sgs1::RECQL4.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::ura3::TRP1/YEL069C::URA3,
SGS1/sgs1::RECQL4.HIS3, MEC3/mec3::G418
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Strain table continued

KHSY2583

ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::ura3::TRP1/YEL069C::URA3,
SGS1/sgs1::RECQL4.HIS3, MEC3/mec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
lig4::loxP-G418-loxP
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3

KHSY2584

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3

KHSY2180
KHSY2331

KHSY2599

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
SGS1/sgs1::loxP-kanMX6
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
SGS1/sgs1::loxP-kanMX6
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
SGS1/sgs1::loxP-kanMX6
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1::RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1::RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1::RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3

KHSY2600

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3

KHSY2601

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3

KHSY2590
KHSY2591
KHSY2592
KHSY2596
KHSY2597
KHSY2598

KHSY2602
KHSY2603
KHSY2604
KHSY2620
KHSY2621
KHSY2622
KHSY2636
KHSY2637

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::ura3::TRP1/YEL069C::ura3::TRP1, sgs1::loxP-kanMX6/sgs1::loxP-kanMX6
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::ura3::TRP1/YEL069C::ura3::TRP1, sgs1::loxP-kanMX6/sgs1::loxP-kanMX6
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8,
YEL069C::ura3::TRP1/YEL069C::ura3::TRP1, sgs1::loxP-kanMX6/sgs1::loxP-kanMX6
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::RECQL1.HIS3/sgs1::loxP-kanMX6
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::RECQL1.HIS3/sgs1::loxP-kanMX6
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::RECQL1.HIS3/sgs1::loxP-kanMX6
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
SGS1/sgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
SGS1/sgs1::RECQL4.HIS3
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Strain table continued
KHSY2638
KHSY2639
KHSY2640
KHSY2641
KHSY2642
KHSY2643
KHSY2644
KHSY2645
KHSY2646
KHSY2647

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
SGS1/sgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::RECQL1.HIS3/sgs1::loxP-kanMX6
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::RECQL1.HIS3/sgs1::loxP-kanMX6
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::RECQL1.HIS3/sgs1::loxP-kanMX6
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::RECQL1.HIS3/sgs1::RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::RECQL1.HIS3/sgs1::RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::RECQL1.HIS3/sgs1::RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::RECQL1.HIS3/sgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::RECQL1.HIS3/sgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::RECQL1.HIS3/sgs1::RECQL4.HIS3

KHSY2674
KHSY2675
KHSY2676
KHSY2677
KHSY2678
KHSY2679
KHSY2723
KHSY2724
KHSY2725
KHSY2726
KHSY2727
KHSY2728

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::URA3,
Δsgs1::RECQL4.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::URA3,
sgs1::RECQL4.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::URA3,
sgs1::RECQL4.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::URA3,
sgs1::RECQL4.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, YEL069C::URA3,
sgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/SGS1.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/SGS1.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/SGS1.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1C200.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1C200.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1C200.myc.HIS3
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Strain table continued
KHSY2732
KHSY2733
KHSY2734
KHSY2735
KHSY2736
KHSY2791
KHSY2792
KHSY2793
KHSY2794
KHSY2795
KHSY2796
KHSY2797
KHSY2798
KHSY2799
KHSY2826
KHSY2827
KHSY2828
KHSY2829
KHSY2830
KHSY2831
KHSY2832
KHSY2833

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::sgs1-hd.myc.HIS3/SGS1
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::sgs1-hd.myc.HIS3/SGS1
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::sgs1-hd.TRP1/SGS1
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::sgs1-hd.TRP1/SGS1
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::sgs1-hd.TRP1/SGS1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::sgs1-hd.myc.HIS
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::sgs1-hd.myc.HIS
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::sgs1-hd.myc.HIS
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::sgs1-hd.myc.HIS
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::sgs1-hd.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::sgs1-hd.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::sgs1-hd.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::sgs1-hd.TRP1
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1C200.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1C200.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1C200.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1C200.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1C200.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1C200.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1::sgs1-hd.TRP1
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1::sgs1-hd.TRP1
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1::sgs1-hd.TRP1
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Strain table continued
KHSY2837
KHSY2838
KHSY2860
KHSY2861
KHSY2867
KHSY2868
KHSY2869
KHSY2880
KHSY2881
KHSY2882
KHSY2883
KHSY2884
KHSY2885
KHSY2886
KHSY2887
KHSY2888
KHSY2889
KHSY2890
KHSY2891
KHSY2892
KHSY2893

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1C300.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1C300.myc.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL1.myc.TRP
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL1.myc.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL4.myc.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL4.myc.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL4.myc.TRP1
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC300
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC300
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC300
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC400
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC400
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC400
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC500
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC500
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC500
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC600
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC600
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC600
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC700
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC700

225

Strain table continued
KHSY2894
KHSY2895
KHSY2896
KHSY2897
KHSY2898
KHSY2899
KHSY2928
KHSY2929
KHSY2930
KHSY2931
KHSY2932
KHSY2933
KHSY2934
KHSY2935
KHSY2936
KHSY2937
KHSY2938
KHSY2939
KHSY2940

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC700
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1C1428.myc.His3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC1428
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC400
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC400
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC400
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC500
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC500
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC500
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC600
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC600
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC600
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC700
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC700
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC700
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC800
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Strain table continued
KHSY2941
KHSY2942
KHSY2943
KHSY2944
KHSY2945
KHSY3130
KHSY3131
KHSY3181
KHSY3182
KHSY3183
KHSY3184
KHSY3185
KHSY3186
KHSY3187
KHSY3188
KHSY3189
KHSY3190
KHSY3191
KHSY3192
KHSY3203
KHSY3204

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC800
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC800
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC1428
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC1428
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC1428
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3,
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ
MATα, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3,
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC1100
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC1100
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC1100
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔN100
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔN100
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔN100
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔN100
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔN100
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔN100
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/N647-SGS1-C-BLM
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/N647-SGS1-C-BLM
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/N647-SGS1-C-BLM
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3
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Strain table continued

KHSY3335

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::PGAL1.TRP.blm-K695R.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::PGAL1.TRP.blm-K695R.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::PGAL1.TRP.blm-K695R.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3::TRP1/YEL069C::URA3,
SGS1/sgs1::blm.K695R.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3::TRP1/YEL069C::URA3,
SGS1/sgs1::blm.K695R.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3::TRP1/YEL069C::URA3,
SGS1/sgs1::blm.K695R.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
YEL069C::ura3::TRP1, sgs1::blm-K695R.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
Pgal.TRP1.SGS1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
Pgal.TRP1.SGS1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
Pgal.TRP1.SGS1
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔN700
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔN700
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
Δsgs1::BLM.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::BLM.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::BLM.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::BLM.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::BLM.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::BLM.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3

KHSY3336

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3

KHSY3337

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3

KHSY3338

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3

KHSY3339

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3

KHSY3205
KHSY3206
KHSY3207
KHSY3208
KHSY3209
KHSY3210
KHSY3211
KHSY3212
KHSY3213
KHSY3214
KHSY3215
KHSY3216
KHSY3217
KHSY3218
KHSY3219
KHSY3220
KHSY3221
KHSY3222
KHSY3329
KHSY3330
KHSY3331
KHSY3332
KHSY3333
KHSY3334
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KHSY3340

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3

KHSY3341

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3

KHSY3342

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3

KHSY3355
KHSY3356
KHSY3357
KHSY3358
KHSY3359
KHSY3360
KHSY3361
KHSY3362
KHSY3363
KHSY3364
KHSY3365
KHSY3366
KHSY3367
KHSY3368
KHSY3369
KHSY3370
KHSY3374
KHSY3375
KHSY3376
KHSY3377
KHSY3429
KHSY3430
KHSY3431

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HIS3, MEC3/Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::ura3::TRP1, BLM.myc.G418.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::ura3::TRP1, BLM.myc.G418.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::ura3::TRP1, BLM.myc.G418.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8.
YEL069C::ura3::TRP1, BLM.myc.G418.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
Pgal.G418.BLM.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
Pgal.G418.BLM.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
Pgal.G418.BLM.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
Pgal.G418.BLM.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC1100
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC1100
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC1100
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KHSY3432

KHSY3433

KHSY3434

KHSY3435

KHSY3436
KHSY3437
KHSY3438
KHSY3439
KHSY3440
KHSY3441
KHSY3442
KHSY3443
KHSY3444
KHSY3445
KHSY3446
KHSY3447
KHSY3448
KHSY3449

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::BLM.HIS3/sgs1::BLM.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::BLM.HIS3/sgs1::BLM.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::BLM.HIS3/sgs1::BLM.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::BLM.HIS3/sgs1::BLM.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC1428.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC1428.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC1428.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC1100.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC1100.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC1000.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC1000.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC1000.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC900.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC900.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC900.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC800.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC800.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC700.myc.HIS3

230

Strain table continued
KHSY3450
KHSY3451
KHSY3452
KHSY3453
KHSY3454
KHSY3455
KHSY3456
KHSY3457
KHSY3458
KHSY3459
KHSY3460
KHSY3461
KHSY3462
KHSY3525
KHSY3526
KHSY3527
KHSY3528
KHSY3529
KHSY3530

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC700.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC700.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC600.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC600.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC500.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC500.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC500.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC400.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC400.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC300.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/sgs1ΔC300.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/SGS1.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
PGAL.G418.BLM.HIS3/SGS1.myc.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800.myc.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800.myc.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/ trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8./ade8. YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800.myc.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC1000
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC1000
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC1000
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KHSY3531
KHSY3532
KHSY3533
KHSY3534
KHSY3535
KHSY3536
KHSY3537
KHSY3538
KHSY3539
KHSY3540
KHSY3541
KHSY3542
KHSY3548
KHSY3549
KHSY3550
KHSY3551
KHSY3552
KHSY3553
KHSY3554
KHSY3566
KHSY3604

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC1000
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC900
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC900
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC900
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::ura3::TRP1,
sgs1::loxP-kanMX6/sgs1ΔC900
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::loxP-kanMX6/sgs1ΔC1000
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::loxP-kanMX6/sgs1ΔC1000
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::loxP-kanMX6/sgs1ΔC1000
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::loxP-kanMX6/sgs1ΔC900
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::loxP-kanMX6/sgs1ΔC900
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::loxP-kanMX6/sgs1ΔC900
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1::loxP-kanMX6/sgs1ΔC900
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1C800.myc.His3, mec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1C800.myc.His3, mec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1C800.myc.His3, mec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1C800.myc.His3, mec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
lig4::loxP-G418-loxP
pBDC-RECQL4
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8, yKu70::HIS3
pYES3-BLM
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
lig4::loxP-G418-loxP
pBDC-RECQL1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::blm.HD.HIS3
trp1-901 leu2-3,112 ura3-52 his3-200 gal4(deleted) gal80(deleted) LYS2::GAL1-HIS3
GAL2-ADE2 met2::GAL7-lacZ
pBDC.RECQL1
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KHSY3605
KHSY3606
KHSY3607
KHSY3608
KHSY3609
KHSY3610
KHSY3611
KHSY3686
KHSY3687
KHSY3688
KHSY3689
KHSY3690
KHSY3691
KHSY3692
KHSY3693
KHSY3694
KHSY3695
KHSY3696
KHSY3697
KHSY3698
KHSY3699
KHSY3700
KHSY3701

trp1-901 leu2-3,112 ura3-52 his3-200 gal4(deleted) gal80(deleted) LYS2::GAL1-HIS3
GAL2-ADE2 met2::GAL7-lacZ
pBDC.RECQL1
trp1-901 leu2-3,112 ura3-52 his3-200 gal4(deleted) gal80(deleted) LYS2::GAL1-HIS3
GAL2-ADE2 met2::GAL7-lacZ
pBDC.RECQL1
trp1-901 leu2-3,112 ura3-52 his3-200 gal4(deleted) gal80(deleted) LYS2::GAL1-HIS3
GAL2-ADE2 met2::GAL7-lacZ
pBDC.RECQL4
trp1-901 leu2-3,112 ura3-52 his3-200 gal4(deleted) gal80(deleted) LYS2::GAL1-HIS3
GAL2-ADE2 met2::GAL7-lacZ
pBDC.RECQL4
trp1-901 leu2-3,112 ura3-52 his3-200 gal4(deleted) gal80(deleted) LYS2::GAL1-HIS3
GAL2-ADE2 met2::GAL7-lacZ
pBDC.RECQL4
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HD.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HD.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL1.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL4.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL4.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-RECQL1.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-RECQL1.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-RECQL1.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-RECQL4.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-RECQL4.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-RECQL4.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-RECQL4.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-RECQL4.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-RECQL4.HIS3, MEC3/Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::G418.PGAL.blm.HD.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::G418.PGAL.blm.HD.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::G418.PGAL.blm.HD.HIS3
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KHSY3702
KHSY3703
KHSY3704
KHSY3705
KHSY3706
KHSY3707
KHSY3708
KHSY3709
KHSY3710
KHSY3711
KHSY3712
KHSY3713
KHSY3714
KHSY3715
KHSY3723
KHSY3724
KHSY3725
KHSY3726
KHSY3727
KHSY3728
KHSY3729
KHSY3730
KHSY3731
KHSY3732
KHSY3733

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::G418.PGAL.blm.HD.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL1.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL1.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL1.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL1.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL4.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL4.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL4.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL4.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL4.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL4.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL4.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-RECQL4.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8,
pYES3-BLM
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/lys2ΔBgl,
hom3-10/hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, MEC3/mec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::TRP1.PGAL1.RECQL1.myc.G418.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::G418.Pgal.BLM.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::G418.Pgal.BLM.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::G418.Pgal.BLM.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3
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KHSY3734
KHSY3735
KHSY3736
KHSY3737
KHSY3738
KHSY3739
KHSY3740
KHSY3741
KHSY3742
KHSY3743
KHSY3744
KHSY3745
KHSY3746
KHSY3747
KHSY3748
KHSY3749
KHSY3750
KHSY3751
KHSY3752

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::G418.Pgal.BLM.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::G418.Pgal.BLM.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::G418.Pgal.BLM.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::BLM.HIS3/Δsgs1::RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::BLM.HIS3/Δsgs1::RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::BLM.HIS3/Δsgs1::RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::BLM.HIS3/Δsgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::BLM.HIS3/Δsgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::BLM.HIS3/Δsgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::RECQL1.HIS3/Δsgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::RECQL1.HIS3/Δsgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::RECQL1.HIS3/Δsgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::BLM.HIS3/Δsgs1::RECQL5.HIS3
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Strain table continued
KHSY3753
KHSY3754
KHSY3755
KHSY3756
KHSY3757
KHSY3758
KHSY3759
KHSY3760
KHSY3761
KHSY3762
KHSY3763
KHSY3764
KHSY3765
KHSY3766
KHSY3767
KHSY3768
KHSY3769
KHSY3770
KHSY3771
KHSY3772
KHSY3773
KHSY3774
KHSY3775
KHSY3776
KHSY3777

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::BLM.HIS3/Δsgs1::RECQL5.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::BLM.HIS3/Δsgs1::RECQL5.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::RECQL1.HIS3/Δsgs1::RECQL5.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::RECQL1.HIS3/Δsgs1::RECQL5.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::RECQL4.HIS3/Δsgs1::RECQL5.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::RECQL4.HIS3/Δsgs1::RECQL5.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::RECQL4.HIS3/Δsgs1::RECQL5.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/Δsgs1::RECQL5.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/Δsgs1::RECQL5.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/Δsgs1::RECQL5.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HD.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HD.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HD.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HD.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::TRP1.PGAL1.RECQL4.myc.G418.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::G418.PGAL1.RECQL4.myc.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL5.HIS
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Strain table continued
KHSY3778
KHSY3779
KHSY3780
KHSY3781
KHSY3788
KHSY3789
KHSY3790
KHSY3808
KHSY3809
KHSY3810
KHSY3811
KHSY3812
KHSY3813
KHSY3814
KHSY3815
KHSY3816
KHSY3817
KHSY3818
KHSY3819
KHSY3820
KHSY3821
KHSY3822

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL5.HIS
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL5.HIS
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL5.HIS
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::RECQL5.HIS
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::RECQL4.HIS3/Δsgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::RECQL4.HIS3/Δsgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::RECQL4.HIS3/Δsgs1::RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL4.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL4.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1C1428.myc.His3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1C1428.myc.His3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1C1428.myc.His3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(D1064V)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(D1064V)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(D1064V)ΔN647.HIS3, MEC3/Δmec3::G418
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Strain table continued
KHSY3823
KHSY3824
KHSY3825
KHSY3826
KHSY3827
KHSY3828
KHSY3829
KHSY3888
KHSY3889
KHSY3890
KHSY3891
KHSY3892
KHSY3893
KHSY3894
KHSY3895
KHSY3896
KHSY3897
KHSY3898
KHSY3899
KHSY3900
KHSY3901
KHSY3902

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(D1064V)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(C1055S)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(C1055S)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(C1055S)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::TRP1.PGAL1.RECQL5.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::TRP1.PGAL1.RECQL5.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1::TRP1.PGAL1.RECQL5.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1C1428.myc.His3/sgs1C1428.myc.His3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1C1428.myc.His3/sgs1C1428.myc.His3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1C1428.myc.His3/sgs1C1428.myc.His3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL5.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL5.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL1.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL4.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL4.HIS3/Δsgs1::TRP1.PGAL1.RECQL1.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(D1064V)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(D1064V)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(D1064V)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(D1064V)ΔN647.HIS3, Δmec3::G418
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Strain table continued
KHSY3903
KHSY3904
KHSY3905
KHSY3906
KHSY3907
KHSY3908
KHSY3909
KHSY3910
KHSY3911
KHSY3912
KHSY3913
KHSY3914
KHSY3915
KHSY3916
KHSY3953
KHSY3954
KHSY3955
KHSY3956
KHSY3957
KHSY3958
KHSY3959
KHSY3960
KHSY3961

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1055S)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1055S)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1055S)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1055S)ΔN647.HIS3, Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::G418.Pgal.BLM.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::G418.Pgal.BLM.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::TRP1.PGAL1.RECQL4.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::G418.Pgal.BLM.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::G418.Pgal.BLM.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
Δsgs1::TRP1.PGAL1.RECQL5.HIS3/Δsgs1::G418.Pgal.BLM.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(C1036F)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(C1036F)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(C1036F)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418

239

Strain table continued
KHSY3962
KHSY3963
KHSY3964
KHSY3965
KHSY3966
KHSY3967
KHSY3968
KHSY3969
KHSY3970
KHSY3971
KHSY3972
KHSY3973
KHSY3974
KHSY3975
KHSY3976
KHSY3977
KHSY3978
KHSY3979
KHSY3980
KHSY3981
KHSY3982
KHSY3989

KHSY3990

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3, Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(R717T)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(Q752H)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(P868L)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(P868L)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(R791C)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(R791C)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R717T)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R717T)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R717T)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R717T)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G752H)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G752H)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G752H)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G752H)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3, Δmec3::G418
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3,
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ
pBDC
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3,
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ
pBDC
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Strain table continued
KHSY3991

KHSY3992

KHSY3993
KHSY3994
KHSY3995
KHSY4063
KHSY4064
KHSY4065
KHSY4066
KHSY4067
KHSY4068
KHSY4069
KHSY4070
KHSY4071
KHSY4072
KHSY4073
KHSY4074
KHSY4075
KHSY4076
KHSY4077
KHSY4078
KHSY4079
KHSY4080
KHSY4081
KHSY4082
KHSY4083
KHSY4084

MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3,
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ
pBDC
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3,
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ
pBDC
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(R791C)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(R791C)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(R791C)ΔN647.HIS3, MEC3/Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G972V)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G972V)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G972V)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G972V)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G972V)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Y811C)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Y811C)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Y811C)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Y811C)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(H1014R)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(A1043D)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(E1143K)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(V1198M)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(V1198M)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(E1213K)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(E1213K)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(H1324T)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(H1324T)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(H1324T)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(XL-47-3)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(XL-47-3)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(XL-48-15)ΔN647.HIS3
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Strain table continued
KHSY4085
KHSY4086
KHSY4087
KHSY4088
KHSY4089
KHSY4090
KHSY4091
KHSY4092
KHSY4093
KHSY4094
KHSY4095
KHSY4096
KHSY4097
KHSY4098
KHSY4099
KHSY4100
KHSY4101
KHSY4102
KHSY4103
KHSY4104
KHSY4105
KHSY4106
KHSY4127
KHSY4128
KHSY4129
KHSY4130
KHSY4131

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(I658T)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(I658T)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P690L)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P690L)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R717T)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R717T)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R717T)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R791C)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R791C)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R791C)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(W803R)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(W803R)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Y811C)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Y811C)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(F857L)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(K755E)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G972V)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G972V)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(S778C)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(S778C)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Y995H)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Y995H)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, EXO1/Δexo1::loxP-G418-loxP
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, EXO1/Δexo1::loxP-G418-loxP
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(W803R)ΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP
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Strain table continued
KHSY4132
KHSY4133
KHSY4134
KHSY4135
KHSY4136
KHSY4137
KHSY4138
KHSY4139
KHSY4140
KHSY4141
KHSY4142
KHSY4143
KHSY4144
KHSY4147
KHSY4148
KHSY4149
KHSY4150
KHSY4151
KHSY4152
KHSY4153
KHSY4154
KHSY4155
KHSY4233
KHSY4234

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(W803R)ΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(P690L)ΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(P690L)ΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(V1198M)ΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(V1198M)ΔN647.HIS3, EXO1/Δexo1::loxP-G418-loxP
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blmΔN647.HD.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(W803R)ΔN647.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(W803R)ΔN647.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(V1198M)ΔN647.HIS3, MEC3/mec3::G418
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
SGS1/sgs1ΔC800-blm(V1198M)ΔN647.HIS3, MEC3/mec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(K1133E)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(H1324T)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(H1324T)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(H1324T)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(H1324T)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(H1324T)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(H1324T)ΔN647.HIS3, Δmec3::G418
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(H660Y)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P707S)ΔN647.HIS3
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Strain table continued
KHSY4235
KHSY4236
KHSY4237
KHSY4238
KHSY4239
KHSY4240
KHSY4241
KHSY4242
KHSY4243
KHSY4244
KHSY4245
KHSY4246
KHSY4247
KHSY4248
KHSY4249
KHSY4250
KHSY4251
KHSY4252
KHSY4253
KHSY4254
KHSY4255
KHSY4256
KHSY4257
KHSY4258
KHSY4259
KHSY4260
KHSY4261
KHSY4262
KHSY4263
KHSY4264

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P707S)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Q752H)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Q752H)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Q752H)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(T843I)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(T843I)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(K873N)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(K873N)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(K873N)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(K873N)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G1120E)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G1120E)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R1331G)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R1331G)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Q1387K)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(A1043D)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(A1043D)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(K1133E)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(E1143K)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(K755E)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(F857L)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G972V)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(W803R)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R717T)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R791C)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Y811C)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Y811C)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Y811C)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Y811C)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P690L)ΔN647.HIS3.MYC.TRP1
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Strain table continued
KHSY4265
KHSY4266
KHSY4267
KHSY4268
KHSY4269
KHSY4270
KHSY4271
KHSY4272
KHSY4273
KHSY4274
KHSY4275
KHSY4276
KHSY4277
KHSY4278
KHSY4290
KHSY4291
KHSY4292
KHSY4293
KHSY4294
KHSY4295
KHSY4296
KHSY4297
KHSY4298
KHSY4299
KHSY4300
KHSY4301
KHSY4302
KHSY4303
KHSY4304
KHSY4305

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P690L)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P690L)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P690L)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P690L)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(F857L)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(F857L)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(F857L)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G1120E)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G1120E)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G1120E)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G1120E)ΔN647.HIS3.MYC.TRP1
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R717T)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R717T)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Q752H)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(Q752H)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R791C)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(R791C)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P690L)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(P690L)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(D1064V)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(D1064V)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HD.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HD.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3
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Strain table continued
KHSY4306
KHSY4307
KHSY4308
KHSY4309
KHSY4311
KHSY4312
KHSY4313
KHSY4314
KHSY4315
KHSY4316
KHSY4317
KHSY4318
KHSY4319
KHSY4320
KHSY4321
KHSY4322
KHSY4323
KHSY4324
KHSY4325
KHSY4326
KHSY4327
KHSY4328

ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(V1198M)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(W803R)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(W803R)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blmΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blmΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blmΔN647-HD.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blmΔN647-HD.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blmΔN647-HD.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blmΔN647-HD.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3
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Strain table continued
KHSY4329
KHSY4330
KHSY4331
KHSY4332
KHSY4333
KHSY4334
KHSY4335
KHSY4336
KHSY4337
KHSY4338
KHSY4339
KHSY4340
KHSY4341
KHSY4342
KHSY4343
KHSY4344
KHSY4345
KHSY4346
KHSY4347
KHSY4348

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blmΔN647-HD.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(W803R)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(P868L)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3
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KHSY4349
KHSY4350
KHSY4351
KHSY4352
KHSY4353
KHSY4590
KHSY4591
KHSY4592
KHSY4593
KHSY4594
KHSY4595
KHSY4596
KHSY4597
KHSY4598
KHSY4599
KHSY4600
KHSY4601
KHSY4602
KHSY4603
KHSY4604
KHSY4605

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(V1198M)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(V1198M)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(V1198M)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(V1198M)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1055S)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G1120R)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G1120R)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G1120R)ΔN647.HIS3
ura3-52, leu2Δ1, trp1Δ63, his3Δ200, lys2ΔBgl, hom3-10, ade2Δ1, ade8. YEL069C::URA3,
sgs1ΔC800-blm(G1120R)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1055S)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1055S)ΔN647.HIS3/sgs1ΔC800-blm(C1055S)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(C1036F)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(C1036F)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blmΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blmΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(K695R)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(K695R)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(W803R)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3
ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(P868L)ΔN647.HIS3
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KHSYR1-1

ura3-52/ura3-52, leu2Δ1/ leu2Δ1, trp1Δ63/trp1Δ63, his3Δ200/his3Δ200, lys2ΔBgl/ lys2ΔBgl,
hom3-10/ hom3-10, ade2Δ1/ade2Δ1, ade8/ade8, YEL069C::URA3/YEL069C::URA3,
sgs1ΔC800-blm(C1036F)ΔN647.HIS3/sgs1ΔC800-blm(V1198M)ΔN647.HIS3
MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3,
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ, pBDC-RECQL1

KHSYR1-2

MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3,
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ, pBDC-RECQL1

KHSYR1-3

MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3,
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ, pBDC-RECQL1

KHSYR4-1

MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3,
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ, pBDC-RECQL4

KHSYR4-2

MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3,
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ, pBDC-RECQL4

KHSYR4-3

MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, gal4Δ, gal80Δ, lys2::Gal1uas-Gal1tata-HIS3,
GAL2uas-GAL2tata-ADE2, URA3::MEL1uas-MEL1tata-lacZ, pBDC-RECQL4

KHSY4606
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Appendix B: Oligo Table
Oligo #

Oligo Name

Sequence

1029

1029-TRP1-5'Chk

GCCAACCAAGTATTTCGGAGTGCC

1030

1030-TRP1-3'Chk

GGCACTCCGAAATACTTGGTTGGC

1031

1031-HIS3-5'Chk

TCGAGTGCTCTATCGCTAGGGGACC

1032

1032-HIS3-3'Chk

AGTGCGTTCAAGGCTCTTGCGGTTG

1033

1033-G418-5'Chk

TAATCGCGGCCTCGAAACGTGAGTC

1034

1034-G418-3'Chk

1043

1043-SGS1PGAL-F

1044

1044-SGS1PGAL-R

1045

1045-SGS1CONFIRM

AATAGGTTGTATTGATGTTGGACG
CTGATCTAAAAGCTGATATACGGATCAATAGAGGGCAC
TTAGCAGGCTGGGAATTCGAGCTCGTTTAAAC
TCCTTTAACCATTTGTGCTCCCATCTTAAGTTATGTGAC
GGCTTCGTCACCATTTTGAGATCCGGGTTTT
GGTTGATATACCAGCCAGCA

1066

1066-BLM-F

ATGGCTGCTGTTCCTCAAAA

1067

1067-BLM-R

1116

1116-BLM-F

1117

1117-BLM-R

1118

1118-UNIV-F

TTATGAGAATGCATATGAAG
ATTATTGTTGTATATATTTAAAAAATCATACACGTACAC
ACAAGGCGGTAATGGCTGCTGTTCCTCAAAA
TTGGCGAATGGTGTCGTAGTTATAAGTAACACTATTTA
TTTTTCTACTCTTTATGAGAATGCATATGAAG
GAGCAGATTGTACTGAGAGTGCACC

1119

1119-UNIV-R

CTCCTTACGCATCTGTGCGGTATTTC

1143

1143-SGS1-5'chk

CTGGGTGATCATTGGTGATAC

1144

1144-SGS1-3'chk

1187

1187-SGS1-UNIV-D

1189

1189-BLM-confirm

1211

1211-BLM-F-tag

1212

1212-BLM-R-tag

1213

1213 BLM-tag confirm

1224

1224-BLM-Pgal-R

1229

1229-RecQ1-seq

GCACACCACAATATGTCGTG
TTGGCGAATGGTGTCGTAGTTATAAGTAACACTATTTA
TTTTTCTACTCTGAGCAGATTGTACTGAGAGTGCACC
CAAAGTGACTTTGGGGTGGTG
CACCGAAGCCTATAAATAGACCGTTTCTTAAGCCTTCA
TATGCATTCTCACGGATCCCCGGGTTAATTAA
TAATTTCAGATGCTGACAAACAAGAAAGAGGGTCTATG
TACATTGAGATTGAATTCGAGCTCGTTTAAAC
GTGCCGCTGAGGAGCTTGAC
GAGTGACGTTCTAGTTGCTCCTGTAGATTATTTTGAGG
AACAGCAGCCATCATTTTGAGATCCGGGTTTT
TGCAAGTGACAAAGTCCACG

1230

1230-RecQ4-seq

AGGAGAAGTTCTCCAGCAGG

1233

1233-SGS1-int

GAACACCCACCACCATCTTG

1236

1236-UNIV-XhoI-F

CAATCTCGAGGAGCAGATTGTACTGAGAGTGCACC

1237

1237-UNIV-XhoI-R

CAATCTCGAGCTCCTTACGCATCTGTGCGGTATTTC

1240

1240-RECQ5-INT

1245

1245-RECQL1-INT-F

1246

1246-RECQL1-INT-R

1253

1253-RECQL4-KI-F

1254

1254-RECQL4-KI-R

1256

1256-SGS1-Seq1

AGTCCGTGAAGAAGGTAC
TTGGCGATTGGTGTCGTAGTTATAAGTAACACTATTTA
TTTTTCTACTCTATGGCGTCCGTTTCAGCTCT
ATTATTGTTGTATATATTTAAAAAATCATACACGTACAC
ACAAGGCGGTAATGGGAGCAGATTGTACTGAGAGT
TTGGCGATTGGTGTCGTAGTTATAAGTAACACTATTTA
TTTTTCTACTCTATGACCAGGAAGCAACGGGA
ATTATTGTTGTATATATTTAAAAAATCATACACGTACAC
ACAAGGCGGTAATGGGAGCAGATTGTACTGAGAGT
ATGGTGACGAAGCCGTCACA

1257

1257-SGS1-Seq2

GTATAGGCAAACAGCTCGAA
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1258

1258-SGS1-Seq3

ACTGTGACCCTCCTGTAATA

1259

1259-SGS1-Seq4

GTTCCCTCAAATGGCCAAAA

1260

1260-SGS1-Seq5

GAGGAAGACGATTTTGATGA

1261

1261-SGS1-Seq6

GAAGTCTTTAAACTGCCTGG

1262

1262-SGS1-Seq7

CTGCAAGTGAACAAGTCAGA

1263

1263-SGS1-Seq8

GCAGACAATGATCCAGAAGG

1264

1264-SGS1-Seq9

GCTGACTGGAAAAATGGAGA

1265

1265-SGS1-Seq10

GATCAAGCGAGGATCATGAA

1266

1266-SGS1-Seq11

CCGAGGTCACTACAGAGGAA

1267

1267-SGS1-Seq12R

TAACCATTTGTGCTCCCTTC

1268

1268-SGS1-Seq13R

CTTGAAGGCGGATCACCTCT

1269

1269-RECQL4-F1

ATGACCAGGAAGCAACGGGA

1270

1270-RECQL4-F2

CCTGCACGCAGCCTGGGTCC

1271

1271-RECQL4-F3

CCCCAGGACCCAGAAGGGTC

1272

1272-RECQL4-F4

GGCCGTGTGCAGGCCCGGGA

1273

1273-RECQL4-R1

GTGCGGCGTGTGGCTGTGGC

1274

1274-RECQL1-F1

ATGGCGTCCGTTTCAGCTCT

1275

1275-RECQL1-F2

GGAGCATGTTAAATGGGTTC

1276

1276-RECQL1-F3

TGCAGAATCTGGGAATTCAT

1277

1277-RECQL1-F4

GCAGGCAGAGGAACTGAATG

1278

1278-RECQL1-R1

1279

1279-RECQL1-Pgal-R

1280

1280-RECQL4-Pgal-R

1281

1281-RECQL1-tag-F

1282

1282-RECQL4-tag-F

1283

1283-RECQL1/4-tag-R

1300

1300-RECQL1-F5

CCAGTTTAAAGACATTTTGC
AGCTCACTGGTTATAGAATCCAGTTCCTCAGTTAGAGC
TGAAACGGACGCCATTTTGAGATCCGGGTTTT
ACCTGGGCTGCCCGAATCTTCTGCAGGACAGATTCCC
GTTGCTTCCTGGTCATTTTGAGATCCGGGTTTT
CTGGTTCTAAGAATACAGGAGCTAAGAAAAGAAAAATC
GATGATGCCCGGATCCCCGGGTTAATTAA
ATGCCCTGGTGGGCCTGGCCACGGAAGAGCTCCTGC
AGGTGGCCCGCCGGATCCCCGGGTTAATTAA
ACTGAAGACTGCGGGATTGCTCTCGGTCAAGCTTTTAA
AGAGGCCCTACTGAATTCGAGCTCGTTTAAAC
CTACAGGAGGTGGAAAGAGC

1301

1301-RECQL1-F6

CTGCTGTAGTCAGTGGGGAC

1302

1302-RECQL4-F5

TCAAGAGGCTGAGCAGCTTA

1357

1357-RECQL4+1051

1367

1367-BS-Q673R-F

1368

1368-BS-Q673R-R

1369

1369-BS-C878R-F

1370

1370-BS-C878R-R

1371

1371-BS-H963Y-F

1372

1372-BS-H963Y-R

1373

1373-BS-C1036F-F

AAAGCCTGTACGGTAAGCTG
GCATAATTTTAGAACTAATCGGCTAGAGGCGATCAATG
CTGC
GCAGCATTGATCGCCTCTAGCCGATTAGTTCTAAAATT
ATGC
GCCTAAAAAGGTGGCATTTGATCGCCTAGAATGGATC
AGAAAGC
GCTTTCTGATCCATTCTAGGCGATCAAATGCCACCTTT
TTAGGC
CGGACGTGCGATTTGTGATTTATGCATCTCTCCCTAAA
TCTGTGG
CCACAGATTTAGGGAGAGATGCATAAATCACAAATCGC
ACGTCCG
CTGTGAAAATATAACAGAATTCAGGAGAATACAGCTTT
TGGCC
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Oligo table continued
1374

1374-BS-C1036F-R

1375

1375-BS-C1055S-F

1376

1376-BS-C1055S-R

1377

1377-BS-C1055G-F

1378

1378-BS-C1055G-R

1379

1379-BS-C1055R-F

1380

1380-BS-C1055R-R

1381

1381-BS-C1066Y-F

1382

1382-BS-C1066Y-R

1383

1383-BS-D1063V-F

1384

1384-BS-D1063V-R

1415

1415-RECQL4+1092

GGCCAAAAGCTGTATTCTCCTGAATTCTGTTATATTTTC
ACAG
AATGGATTTAATCCTGATTTTTCTAAGAAACACCCAGAT
GTTTC
GAAACATCTGGGTGTTTCTTAGAAAAATCAGGATTAAA
TCCATT
AATGGATTTAATCCTGATTTTGGTAAGAAACACCCAGA
TGTTTC
GAAACATCTGGGTGTTTCTTACCAAAATCAGGATTAAA
TCCATT
AATGGATTTAATCCTGATTTTCGTAAGAAACACCCAGA
TGTTTC
GAAACATCTGGGTGTTTCTTACGAAAATCAGGATTAAA
TCCATT
CAGATGTTTCTTGTGATAATTACTGTAAAACAAAGGATT
ATAAA
TTTATAATCCTTTGTTTTACAGTAATTATCACAAGAAAC
ATCTG
CACCCAGATGTTTCTTGTGTTAATTGCTGTAAAACAAA
GGATTA
TAATCCTTTGTTTTACAGCAATTAACACAAGAAACATCT
GGGTG
GGTAGCACAGCAAAGTCTCG

1416

1416-RECQL4+1153

ACGGCAATGGGTATAGGT

1417

1417-BLM-seq-F1

CAAGACAGACTGTCTTCCAG

1418

1418-BLM-seq-F2

CACGTTTTGTTATTGATGAA

1419

1419-BLM-seq-R3

GTGTCGTGAATAAGCAGATC

1420

1420-BLM-seq-F4

TCAAAAGATCTTTTGTCAAA

1421

1421-BLM-seq-R5

CTGACACATTAGTTACAGAT

1422

1422-BLM-seq-F6

CTGGGCTGAAACACCAAGAC

1423

1423-BLM-seq-F7

1436

1436-BS-K695T-F

1437

1437-BS-K695T-R

1438

1438-BS-K695A-F

1439

1439-BS-K695A-R

1445

1445-BLM-seq-F9

1533

1533 - SGS1 PGAL R

CTGTCCAGCAGCAGAGGCCC
TGATGCCGACTGGAGGTGGTACGAGTTTGTGTTACCA
GCTCCC
GGGAGCTGGTAACACAAACTCGTACCACCTCCAGTCG
GCATCA
TGATGCCGACTGGAGGTGGTAGGAGTTTGTGTTACCA
GCTCCC
GGGAGCTGGTAACACAAACTCCTACCACCTCCAGTCG
GCATCA
CTGCTTTTCTATACCTATCA
TCCTTTAACCATTTGTGCTCCCTTCTTAAGTTATGTGAC
GGCTTCGTCACCATTTTGAGATCCGGGTTTT

1559

1534 - SGS1 5’ Chk for
PGAL
1559-BLM SEQ REV

1562

1562-pOBD2-RECQL1 F

1563

1563-pOBD2-RECQL1 R

1564

1564-pOBD2-RECQL4 F

1565

1565-pOBD2-RECQL4 R

1568

1568-BLM YES3-R
no-stop

1534

GCAATGCACATATAACAAGA
GCTGTAAACTTATCTGTCTA
AAGATACCCCACCAAACCCAAAAAAAGAGATCGAATTC
CAGCTGACCACCATGGCGTCCGTTTCAGCTCT
CTACGATTCATAGATCTCTGCAGGTCGACGGATCCCC
GGGAATTGCCATGTCAGGCATCATCGATTTTTC
AAGATACCCCACCAAACCCAAAAAAAGAGATCGAATTC
CAGCTGACCACCATGACCAGGAAGCAACGGGA
CTACGATTCATAGATCTCTGCAGGTCGACGGATCCCC
GGGAATTGCCATGTCAGCGGGCCACCTGCAGGA
TAAGGCGGCCGCTTTGAGAATGCATATGAAGGCT
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Oligo table continued
1569

1569-BLM YES3-R

TAAGGCGGCCGCTTTTATGAGAATGCATATGAAG

1570

1570-BLM YES3-F

1586

1586-SGS1-BLM-647F

1617

1617_BLM_pYES_F

1618

1618_BLM_pYES_R_nost
op

1688

1688-SGS1n647-Recql4

1690

1690_SGS1n647-recql1

1758

1758-pOAD-spec-F

CTTAGAGCTCATGGCTGCTGTTCCTCAAAA
ATGAGGAAGACGATTTTGATGACGATTTTTCATTAAGT
GATATAGTGAGTAGTTTTCCTCATACAAAGGA
GCAGCTGTAATACGACTCACTATAGGGAATATTAAGCT
TGGTACCGAGCTATGGCTGCTGTTCCTCAAAA
AGAGGGTTAGGGATAGGCTTACCTTCGAAGGGCCCTC
TAGACTCGAGCGGTGAGAATGCATATGAAGGCT
ATGAGGAAGACGATTTTGATGACGATTTTTCATTAAGT
GATATAGTGAGTATGACCAGGAAGCAACGGGA
ATGAGGAAGACGATTTTGATGACGATTTTTCATTAAGT
GATATAGTGAGTATGGCGTCCGTTTCAGCTCT
AATACCACTACAATGGATGATG

1759

1759-pOAD-spec-R

TGCACGATGCACAGTTGAAG

1797

1797-pACT2AD-F

AATACCACTACAATGGATGA

1798

1798-pACT2-R

TGAAAAACCCCGCAAGTTCA

1941

1941-blmR717T-F

GTCATTTCTCCCTTGACATCACTTATCGTAGATC

1942

1942-blmR717T-R

GATCTACGATAAGTGATGTCAAGGGAGAAATGAC

1943

1943-blmQ752H-F

CAAATATTTACCTCCACTTATCAAAAAAAGACC

1944

1944-blmQ752H-R

GGTCTTTTTTTGATAAGTGGAGGTAAATATTTG

1945

1945-blmR791C-F

GAGGAAGCTCTTGGCATGTTTTGTTATTGATG

1946

1946-blmR791C-R

CATCAATAACAAAACATGCCAAGAGCTTCCTC

1947

1947-blmA1043D-F

GAATACAGCTTTTGGACTACTTTGGTGAAAATG

1948

1948-blmA1043D-R

CATTTTCACCAAAGTAGTCCAAAAGCTGTATTC

1949

1949-blmE1213K-F

GTGTCTCAGAGGGAAAAGATGGTTAAAAAATG

1950

1950-blmE1213K-R

CATTTTTTAACCATCTTTTCCCTCTGAGACAC

1951

1951-blmP690L-F

GTTTTATCCTGATGCTGACTGGAGGTGGTAA

1952

1952-blmP960L-R

TTACCACCTCCAGTCAGCATCAGGATAAAAC

1953

1953-blmV1198M-F

CAGAAAATTCCAGCAGTATGAAAAAACAAAAAGC

1954

1954-blmV1198M-R

GCTTTTTGTTTTTTCATACTGCTGGAATTTTCTG

1955

1955-blmH1324Y-F

GAAATACCCGTATCTTCCTACTACTTTGCAAGTAAAAC

1956

1956-blmH1324Y-R

1957

1957-blmX47-3F

1958

1958-blmX47-3R

1959

1959-blmX48-15F

1960

1960-blmX48-15R

GTTTTACTTGCAAAGTAGTAGGAAGATACGGGTATTTC
GACTTATAATGATGGAAAAAAGATGGAAACCATCATAC
AAG
CTTGTATGATGGTTTCCATCTTTTTTCCATCATTATAAG
TC
GTCCAGCAGCAGAGGCCCGGAAGAAGTGCCGCTGAG
G
CCTCAGCGGCACTTCTTCCGGGCCTCTGCTGCTGGAC

1961

1961-blmP868L-F

GAAATACTATGTATTACTGAAAAAGCCTAAAAAG

1962

1962-blmP868L-R

CTTTTTAGGCTTTTTCAGTAATACATAGTATTTC

1975

1975-pact2ADF

ACCACTACAATGGATGATGT

2012

2012-AIMP2-5'CHK

GGTTTGCGTTGATCACGATG

2013

2013-AIMP2-3'CHK

AACCTTCTCAAGTGCTTTGG

2043

2043-BLM-658F

CAAAGGAAATGATGAAGACTTTTCATAAAAAATTTGG

2044

2044-BLM-843F

GTACAGAAGGACATCCTGATTCAGCTGAAGATTCTCAG

2045

2045-BLM-1331F

CTTTGCAAGTAAAACCGGAAATGAAAGGAAGAGG
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Oligo table continued
2046

2046-BLM-778F

GCAAGTAACAGACTCATTTGTACTCTGGAGAATCTC

2047

2047-BLM-995F

CCTGCTTTTCTATACCCATCATGATGTGACCAGAC

2048

2048-BLM-873F

ACCGAAAAAGCCTAAAAACGTGGCATTTGATTGCC

2049

2049-BLM-1387F

GCCTCACATACTTCTAAAGCGACATCAGGAGCC

2050

2050-BLM-1133F

GTCAGGTATATTTGGAGAAGGATCTGCTTATTCAC

2051

2051-BLM-1143F

TTCACGACACAATGCCAAAAGACTTTTTAAAAAGC

2052

2052-BLM-658R

CCAAATTTTTTATGAAAAGTCTTCATCATTTCCTTTG

2053

2053-BLM-843R

CTGAGAATCTTCAGCTGAATCAGGATGTCCTTCTGTAC

2054

2054-BLM-1331R

CCTCTTCCTTTCATTTCCGGTTTTACTTGCAAAG

2055

2055-BLM-778R

GAGATTCTCCAGAGTACAAATGAGTCTGTTACTTGC

2056

2056-BLM-995R

GTCTGGTCACATCATGATGGGTATAGAAAAGCAGG

2057

2057-BLM-873R

GGCAATCAAATGCCACGTTTTTAGGCTTTTTCGGT

2058

2058-BLM-1387R

GGCTCCTGATGTCGCTTTAGAAGTATGTGAGGC

2059

2059-BLM-1133R

GTGAATAAGCAGATCCTTCTCCAAATATACCTGAC

2060

2060-BLM-1143R

GCTTTTTAAAAAGTCTTTTGGCATTGTGTCGTGAA

2073

2073-BLM-803F

CACATTGTGTCAGTCAGCGGGGACATGATTTTCGTC

2074

2074-BLM-811F

GATTTTCGTCAAGATTGCAAAAGAATGAATATGC

2075

2075-BLM-972F

2076

2076-BLM-1014F

2077

2077-BLM-660F

CCCTAAATCTGTGGAGGTTTACTACCAAGAATCTG
GAAAAAGATGGAAACCATCGTACAAGAGAAACTCACTT
C
GAAATGATGAAGACTTTTTATAAAAAATTTGGCCTG

2078

2078-BLM-1120F

2079

2079-BLM-857F

2080

2080-BLM-707F

2081

2081-BLM-755F

2082

2082-BLM-803R

GGTCGACATTTTCTTGGAGAGTAAGAGTGCAAAAATC
GTGTTTAGCATGAGCTTGAACAGACATAATCTGAAATA
C
CCCTGCCTGTGTTTCTCTTGGGGTCACTGTTGTCATTT
C
CAAATATTTACCTCCAGTTATCAGAAAAAGACCCAATC
ATAAAAC
GACGAAAATCATGTCCCCGCTGACTGACACAATGTG

2083

2083-BLM-811R

GCATATTCATTCTTTTGCAATCTTGACGAAAATC

2084

2086

2084-BLM-972R
CAGATTCTTGGTAGTAAACCTCCACAGATTTAGGG
2085-BLM-1
GAAGTGAGTTTCTCTTGTACGATGGTTTCCATCTTTTTC
014R
2086-BLM-660R
CAGGCCAAATTTTTTATAAAAAGTCTTCATCATTTC

2087

2087-BLM-1120R

2088

2088-BLM-857R

2089

2089-BLM-707R

2090

2090-BLM-755R

2110

2110-BLM-707-F2

GATTTTTGCACTCTTACTCTCCAAGAAAATGTCGACC
GTATTTCAGATTATGTCTGTTCAAGCTCATGCTAAACA
C
GAAATGACAACAGTGACCCCAAGAGAAACACAGGCAG
GG
GTTTTATGATTGGGTCTTTTTCTGATAACTGGAGGTAA
ATATTTG
CTGCCTGTGTTTCTCTTGGGGTCACTGTTGTCATTTC

2111

2111-BLM-707-R2

GAAATGACAACAGTGACCCCAAGAGAAACACAGGCAG

2112

2112-BLM-873-F2

CCGAAAAAGCCTAAAAACGTGGCATTTGATTGCCTAG

2113

2113-BLM-873-R2

2114

2114-BLM-843-F2

CTAGGCAATCAAATGCCACGTTTTTAGGCTTTTTCGG
CAGAAGGACATCCTGATTCAGCTGAAGATTCTCAGAC
C

2085
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Oligo table continued
2115

2115-BLM-843-R2

GGTCTGAGAATCTTCAGCTGAATCAGGATGTCCTTCTG

2116

2116-BLM-660-F2

GAAATGATGAAGATTTTTTATAAAAAATTTGGCCTGC

2117

2117-BLM-660-R2

GCAGGCCAAATTTTTTATAAAAAATCTTCATCATTTC

2118

2118-traf3ip1 3'chk

TTACAATGTTATTATCCAGC

2119

2119-traf3ip1 5'chk

ACGTGCGGAGCTTCTCTATC

2120

2120-c10 137 3'chk

GTACCTCGGTATTAACAGAC

2121

2121-c10 137 5'chk

2140

2140-BLM-660F3

2141

2141-BLM-660R3

2147

2147 - Sgs1Seq11F

GCAGGTGGACGATAACGTTG
CATACAAAGGAAATGATGAAGATTTTTTATAAAAAATTT
GGCC
GGCCAAATTTTTTATAAAAAATCTTCATCATTTCCTTTG
TATG
ACCACTACAATGGATGATGT

2148

2148 - Sgs1Seq12F

TCTGCCCAGCCCCTTGGAAT

2149

2149 - Sgs1Seq13F

TGCCCATTCCAGCTACATGA

2150

2150 - Sgs1Seq14F

CTCAGAACAATGCAAGAGAG

2151

2151 - Sgs1Seq15F

ATAGAATGGTTCCTCCAGTT

2152

2152 - Sgs1Seq3R

AGGCCTGAAATCGTGGCCCC

2153

2153 - Sgs1Seq4R

AGTACTTTGGGCAATCCCAT

2209

2209-blmG1120R-F

GTCGACATTTTCTTGAGGAGTAAGAGTGCAA

2210

2210-blmG1120R-R

TTGCACTCTTACTCCTCAAGAAAATGTCGAC

2287

2287-DNAJC7

CTGCATGGACCGTGCCCTAG

2288

2288-RORC

CTGACAGAGATAGAGCACCT

2289

2289-CLU

CCAGCATCATAGACGAGCTC

2290

2290-MNAT1

ACAATGTGGATTTGGACAAC

2291

2291-NISCH

GTGCTCATGGGCTACCAGAC

2292

2292-ACTL7B

GTGTGGCGGCTGCACTATGC

2293

2293-MRPL38

TCCACGGTGCCACCTTTGTG

2294

2294-PSMB9

GGTATATGGAACCCTGGGAG

2321

2321-Sgs1-P701L-F

GTTTTTGTTCTTATGCTAACAGGGGGTGGTAAATCTC

2322

2322-sgs1-P701L-R

GAGATTTACCACCCCCTGTTAGCATAAGAACAAAAAC

2323

2323-sgs1-I732T-F

GTCATCTCTCCGCTAACTTCCCTGATGCAAGATCAAG

2324

2324-sgs1-I732T-R

CTTGATCTTGCATCAGGGAAGTTAGCGGAGAGATGAC

2325

2325-sgs1-R804C-F

CAGACGGTAAGTTGGCTTGTATTGTTGTAGATGAAG

2326

2326-sgs1-R804C-R

CTTCATCTACAACAATACAAGCCAACTTACCGTCTG

2327

2327-sgs1-W816R-F

CACATTGTGTTTCTAACCGGGGCCACGATTTCAGGC

2328

2328-sgs1-W816R-R

2329

2329-sgs1-Y824C-F

2330

2330-sgs1-Y824C-R

2331

2331-sgs1-F870L-F

GCCTGAAATCGTGGCCCCGGTTAGAAACACAATGTG
GGGGCCACGATTTCAGGCCTGATTGTAAAGAATTAAAA
TTTTTC
GAAAAATTTTAATTCTTTACAATCAGGCCTGAAATCGTG
GCCCC
GTTTTCCTAAAACAAAGTCTTAATAGAACAAATTTG

2332

2332-sgs1-F870L-R

2333

2333-sgs1-K881L-F

CAAATTTGTTCTATTAAGACTTTGTTTTAGGAAAAC
CAAATTTGTATTACGAAGTAAACCTGAAGACCAAAAAT
ACC
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Oligo table continued
2334

2334-sgs1-K881L-R

2335

2335-sgs1-G983V-F

2336

2336-sgs1-G983V-R

2337

2337-sgs1-G1115R-F

GGTATTTTTGGTCTTCAGGTTTACTTCGTAATACAAATT
TG
GTTCCCCGAACATTAGAAGTCTATTATCAAGAAACCGG
CCG
CGGCCGGTTTCTTGATAATAGACTTCTAATGTTCGGGG
AAC
GCCAAGATGTCTTTAAACGTTCGAGAAGCTCC

2338

2338-sgs1-G1115R-R

GGAGCTTCTCGAACGTTTAAAGACATCTTGGC

2341

2341-sgs1.P701L-F

GTTTTTGTTCTTATGCTAACAGGGGGTGGTAAA

2342

2342-sgs1.P701L-R

TTTACCACCCCCTGTTAGCATAAGAACAAAAAC

2343

2343-sgs1.I732T-F

GTCATCTCTCCGCTAACTTCCCTGATGCAAGATC

2344

2344-sgs1.I732T-R

GATCTTGCATCAGGGAAGTTAGCGGAGAGATGAC

2345

2345-sgs1.R804C-F

GACGGTAAGTTGGCTTGTATTGTTGTAGATG

2346

2346-sgs1.R804C-R

CATCTACAACAATACAAGCCAACTTACCGTC

2347

2347-sgs1.W816R-F

CATTGTGTTTCTAACCGGGGCCACGATTTCAG

2348

2348-sgs1.W816R-R

CTGAAATCGTGGCCCCGGTTAGAAACACAATG

2349

2349-sgs1.Y824C-F

GATTTCAGGCCTGATTGTAAAGAATTAAAAT

2350

2350-sgs1.Y824C-R

ATTTTAATTCTTTACAATCAGGCCTGAAATC

2351

2351-sgs1.F870L-F

CCTAAAACAAAGTTTGAATAGAACAAATTTGTA

2352

2352-sgs1.F870L-R

TACAAATTTGTTCTATTCAAACTTTGTTTTAGG

2353

2353-sgs1.K881L-F

GTATTACGAAGTAAACCTGAAGACCAAAAATACC

2354

2354-sgs1.K881L-R

GGTATTTTTGGTCTTCAGGTTTACTTCGTAATAC

2355

2355-sgs1.G983V-F

CCCCGAACATTAGAAGTCTATTATCAAGAAAC

2356

2356-sgs1.G983V-R

GTTTCTTGATAATAGACTTCTAATGTTCGGGG

2357

2357-sgs1.G1115R-F

CAAGATGTCTTTAAACGTTCGAGAAGCTCCA

2358

2358-sgs1.G1115R-R

TGGAGCTTCTCGAACGTTTAAAGACATCTTG
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Appendix C: Plasmid Table
Plasmid ID
pRS415
p2823112
p3634266
pKHS229
pKHS230
pKHS235
pKHS236
pKHS257
pKHS337
pKHS338
pKHS339
pKHS340
pKHS344
pKHS345
pKHS346
pKHS392
pKHS401
pKHS402
pKHS403
pKHS404
pKHS408
pKHS481
pKHS487
pKHS560
pKHS562
pKHS564
pKHS566
pKHS567
pKHS569
pKHS572
pKHS574
pKHS577
pRS303
pRS304
pYES3/ct

Description
CEN/ARS, LEU2
pOBT7-RECQL1
pOBT7-RECQL4
pFA6a-13Myc-kanMX6
pFA6a-13Myc-TRP1
pFA6a-kanMX6-PGAL1
pFA6a-TRP1-PGAL1
pFA-kanMX
pCR2.1-HIS3MX6
pOBT7-RECQL1.HIS3
pOBT7-RECQL1.HIS3
pOBT7-RECQL1.HIS3
pOBT7-RECQL4.HIS3
pOBT7-RECQL4.HIS3
pOBT7-RECQL4.HIS3
pBDC
pBDC-RECQL1
pBDC-RECQL1
pBDC-RECQL4
pYES3/CT-BLM
pBDC-BLM
pRS415-SGS1
pOAD
pRS415-sgs1-P701L
pRS415-sgs1-I732T
pRS415-sgs1-R804C
pRS415-sgs1-W816R
pRS415-sgs1-Y824R
pRS415-sgs1-F870L
pRS415-sgs1-K881L
pRS415-sgs1-G983V
pRS415-sgs1-G1115R
HIS3
TRP1
2µ origin, TRP1

Source
(Sikorski and Hieter 1989)
Open Biosystems
Open Biosystems
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Longtine, McKenzie et al. 1998)
(Goldstein and McCusker 1999)
this study
this study
this study
this study
this study
this study
this study
(Uetz, Giot et al. 2000)
this study
this study
this study
this study
this study
(Mullen, Kaliraman et al. 2000)
(Uetz, Giot et al. 2000)
this study
this study
this study
this study
this study
this study
this study
this study
this study
(Sikorski and Hieter 1989)
(Sikorski and Hieter 1989)
Invitrogen
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Appendix E: Chapter 4.2 supplementary figures
SC-LEU-TRP

SC-LEU-TRP-HIS

SC-LEU-TRP-HIS+3AT

Plate 1

Plate 2

Plate 3

Plate 4

Figure E.1 Re-evaluation of candidates 1 through 384 obtained from the initial
screen for RecQL4 interacting proteins
To reduce the number of false positives the initial 1200 candidates were re-evaluated on
(from left to right) SC-LEU-TRP, SC-LEU-TRP-HIS, and SC-LEU-TRP-HIS+3AT agar
plates. The SC-LEU-TRP agar plates controlled for the presence of both bait and prey
plasmids, the SC-LEU-TRP-HIS agar plates provided low stringency selection for
protein-protein interactions, and the SC-LEU-TRP-HIS+3AT agar plates provides a more
stringent selection for protein-protein interactions. Colonies that appeared on
SC-LEU-TRP-HIS+3AT agar plates were selected for Western blot analysis to confirm
expression of the cDNA insert.
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SC-LEU-TRP

SC-LEU-TRP-HIS

SC-LEU-TRP-HIS+3AT

Plate 5

Plate 6

Plate 7

Plate 8

Figure E.2 Re-evaluation of candidates 385 through 768 obtained from the initial
screen for RecQL4 interacting proteins
To reduce the number of false positives the initial 1200 candidates were re-evaluated on
(from left to right) SC-LEU-TRP, SC-LEU-TRP-HIS, and SC-LEU-TRP-HIS+3AT agar
plates. The SC-LEU-TRP agar plates controlled for the presence of both bait and prey
plasmids, the SC-LEU-TRP-HIS agar plates provided low stringency selection for
protein-protein interactions, and the SC-LEU-TRP-HIS+3AT agar plates provides a more
stringent selection for protein-protein interactions. Colonies that appeared on
SC-LEU-TRP-HIS+3AT agar plates were selected for Western blot analysis to confirm
expression of the cDNA insert.
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SC-LEU-TRP

SC-LEU-TRP-HIS

SC-LEU-TRP-HIS+3AT

Plate 9

Plate 10

Plate 11

Plate 12

Plate 13

Figure E.3 Re-evaluation of candidates 769 through 1200 obtained from the initial
screen for RecQL4 interacting proteins
To reduce the number of false positives the initial 1200 candidates were re-evaluated on
(from left to right) SC-LEU-TRP, SC-LEU-TRP-HIS, and SC-LEU-TRP-HIS+3AT agar
plates. The SC-LEU-TRP agar plates controlled for the presence of both bait and prey
plasmids, the SC-LEU-TRP-HIS agar plates provided low stringency selection for
protein-protein interactions, and the SC-LEU-TRP-HIS+3AT agar plates provides a more
stringent selection for protein-protein interactions. Colonies that appeared on
SC-LEU-TRP-HIS+3AT agar plates were selected for Western blot analysis to confirm
expression of the cDNA insert.
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K
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1"A5
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Figure E.3 Western blot analysis of the 166 candidates identified in the screen of
human testis cDNA library for RecQL4 interacting proteins
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Cells were grown to an OD600 = 0.5 in SC-LEU-TRP, and whole- cell extracts were
prepared from 5 ml of culture (3.5 × 107 cells) by standard TCA extraction to confirm
expression of DNA activation domain and the testis cDNA library (Foiani, Liberi et al.
1999). 10 µμl of TCA extract was separated on 10% SDS-PAGE, transferred to a PVDF
membrane (Bio-Rad), probed with anti-AD monoclonal antibody (Santa Cruz), and
visualized by chemiluminescence (ECL Plus, GE Healthcare). Molecular weight marker
(Broad Range) was obtained from Bio-Rad. The table to the right of each blot provides
the name of each candidate and the corresponding molecular weight of the encoded
peptide.
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Appendix F: Chapter 6 supplementary figures
Figures F Patch assay for the analysis of gross-chromosomal rearrangements
(GCR)
Panels 1 through 11 show the 1000 independent transformation analyzed by the patch
assay. The previously described GCR assay (Schmidt, Pennaneach et al. 2006) was
modified for the purposes of this screen. Yeast transformants harboring mutagenized
pKHS404 plasmids were positively selected for by plating on SC-TRP agar plates. To
induce BLM expression from the GAL1 promoter, colonies were picked at random from
the transformation plate and streaked (1 cm long) on an SC/Gal-TRP plate followed by
four days of incubation at 30˚C. Each streak was then patched as a 1” by 1” square on a
fresh SC/Gal-TRP agar plate and incubated for four days. This plate is referred to as the
master plate and is used to recover the mutated plasmid of interest. The patched plates
are then replica-plated onto a GCR/Gal agar plate to screen for loss of accumulation of
GCRs. In this media, dextrose was substituted with galactose.
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